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Introduction
Intro d u c t io n
The most c o m m o n  typ e  of hea ring  im pa irm en t is sensorineural hearing  
loss. Its e tio log y  lies m a in ly  in a  dysfunction of th e  co ch le a . Hearing c an  
usually b e  re hab ilita ted  by m eans of a  hea ring  a id  beh ind  the  e a r  o r in 
the  e a r  cana l.
A less co m m on  typ e  of hea ring  im pa irm en t is c o n d uc tive  hea ring  loss. 
This is mostly caused  by a  dysfunc tiona l m idd le  e a r  bu t som etim es by an  
o c c lu d e d  ex te rna l e a r cana l, as in co ng en ita l au ra l atresia. Sound is no
Figure 1; Schematic artist's impression of bone conduction with a Bone 
anchored hearing aid. 1) BAHA sound processor; 2) Abutment; 3) Implant; 4) 
stapes fixed on the oval window; 5) round window; 6) Basilar membrane; 7)
The cochlea comprises three fluid components; the scala vestibuli and scala 
tympani containing perilymph and the scala media containing endolymph; 8) 
longitudinal fluid wave.
lo nge r transm itted  to the  c o c h le a  effic iently, resulting in an  ove ra ll 
d a m p in g  of th e  sound. Patients w ith  a  pu re  o r m ixed co n d u c tiv e  hearing  
loss h a ve  severa l options for rehab ilita tion . They m a y  b e  e lig ib le  for 
reconstruc tive  surgery; if not, an  a ir co nduc tio n  hea ring  a id  m a y  be  
ap p ro p ria te . In som e cases these pa tien ts c a n n o t use a ir co nduc tio n  
hearing  aids b ecause  of co ng en ita l m a lfo rm ations of th e  o u te r and  
m idd le  e a r  o r recu rren t otitis, mostly d u e  to the  o cc lud ing  earm olds. An 
op tion  for these patien ts is a  bone  co nduc tio n  hea ring  a id. Briefly, a 
bone  co nduc tio n  d e v ic e  transmits sound as v ib rations th rough  the  skull 
d irec tly  to  the  co ch le a , bypassing the  o u te r and  m idd le  e a r (Figure 1). 
The Bone an cho red  hearing  a id  (BAHA) comprises an  ex te rna lly  w orn
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a ud io  processor fas tened  to the  skull b y a  surg ica lly inserted 
pe rcu taneous  coup ling . This coup ling  consists of a  skin-penetrating 
a b u tm e n t c o n n e c te d  to an  im p lan te d  fixture b y  m eans of an  inne r 
sc rew  (Figure 1). S ince it a llows b e tte r speech  unde rs tand ing  than  
co nven tio na l b one  co n d u c to r devices, th e  BAHA is now  the  go ld  
s tanda rd  for these pa tien ts .1
In N ijm egen  the  first th ree  patien ts w e re  fitted  w ith  a  BAHA in June  1988. 
This w as the  starting po in t of m o re  than  20 years of c lin ica l a nd  
aud io lo g ica l research resulting in o ve r 50 pub lica tions on various BAHA 
re la ted  fields a nd  up  to  now  four PhD theses. In add itio n  tw o  PhD theses 
from  the  B irm ingham  BAHA te a m  h a ve  b een  d e fe n d e d  in N ijm egen. The 
N ijm egen  PhD theses a re  listed be low .
1995 EAM Mylanus
The Bone Anchored hearing aid, clinical and audiological aspects
1998 CTM van der Pouw
Bone anchored hearing, short and long term results
2002 SN Dutt
The Birmingham Bone Anchored Hearing Aid Programme, Some audiological 
and quality of life outcomes
2005 MKS Hol
BAHA - New indications and long-term patient satisfaction
2008 A-L McDermott
The benefit and success of BAHA (bone anchored hearing aids)
2008 S Kunst
BAHA, evaluation of extended indications such as mental retardation and 
unilateral hearing impairment
The present thesis is th e  fifth BAHA PhD thesis o rig ina ted  in N ijm egen. It 
presents a  c lin ica l e va lu a tio n  of th e  linea r incision te c hn iq ue  th a t was 
d e ve lo p e d  in N ijm egen  a nd  refined  th e re  o ve r the  past 15 years. The 
studies h a ve  focused on the  p ed ia tr ic  popu la tio n  as w e ll as the  (older) 
a d u lt popu la tion .
Before describ ing the  key featu res of BAHA surgery and  p a tie n t o u tc o m e  
measures, som e backg ro und  in fo rm ation  is p ro v id ed  on bone  
co nduc tio n  phys io logy a n d  osseo integration. The key fea tu res com prise 
a  historical o ve rv ie w  of the  surg ical techn iques, c lin ica l ou tcom es in 
adults, ch ild ren  a n d  older-adults. Finally, th e  p a tie n t o u tc o m e  measures 
a re  in troduced .
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Introduction
Bo n e  c o n d u c t io n  ph ys io lo g y
The p rinc ip le  of a ud ito ry  p e rcep tio n  is th a t sensory cells a re  e ffec tive ly  
s tim u la ted  w he n  an  acoustic  signal is p resented. These sensory cells, or 
inne r ha ir cells, d irec tly  a c t iv a te  the  (auditory) ne rve  fibers. As pa rt of the  
basila r m em b rane , the  ha ir cells d e te c t deflections of this m em b rane . 
M o ve m e n t of th e  basila r m em b rane , w h ich  is caused  by sound 
stimulation, c an  b e  a c h ie ve d  in tw o  ways: v ia  the  a ir conduc tio n  
p a th w a y  and  v ia  the  bone  co nduc tio n  p a thw ay .
Figure 2: Schematic artist's impression of three phenomena describing bone 
conduction physiology: 1) Sound energy radiation concept; 2) Bone 
conduction concept. 3) Bone compression concept.
In th e  a ir co nd uc tio n  p a th w a y , th e  acoustic  signal trave ls th rough  the  
ex te rna l e a r  c a n a l a nd  is transfo rm ed into v ib rations by the  ea rd rum . 
These v ib rations a re  transm itted  to the  c o c h le a  v ia  the  m idd le  e a r 
ossicles. The third ossicle, c a lle d  the  stapes, is c o n n e c te d  to the  sca la  
tym p an i b y  the  o va l w in d o w  (Figure 1). The v ib ra ting  stapes induces a 
long itud ina l fluid w a ve , tra ve ling  from  the  o va l w in d o w  to  the  (h ighly 
m obile) round  w indow . As the  fluid moves, in respec tive ly  th e  up p e r and  
low e r sca la  (scala vestibuli a nd  sca la  tym pan i), it p roduces a  'trave ling  
w a ve ' of th e  basila r m em b rane , w ith  a  freq uenc y  specific  p a tte rn  
(Figure 1). It is this basila r m o ve m e n t th a t stimulates the  sensory ha ir cells.
13
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As yet, th e  b o ne  c o n d uc tio n  p a th w a y  is no t en tire ly  understood. Bone 
co nduc tio n  hearing  is a  result of v ib ra tion  of th e  skull bone, e.g. by a 
v ib ra to r p la c e d  beh ind  the  ear. The skull transmits such v ib rations w ith  
re la tive ly  high effic iency. V ib ra tions of th e  bony c o c h le a r shell cause  the  
fluids in the  c o c h le a  to v ib ra te . This fluid is incom pressib le, so in p rinc ip le  it 
should v ib ra te  in phase  w ith  the  bone. But in e ffe c t th e  c o c h le a  has tw o  
m ob ile  w indows; the  o va l a nd  round w indow . The ine rtia  of th e  inner-ear 
fluids will result in long itud ina l fluid w aves  from  one  w in d o w  to the  o ther, 
causing  the  basila r m e m b ra n e  to v ib ra te , as in a ir co nduc tio n  
transmission (Figure 1). Furtherm ore th e re  a re  severa l o the r m echan ism s 
(described b y  Tonndorf 1966) th a t co n trib u te  to the  stim ulation of the  
co ch lea , these a re  desc ribed  be low .2
First, th e  c o c h le a r fluids a re  go ve rn ed  by ine rtia  as exp la in ed  a b o ve  
(Figure 1).
Second , w he n  a  v ib ra tion  is transm itted  to the  skull, en e rg y  is ra d ia te d  
into the  ex te rna l e a r  c a n a l by its v ib ra ting  bony a nd  ca rtilag inous walls. 
This acoustic  signal is processed v ia  the  a ir co nduc tio n  p a th w a y  (Figure 
2).
Third, ow ing  to the  inertia  of the  m idd le  e a r ossicles the  v ib ra ting  skull 
bone  results in pendu ling  ossicles. This e ffe c t occurs a t its ow n 
cha rac te ris tic  freq uenc y  (in hum ans ap p ro x im a te ly  2 kHz) and , 
subsequently, th e  inne r e a r  is s tim u la ted  in the  no rm a l w a y  (Figure 2).
Fourth, th e  walls of th e  c o c h le a  b e c o m e  com pressed. W hen  the  bone  
surrounding the  inner-ear fluid co m pa rtm en ts  vib rates, th e  fluid 
co m pa rtm en ts  them selves will b e  com pressed. These co m pa rtm en ts  
h a ve  d iffe ren t vo lum es; the  sca la  vestibuli is re la tive ly  la rg e  c o m p a re d  to 
the  sca la  tym p an i b ecause  of th e  fluid co nnec tio n  b e tw e e n  the  sca la  
vestibuli a nd  the  vestibu le. Thus, in the  p resence  of m ob ile  c o c h le a r 
w indows, the  com pression will le ad  to d isp lacem en t of fluid a n d  the  
basila r m em b rane . As the  up p e r sca la  (scala vestibuli, c o n n e c te d  to the  
vestibu le), is m uch la rge r than  the  sca la  tym p an i (Figure 2).
Fifth, the  c ran ium  is c o n n e c te d  to the  c o c h le a  a t severa l points. A n y  
vib rations in the  ce reb rosp ina l fluid caused  by skull v ib rations c a n  re ach  
the  c o c h le a  th rough these connec tions. They c an  then  in d uc e  an  
ad d itio na l long itud ina l fluid w a v e  there. However, this will on ly  o c cu r if 
th e  c o c h le a r w indow s a re  m obile.
Bone co nduc tio n  hearing  works bu t is fa r less e ffe c tive  than  a ir 
conduc tio n .9 It p roduces the  sam e typ e  of stim ulation as a ir conduc tion .
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W hen  a  pu re  to ne  is transm itted  v ia  bone  co nduc tio n  it c a n  b e  
c a n c e lle d  by s im u ltaneously p resenting a  to ne  w ith  the  sam e freq uency  
v ia  a ir co nduc tio n  of th e  sam e p e rc e ived  m a g n itu d e  (in dB HL).
H istorical o v e r v ie w  of  the o sseo-in teg ratio n  c o n c e p t
The term  osseo in tegration m eans “d irec t c o n ta c t b e tw e e n  living bone  
and  an  im p lan t su rface” a nd  w as co in c id en ta lly  d iscove red  by Per- 
Ingva r B rânem ark. In 1950 this bio logist d iscove red  th a t th e  titan ium  
inspection cham be rs  he used to obse rve  red  b lood  cells in the  bone  
m a rrow  of rats w e re  fixed to the  bone  a nd  cou ld  not b e  rem oved . It was 
not until the  e a rly  1960s th a t he  c o n d u c te d  fu rthe r research  on this 
p h e n o m e n o n .10 It led to  the  in troduc tion  of osseo in teg ra ted  titan ium  
im p lants for d e n ta l prostheses in 1965.12 The osseo in teg ration  c o n c e p t 
w as stud ied extens ive ly by the  b iom ate ria ls  g roup  a t th e  D e p a rtm en t of 
B iomateria ls and  H and icap  Research, w ith in  the  Institute (BHI) of Surg ical 
Sciences, G o thenb u rg  University, Sw eden. They found  th a t th e  c lin ica l 
success of osseo in teg ra ted  titan ium  im plants in dentistry d epends  on 
severa l factors.
1. Commercially pure titanium is the best material to use.13
2. A screw shaped implant results in the largest bone-to-metal surface without 
fibrous tissue.14
3. The screw surface blasted for 75 micro meter is the most stable.15
4. Bone condition must be optimal, e.g. no irradiation or infection present.16
5. Bone is heat-sensitive, so during surgery the temperature should not rise over 
47°C for more than one minute.17
6. Direct loading does not stimulate the osseointegration process.1
Professor Hallén of Sah lg renska University Hospital in Sw eden  w as the  first 
to a tta c h  a  b o ne  co nduc tio n  transduce r to a  pa tien t's  d e n ta l im p lan t. 
Thereby, th e  first step had  b een  ta ken  to w a rd  hea ring  rehab ilita tion  
th rough  this system. In 1977 Tjellström fitted the  first pa tien ts using the  
B rânem ark im p lan t to  a p p ly  a  BAHA.18 This w as the  first t im e  a  titan ium  
im p lan t w as used outs ide the  ora l cav ity .
15
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H istorical o v e r v ie w  of  BAHA surgery
In essence BAHA surgery has tw o  m a jo r goals: p la c e m e n t of an  im p lan t 
c a p a b le  of op tim a l osseo in teg ration  a nd  p repa ra tio n  of an  im p lan t site 
th a t m inim izes the  o c cu rre nce  of soft tissue reactions surround ing the  
im p lan t in the  future. To e n a b le  op tim a l osseo integration, th e  bone  
should b e  traum a tized  as little as possible. The te m p e ra tu re  of th e  bone  
during  drilling should not rise o ve r 47°C for m o re  than  o ne  m inute. 
Therefore, th e  surgeon must on ly  use sharp  drills. M o reove r, th e  drill speed  
should b e  low, b e tw e en  1500 and  3000 rounds pe r m inu te .8 The 
p la c e m e n t of the  im p lan t itself should b e  d o n e  a t a  ro ta tion  speed  of 
b e tw e en  8 and  15 rpm . During the  en tire  drilling p ro ced u re  coo ling  is 
necessary by m eans of sa line irrigation.8 To m in im ize the  o c cu rre n ce  of
Figure 3: Schematic illustration of fixture placement.16
post o p e ra tiv e  soft tissue reactions a round  the  pa rt of th e  im p lan t th a t 
pene tra tes  the  skin (abu tm en t), tissue m o ve m e n t should b e  restric ted .19 
S ubcu taneous tissue reduc tion  is d o n e  to p re ven t soft tissue m o ve m e n t 
and  the  subsequen t d e ve lo p m e n t of scar tissue a nd  in fec tion  a round  
the  im p lan t. Also ha ir follicles in an  a re a  of a p p ro x im a te ly  1 to  3 cm  
surrounding the  im p lan t should b e  rem o ved  to a vo id  a c cum u la tio n  of 
debris a nd  skin irritation. The a im  is to  p ro v id e  a  thin hairless skin site th a t 
c an  a tta c h  itself firm ly to  the  d e e p e r bony  layer.
16
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G o th e n b u rg
The initial BAHA surg ical te c hn iq ue  was d e ve lo p e d  in G o thenbu rg , 
Sw eden  and  w as desc ribed  b y  Tjellström in 1981.18 A t th a t tim e  14 
patien ts w e re  im p lan ted  in tw o  surg ical sessions a t an  in te rva l of th ree  to 
four months. In the  first session a  re tro au ricu la r incision w as m ade , just 
b e lo w  the  linea tem pora lis, incising the  periosteum  as well. A burr ho le  of 
a p p ro x im a te ly  4 to  6 m m  d e e p  w as p rep a re d  and  w as subsequen tly  
th re a d e d  w ith  a  titan ium  tap . Next, th e  im p lan t w as p la ced , the  
periostea l flap  w as tigh tly  sutured a ro und  the  im p lan t a nd  the  skin flap  
w as sutured sepa ra te ly . In the  second  surg ical session a  ho le  was
Figure 4: schematic overview of the surgical technique based on a free split 
thickness skin graft used in the early days of BAHA surgery.16
punc tu red  in the  skin a nd  the  subcu taneous tissue a b o v e  th e  im p lan t, 
a fte r w h ich  an  a b u tm e n t w as sc rew ed  on to  it. In the  e a rly  days of BAHA 
surgery, soft tissue reduc tio n  w as not pe rfo rm ed . It w as no ted  th a t a  few  
patien ts w ith  a  th ick subcu taneous la ye r a nd  a  skin w ith  sebaceous 
g lands e xp e rienced  skin irritations. O n e  re m e d y  cou ld  b e  to loca lly  
excise the  skin and  c o ve r it w ith  a  thin g ra ft from  the  arm . A lte rna tive ly , 
th e  surgeon cou ld  trim a  th ick subcu taneous flap  o ve r the  im p lan t site. 
These solutions w ou ld  la te r b e c o m e  m a jo r issues in BAHA surgery.
In a  second  repo rt in 1983 looking b a c k  on the ir five years of expe rience , 
G o thenb u rg  BAHA te a m  described  tw o  m od ifications to  th e  surg ical
17
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te c hn iq ue .5 S ince then, surgeons h a ve  used a  spiral drill to  w id e n  the  
ho le  a nd  a  counter-sink to leve l th e  b o ne  su rface w ith  the  purpose of 
ob ta in ing  op tim a l c o n ta c t w ith  the  f la n g e  of the  im p lan t. Figure 3 is a 
schem atic  illustration of th e  im p lan t p la c e m e n t is p resen ted  in.6 The 
second  m od ifica tion  w as that, during  the  second  s tage  of the  
p rocedu re , th e  soft tissue is re d u c ed  such th a t th e  skin slopes n ice ly 
dow n  tow ards the  im p lan t a re a . If the  skin is free  of ha ir follicles, the  loca l 
skin flap  is th inned  ou t as m uch  as possible. But if th e  im p lan t is s itua ted  in 
a  reg ion w ith  ha ir follicles a  p ed ic led  o r free skin g ra ft is used to  establish 
a  ha ir free  zone of a t least 7 m m  a round  the  im p lan t. Figure 4 gives an  
impression of th e  p ro cedu re .6 A p lastic hea ling  c a p  is p la c e d  on the  
im p lan t to keep  an  o in tm ent-soaked g auze  dressing in p la c e  for a  period 
of 7 to 10 days. A fte r rem o va l th e  p a tie n t is asked to c le a n  the  a re a  d a ily  
a nd  a p p ly  a  m ild an tib io tic  o in tm en t like Terra-Cortril® for tw o  weeks.
In 1989, a  n ew  one  s tage  surg ical te c hn iq ue  w as d e ve lo p e d  in 
Sw eden .20 In m ax illo fac ia l surgery, th e  in te rva l b e tw e en  p la c e m e n t and  
load ing  of the  im p lan t is th ree  to  six months. This m uch  tim e  is n e e d e d  for 
osseo in tegration th a t is suffic ient to  w iths tand  the  forces of chew ing . 
Regard ing  BAHA p la cem en t, how ever, th e  forces im p ing ing  on the  
im p lan t a re  m uch  w eake r. Therefo re th e  m od ifica tion  to  one-stage 
surgery cou ld  b e  a d o p te d  and  it has since b e c o m e  the  go ld  s tanda rd  in 
adults. In one-stage surgery, soft tissue hand ling  is pe rfo rm ed  d irec tly  
a fte r th e  im p lan t is p la c e d .8 The m a jo r c lin ica l bene fit of this te c hn iq ue  is 
th a t it reduces hea ling  tim e  to b e tw e e n  six and  ten w eeks a fte r 
p la cem en t. This is m uch  shorter than  the  th ree  to six months in itia lly 
requ ired  b e tw e en  the  first- a nd  second- s tage  surgery plus the  four 
w eeks it took for th e  soft tissue to  hea l a fte r th e  second  s tage .21,22
To im p ro ve  the  o u tcom e , o ve r the  years, th e  skin flap  te c hn iq ue  was 
used as an  a lte rn a tive  to a vo id  a  free  skin transp lan t from  the  retro  
au ric u la r fold. It w as also used w he n  the re  a re  ha ir follicles a t th e  im p lan t 
site. The an te rio r based  skin flap  w as m a d e  thin w ith  a  b la d e  to  rem o ve  
the  ha ir follicles.23,24 However, som e say th a t this te c hn iq ue  is tim e  
consum ing. M o reove r, th e y  say th e re  is a  risk of d e ve lo p in g  pa rtia l 
necrosis of th e  skin flaps and  a  po ten tia l to  d e ve lo p  ad ve rse  skin 
reactions w he n  ha ir follicles a re  still present. To a vo id  this com p lica tion , 
th e  te c hn iq ue  w as s tanda rd ized  b y  d e ve lo p in g  of a  d e rm a to m e , w h ich  
w as in troduced  in 2001 (Figure 8B).25
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Figure 5b: A 3-mm self-tapping 
implant.
This d e v ic e  renders a  split skin flap  25 m m  in w id th  w ith  a  thickness of 0.6 
mm. The base of th e  flap  is p la c e d  a t th e  an te rio r end . However, the  
d irec tion  of th e  flap  is no t of v ita l im po rtance . The ha ir follicles bea ring  
soft tissue is rem o ved  u nd e rnea th  the  flap  and  the  surround ing tissue, 
th e re b y  p rov id ing  a  g e n tle  sloping of th e  skin. The periosteum  is pa rtly  
rem o ved  in an  a re a  of a p p ro x im a te ly  5 to  7 m m  a round  the  im p lan t. The 
flap  is sutured d ow n  on the  th ic ke r la ye r of pe rios teum .25
In 2003 the  new ly  des igned  self-tapping im p lan t w as im p lem en ted  in 
S w eden  (Figure 5a a nd  5b). Facilita ting the  BAHA im p lan ta tio n  
p rocedu re , tap p in g  was no longe r necessary be fo re  insertion. Also the  
in troduc tion  of a  pre-m ounted bone  im p lan t to  the  BAHA coup ling  
m a d e  BAHA surgery easier.23 M o re  re c en t d e ve lop m en ts  c o n c e n tra te  on 
c o a te d  surfaces fo r the  im p lan t a nd  new ly  des igned  a n g u la te d  
abu tm ents.
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N ijm e g e n
In N ijm egen  BAHA surgery sta rted  in June  1988, in itia lly the  G o thenb u rg  
te c hn iq ue  w as used.21,26,27 Early studies repo rted  on c lin ica l o u tc o m e  of 
the  first 36 patien ts (38 implants) w h o  had  b een  fitted  w ith  a  BAHA using 
the  two-stage te chn iq ue .21,26
Shortly a fte r th e  first enco u rag ing  c lin ica l results of the  one-stage surg ical 
te c hn iq ue  from  G o thenb u rg ,20 an  a lte rn a tiv e  one-stage surg ical 
te c hn iq ue  was d e ve lo p e d  in 1991.28 This te c hn iq ue  comprises the  sam e 
drilling a nd  p la c e m e n t p ro ce d u re  as desc ribed  a b o ve .6 However, th e  
te c hn iq ue  takes a  d iffe ren t a p p ro a c h  to  soft tissue hand ling  (Figure 6):
Figure 6: The linear incision technique 
with the use of a skin graft, used 
between 1988 and 1994.25
Figure 7: The linear incision technique 
without the use of a skin graft.25
1. The incision is longitudinal instead of semi-circular, allowing the surgeon to 
reduce the subcutaneous tissue around the implant site more extensively over 
an area of 2 cm around the incision.
2. The periosteum is removed over an area of approximately 1 to 2 cm around the 
intended implant site providing the opportunity for a deeper soft tissue 
reduction than the Gothenburg technique.
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Initially, fo llow ing the  skin incision and  im p lan ta tion , a  free  skin g ra ft 
(w ithout ha ir follicles) is transposed from  the  re tro au ricu la r fold, then  
th inned  a nd  sutured o ve r the  im p lan t. The skin g ra ft then  m akes d irec t 
c o n ta c t w ith  the  b o ne  tissue. Finally th e  g ra ft is p unc tu red  o ve r the  
im p lan t so th a t th e  a b u tm e n t c a n  b e  p la ced . The hea ling  c a p  
p la c e m e n t in te rva l is now  sho rtened  to six o r seven days. Further 
tre a tm e n t consists of a pp ly ing  an  an tib io tic  o in tm en t d a ily  o r e ve ry  o the r 
day.
Due to the  inc reased  risk of skin necrosis using a  free  re tro au ricu la r g ra ft 
a n o th e r a d a p ta t io n  w as m ad e . It resu lted in the  cu rren tly  used linea r 
incision techn ique . In 1999 va n  d e r Pouw  e t al. repo rted  the  first short­
te rm  c lin ica l results of a  m o re  simplified one-stage surg ical techn ique . 
(Figure 7) The new  m e thod  im p lied  a  pu re  long itud ina l incision. A free 
skin g ra ft w as no longe r ap p lie d . This n ew  tec hn iq ue  is desc ribed  
extens ive ly in C h a p te r 2.1. R ecen tly  a  surg ical g u id e  w as p ro v ided  for 
th e  linea r incision techn ique . (C och lea ir BAS, G o thenbu rg , Sw eden ).29,30
B irm in g h a m
In 1996 Proops e t al. repo rted  the  results of BAHA surgery a t the ir c lin ic.31 
For the ir first 60 patien ts th e y  also em p lo ye d  the  tw o  s tage  te chn iq ue .6 
Unlike the ir co lleagues  in G o th en b u rg 20 a nd  N ijm egen28, the  B irm ingham  
BAHA te a m  used the  Ro thera  m e thod , a n o th e r one-stage surg ical 
te c hn iq ue  for soft tissue reduc tion  (Figure 8A).31,32
The Ro thera  m e thod  consists of a  free  loca l split skin graft. The g ra ft is 
ha rves ted  from  a  fla t m oun ted  h e a p  (in jec ted  w ith  loca l anes the tic  fluid) 
b y m eans of a  silver's d e rm a to m e  or a  n um b e r 10 surg ical b lade . The 
periosteum  rem ains in p la c e  while , th e  surround ing soft tissue is 
unde rm ined . A fte r im p lan t p la cem en t, th e  split skin g ra ft is re p la c e d  and  
p unc tu red  a llow ing  the  a b u tm e n t to b e  fitted .32
A no th e r surg ical te c hn iq ue  used in B irm ingham  consists of a  th inned  
p ed ic le  flap  (Figure 8C).31 It w as d e ve lo p e d  in the  sam e period  as the  
one-stage N ijm egen  linea r incision techn ique . This revised skin flap  
te c hn iq ue  w as used in severa l o the r clinics.33 The skin flap  is inferiorly 
based  b ecause  the re  is less need  for unde rm in ing  inferiorly. The ra tio na le  
is th a t g ra v ity  w ou ld  he lp  a n d  the  tissues lo c a ted  superio rly cou ld  be  
m a d e  th inne r (personal com m un ica tio n , M r Proops).
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O th e r c lin ic s
In G lasgow  in 1990, Browning desc ribed  a  Z-plasty te c hn iq ue  to 
transpose a  re tro au ricu la r hairless skin flap  d irec tly  in to the  e a r  by ba ring  
the  im p lan t site. This flap  w as th inned  to a b o u t 2 m m .34 (Figure 8D)
In Staffordshire in 2000, a  m od ifica tion  of Tjellström's free  skin g ra ft 
te c hn iq ue  w as in troduced . Besides using a  re tro au ricu la r transp lan ted  
skin g ra ft o r an  inferio rly based  skin flap, th e y  used four rad ia l incisions a t 
th e  im p lan t site to  fu rthe r re d u c e  the  soft tissue surrounding the  site unde r 
d irec t visual contro l. The periosteum  w as re d u c ed  as w e ll.35 This 
te c hn iq ue  c an  b e  cons ide red  in spec ia l cases, no tab ly  w he n  the re  is an  
unusual a m o u n t of subcu taneous tissue a t th e  im p lan t site (Figure 8E).
In Herts in 2006, Persaud e t al. in tro duced  a n o th e r te c hn iq ue  invo lv ing  
four loca l skin flaps c re a te d  by c ru c ia te  incisions. In this techn ique , the  
ha ir follicles a re  rem o ved  from  the  flaps a nd  the  soft tissue is rem o ved  
und e rnea th  the  flaps a nd  from  the  surround ing a rea . The periosteum  is 
also rem oved . 36 (Figure 8F)
In 2009 àW eng en , speak ing  a t the  Second  In te rna tiona l Symposium  on 
Bone C onduc tio n  Hearing - C ran io fac ia l O sseo in tegration, w h ich  was 
he ld  in June  2009 in G o thenbu rg , Sw eden, p resen ted  his m od ified  
d e rm a to m e  techn ique . It w as co m b in ed  w ith  a  linea r incision and  
trapezo id  extensions. The a im  of this te c h n iq u e  is to p ro v id e  e ve n  w id e r 
exposure w ith  sm a lle r skin flaps, th e reb y  reduc ing  the  risk of necrosis.
In 2009 Hultzcrantz (Stockholm ) a n d  Soo (Hong Kong)37 also addressed 
the  Second  In te rna tiona l Symposium  on Bone C onduc tio n  Hearing - 
C ran io fac ia l O sseo in tegration. There, th e y  p resen ted  p re lim ina ry  c lin ica l 
results of a  m od ifica tion  of th e  linea r incision te c hn iq ue  for pa tien ts w ith  
little o r no subcu taneous tissue. In th a t the ir m od ifica tion  d id  no t in c lude  
a n y  subcu taneous tissue reduc tion . D iabe tic  pa tien ts and  patien ts w ith  
too  m uch  subcu taneous tissue a t th e  im p lan t site w e re  e xc lu d e d  from 
this p rospec tive  trial. Furtherm ore a  spec ia l high a b u tm e n t of 8.5 m m  was 
used instead of the  reg u la r 5.5-mm abu tm en t.
The th ree  surg ical techn iques th a t a re  most c o m m o n ly  used now adays  
a re  he d e rm a to m e  techn ique , the  p ed ic led  skin flap  te c hn iq ue  and  the  
linea r incision te chn iq ue .30,38
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Figure 8 : Author's impression of, A: Rhotera technique(1996);28'29 B: 
Dermatome technique (2001); C: Proops technique (1996) (personal 
communication);28 D: Z-plasty (1994);31 E: Radial incision technique 
(2001);32 F: Cruciate incision technique (2006).33
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Clinical outcome measures 
In tro d u c tio n
The c lin ica l o u tc o m e  m easu rem ents  of BAHA surgery c an  b e  d iv id ed  
rough ly  in to tw o  ca tego ries : bony  tissue com p lica tions  a nd  soft tissue 
com p lications. These com p lica tions  m ay, to  som e extent, b e  re la ted  to 
the  surg ical te c hn iq ue  th a t h ad  been  used.
The bony tissue co m p lic a tio n  is fa ilu re  of osseo integration, le ad ing  to 
subsequen t im p lan t loss. A p a rt from  loss ow ing  to poo r osseo integration, 
extrusion m a y  o c cu r as a  result of tra u m a  o r in fection. Im plants m ay  
h a ve  to b e  rem o ved  b ecause  of ch ron ic  pa in  a t th e  im p lan t site.39,40 No 
e xp lana tio n  for spon taneous loss has been  o ffe red  so far. However, 
H w a ja  e t al. found th a t in tw o  cases (a spon taneous loss a nd  a  surg ica lly 
rem o ved  im p lan t) ke ra tinocytes m a y  p la y  a  ro le  in this process. It is 
though t th a t ke ra tinocytes b lock the  titan ium  osseo in tegration th rough 
m ig ra tion  to  the  im p lan t site.41 y e t o th e r causes of im p lan t rem ova l 
un re la ted  to BAHA surgery a re  possible: no m o re  bene fit b ecause  of 
progressive hea ring  loss; or successful m idd le-ear surgery. The la tte r 
w ou ld  e lim ina te  co n d u c tiv e  hea ring  loss, for e xa m p le  in ch ild ren  w ith  a 
co ng en ita l ossicular cha in  m a lfo rm a tion  w h o  w e re  in itia lly too  young  for 
reconstruc tive  surgery.
Regard ing  soft tissue, the  short-term com p lica tions  m a in ly  conce rn  
in a d e q u a te  w o un d  hea ling  a n d  skin flap  necrosis.25,33,42,43 Long-term 
com p lica tions  m a in ly  com prise  skin reactions a nd  hype rtroph ic  skin 
o ve rg row ing  the  a b u tm en t. Skin reac tions a round  the  a b u tm e n t c a n  be  
classified b y  a  g rad ing  sca le  d e ve lo p e d  by Holgers e t a l (Table 1).3,44
Table1. The Holgers grading scale for the classification of skin reactions around skin 
penetrating titanium implants.
Holgers grading Description
Grade 0 No reaction
Grade 1 Reddish discoloration of the skin around the implant
Grade 2 Red and moist surface of the skin around the implant
Grade 3 Formation of granulation tissue around the implant
Grade 4 Extensive soft tissue reaction that requires implant removal or leads to implant loss
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Skin reaction 0 1 2 3 4
Abutment Fixed Loose Debris + -
Skin High Low
Figure 9: The Nijmegen stamp used for registering the 
state of the skin around the abutment and the status of 
the abutment for the follow-up of the BAHA patient.
A skin reac tion  of Holgers g ra d e  2 or h ighe r is cons ide red  a  severe  
reac tio n  in need  of tre a tm en t.3,45 It is suggested th a t a ll BAHA im p lan t 
check-ups should b e  d o n e  w ith  the  he lp  of this classification. The 
N ijm egen  BAHA te a m  uses a  p re fab ric a ted  s tam p  as shown in figure 9. 
The process of in flam m ation  a ro und  the  BAHA im p lan t is no t fully 
understood yet. However, the  a m o u n t of b iom arkers con ta in ing  fluid 
m igh t b e  re la ted  to a  h ighe r Holgers classification. There a re  also signs of 
inc reased  soft a n d  bony tissue tu rno ve r a t in flam ed  BAHA im p lan t sites.46 
For h ype rtroph ic  skin, the re  is no g rad ing  sca le  o the r th an  ind ica ting  th a t 
th e  BAHA processor c a n n o t b e  used a d e q u a te ly . In terventions like tissue 
reduc tion , co rticoste ro id  in jections,47 o r th e  p la c e m e n t of a  h ighe r (8.5­
mm) a b u tm e n t th an  no rm a l c a n  b e  cons ide red  as w ays to  so lve soft 
tissue p rob lem s.48 A p red ic to r for d e ve lo p in g  hype rtroph ic  skin and  m a jo r 
skin reactions is a  BMI > 30 K g /C M 2 in m a le  BAHA users. In fem a les such a 
re la tion  has not b een  found. In these cases a  8.5-mm a b u tm e n t 
p la c e m e n t is adv ised  to  a t initial surgery.49
To present a  m o re  co m p rehens ive  o ve rv ie w  of c lin ica l ou tcom es pe r 
surg ical te c hn iq ue  the  iden tified  manuscrip ts a re  d iv id ed  into ‘initial 
reports' a n d  ‘cu rren tly  most used techn iques '.
In it ia l re p o rts
The ea rly  c lin ica l results of BAHA surgery a re  from  the  G o thenb u rg  g roup. 
They m a in ly  com prised  the  p ed ic led  o r free  skin g ra ft te c hn iq ue  (Table 
2).3-8 A d e ta ile d  o ve rv iew  pe r study of these c lin ica l results is g iven  in 
c h a p te r 2.2 on p a g e  67.
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The c u rre n t e x p e rie n c e  
D e rm a to m e  te c hn iq ue
The d e rm a to m e  te c hn iq ue  has been  e va lu a te d  by severa l clinics (2007 
to 2008).24,25,42,50-52 Short te rm  com p lica tions  arise in 0.7% to  1.3 % of the  
cases a nd  consist of flap  necrosis in the  first six w eeks a fte r surgery.25,42 
Long-term follow-up (m ean  follow-up of th ree  years) revea ls  an  
in c id ence  of 3.3% of skin reactions classified as Holgers g ra d e  2 or 
h igher.24 Skin o ve rg row th  w as seen in 7.4% of d e rm a to m e  p la ce d  
im p lants (follow-up, zero to  fou r years).42
Skin flap  te c h n iq u e
Reports in the  lite ra tu re  on the  skin flap  te c hn iq ue  a lo n e  a re  sporad ic. 
O n e  study, by Tjellström a n d  G ranström  in 2006, shows an  in c id e n ce  of 
9.2% necrosis a t six w eeks post surgery.25 In the  long term  (m ean  fo llow  
up th ree  years), th e re  w as an  in c id e nce  of 1.6% of Holgers g ra d e  2 or 
h ighe r skin reactions.24
W hen  most o th e r clinics repo rt the ir c lin ica l results, th e y  h a ve  a lre a d y  
m ixed the  series w ith  ou tcom es of subsequen t in terventions. The results 
w ou ld  then  in c lude  the  initial use of a  skin flap  o r g ra ft a nd  la te r surgery 
using the  d e rm a to m e  techn ique . To re la te  the  com p lica tions  to the  
e xa c t te c hn iq ue  used is the re fo re  no t possible.50,52
L inea r incision te c hn iq ue
The first c lin ica l results of th e  lin ea r incision Techn ique  w e re  repo rted  in
Table 2. Concise overview of the initial reports (1983 to 2000) on the pedicled or free 
skin graft technique.
Short-term follow-up (2.4 to 4.4 
years)3-8 Long-term follow-up (6.3 years)1
Overall implant loss 1.5 to 10.7% 17.4 %
Failed osseointegration 0 to 5 % 6%
Infection 0.4 to 1.5% 0%
Other (i.e. trauma, removal, 
chronic pain) 5 to 8 % 11.4%
> Holgers grade 2 1.7 to 4% 2.8%
Graft necrosis( partial / total) - 9.8% / 0.6%
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1994 a nd  co nce rn  the  free  skin g ra ft.53 Two im p lants w e re  lost (3%). 
Holgers skin reactions of g ra d e  2 o r h ighe r w e re  seen in n ine of th e  65 
patien ts (14%). The results on the  linea r incision te c hn iq ue  for one-stage 
surgery show  th a t tw o  im p lants w e re  lost (6%). Skin reactions of Holgers 
g ra d e  2 o r h ighe r w e re  seen in seven patien ts (21%).28 There w e re  no 
sign ificant d iffe rences in the  o c cu rre n ce  of skin reactions b e tw e e n  the  
im p lants p la c e d  by m eans of one-stage surgery w ith  a  skin graft, two- 
s tage  surgery w ith  a  skin graft, or one-stage surgery w ithou t th e  use of a 
skin graft. 54
O n e  of the  m a in  ob jec tives of this PhD thesis is to co m p ile  the  long-term 
c lin ica l results of th e  one-stage linea r incision te c hn iq ue  w ithou t th e  use 
of a  skin g ra ft.55-57
Im p la n t lo c a tio n
In choosing a  loca tion  for th e  im p lan t fixture the  surgeon is g u id ed  by the  
d is tance  b e tw e e n  th e  p inna  and  the  e ve n tu a l position of th e  a ud io  
processor, w h ich  must b e  a b le  to v ib ra te  freely. Som e clinics use 
C o m p u ted  To m og raphy  (CT) to  asce rta in  a d e q u a te  bone  thickness. This 
c an  b e  pa rtic u la rly  useful for BAHA p la c e m e n t in pa tien ts w ith  
co ng en ita l skull deform ities.58 O th e r clinics d e te rm in e  the  id ea l im p lan t 
position by m eans of CT (revea ling  the  thickness of th e  bone) and  
d e te rm in e  the  pa tien t's  best sub jec tive  hea ring  w ith  the  test h e ad  
b and .59 A d is tance  of 25 m m  from  the  ex te rna l acoustic  c a n a l (EAC) 
w ou ld  b e  the  most id ea l p la c e  from  an  aud io lo g ic a l pe rspec tive .60 
However, this is no t p rac tic a l b ecause  of th e  size and  position of the  
auric le . Therefo re p la c e m e n t as c lose to the  m eatus as possible is 
advised , tak ing  into a c c o u n t the  c lin ica l considera tions m en tioned  
a b o ve . This usually am ounts to  a p p ro x im a te ly  55 m m  from  the  EAC.
Most c lin ica l o u tc o m e  m easures found in the  lite ra tu re  co nce rn  im p lan t 
loss and  skin reac tio n  a round  the  im p lan t. However, the re  a re  on ly a  few  
reports on p red ictors of th e  o c cu rre n ce  of such reactions, i.e. 
h ype rtroph ic  skin and  infections. To the  best of ou r kno w led g e  the re  has 
not b een  a n y  study re la ting  im p lan t position to  skin reac tio n .54
A no th e r o b je c tive  of this PhD thesis is to  e v a lu a te  im p lan t loca tion  in 
re la tion  to  skin thickness and  to in c id e nce  a nd  d e g re e  of ad ve rse  skin 
reactions.
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BAHA surgery in children 
In tro d u c tio n
BAHA is a p p lie d  in ch ild ren  to address d iffe ren t issues than  in adults. The 
yo un g e r popu la tio n  is know n to h a ve  m o re  im m a tu re  a nd  th inne r bone, 
m o re  appos itiona l tem p o ra l b one  o ve rg row th  during  the ir g row th  period, 
m o re  risk of soft tissue o ve rg row th  a n d  traum a , as w e ll as c lean ing  
p rob lem s in the  ad o le scen c e .61-65 A cons id e rab le  p roportion  of the  
ch ild ren  fitted w ith  a  BAHA h a ve  co ngen ita l (syndromal) m a lfo rm ations 
of th e  ear, som etim es co m b in ed  w ith  skull deform ities, w h ich  m a ke  
surgery m o re  cha lle ng ing .65-68 W hen  w e igh ing  BAHA surgery in ch ild ren, 
d u e  cons idera tion  should b e  g iven  to the  fo llow ing;
1. Age at implantation
2. Bone thickness
3. Implant position
4. Spare implant and inter-distance
5. Soft tissue reactions
So far, no consensus repo rt has a p p e a re d  on the  id ea l a g e  for BAHA 
im p lan ta tion . In the  USA, stipulations of th e  FDA a p p ro va l restrict the  
ap p lic a tio n  of BAHA to  persons a g e d  of five years o r o lder. O n the  one  
hand , it is of th e  utm ost im p o rta n ce  th a t ch ild ren  should b e  rehab ilita ted  
a t th e  earliest a g e  possible.69 On the  o th e r hand , the  a g e  a t w h ich  
suffic ient thickness of the  b o ne  is re a c h e d  is fou r to seven years.66 In the  
ea rly  days of BAHA surgery in ch ild ren, th e  a g e  of im p lan ta tio n  was 
low e red  to b e tw e e n  1.5 and  2.5 years th rough  bone  a u g m e n ta tio n  
techn iques (see be low ) and  a  p ro longed  in te r surg ical s tag ing .65,66,70,71 
The g ene ra l a d v ic e  w as to im p lan t these ch ild ren  a t th e  a g e  of tw o  to 
four years.65,72 For ch ild ren  too  young  for im p lan ta tion , the  co n ven tio na l 
solution has to b e  used, n a m e ly  a  transcu taneous coup ling  of the  bone  
v ib ra to r to  the  skull. O n e  re c en t d e ve lo p m e n t in this fie ld is a  BAHA w ith  
the  a ud io  processor m oun ted  on a  so ftband, w h ich  w as in troduced  in 
2001. These ch ild ren  a re  now  be ing  fitted  w ith  a  BAHA a t th e  a g e  of 
th ree  months. The BAHA c a n  b e  a p p lie d  b ila te ra lly  on the  so ftband .73,74 
Thereby, it is possible to  a vo id  ea rly  titan ium  im p lan ta tion , for w h ich  the  
best tim ing (mostly a t a g e  four o r five) c a n  b e  a w a ite d .55,72 The decision 
‘w he n  to im p lan t a  ch ild ' w as in itia lly based on the  thickness of th e  skull. 
W ith the  a p p lic a tio n  of th e  transcu taneous bone  conduc to r, the  
decision c a n  now  be  based  on estim ates of no rm a l la n g u a g e  
d e ve lo p m en t, w h ich  is tested regu la rly  to m on ito r the  ch ild 's progress.69,74
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As no ted  a b o ve , the  thickness of th e  co rtic a l b one  in ch ild ren  is a  critica l 
cons ide ra tion .67 Even in ten-year-olds the  thickness of th e  b o ne  m ight 
necessita te  the  use of 3-mm implants. In 50% to  100% of the  p aed ia tr ic  
popu la tion , a  3-mm im p lan t is used.64,67,75,76 Som e reports s ta te  th a t 3-mm 
im p lants m igh t inc rease  the  risk of osseo in tegration fa ilu re .7,22,76 Yet w h ile  
o the r studies d id  no t find such a  co rre la tion .62 Bone thickness of 2.5 m m  is 
cons ide red  to requ ire  p la c e m e n t of a  3-mm im p lan t w ithou t add itio na l 
p rocedures.66 However, such in c o m p le te  inserted im p lants (when the  
thickness of th e  b o ne  is less than  2.5 mm ) m igh t le ad  to  im p lan t loss.67 
Bone a u g m e n ta tio n  te c hn iq ue  w ith  the  use of e-PTFE m em b ranes  or 
PGA/PLA or a  co lla g en  test m e m b ra n e  (OV4, OV6, G o re  & Associates AB 
WL, M o lnd a l Sweden) m igh t so lve this p rob lem .61,64,75,77,78 Also a  m ixture of 
bone  dust a nd  tissue-glue c a n  b e  used to fill the  g a p  b e tw e e n  the  
im p lan t f la ng e  a nd  the  co rtic a l bone. However, in most o ld e r ch ild ren, 
bone  of suffic ient thickness c an  b e  found on the  linea tem po ra lis .79 In 
a p p ro x im a te ly  27% to  55% of the  cases, the  du ra  or s igm oid sinus was 
exposed d u e  to insuffic ient b one  thickness.62,64,67,75,76,80 Usually, the  
exposed du ra  is c losed na tu ra lly  w ith  c o m p a c t b one .64 If a  sigmoid 
b leed ing  occurs during  surgery it c a n  b e  s topped  by im p lan ting  the  
fixture.64 Now adays, BAHA surgery in ch ild ren  is still pe rfo rm ed  as a  two- 
s tage  p ro cedu re .65 In re c en t years, th e  one-stage te c h n iq u e  has been  
used, though  on ly  in ch ild ren  o ld e r th an  ten  years having , a  bone  
thickness of a t least 4 m m .70,76,81 Lately, som e reports h a ve  been  
pub lished on regu la r one-stage BAHA surgery in ch ild ren  yo un g e r than  
four years, a lth o ugh  on ly in small series.76,82 The o ve ra ll consensus is 
nonetheless th a t BAHA tw o  s tage  surgery should still b e  the  go ld  
s tanda rd  for ch ild ren  unde r ten years.72
A no th e r cons ide ra tion  is th e  a p p ro p ria te  position of th e  im p lan t, 
pa rtic u la rly  in a  ch ild  w ith  a  co ng en ita l e a r  m a lfo rm a tion . For ch ild ren  
w ith  an  a no tia  o r m ic ro tia  c o m b in e d  w ith  a  co ngen ita l e a r  c a n a l atresia 
the  im p lan t should be  p la c e d  ap p ro x im a te ly  6.5 to  7 cm  posterio r to the  
p resum ed loca tion  of th e  e a r  cana l. Positioning it the re  w o u ld  fac ilita te  
reconstruc tive  surgery if necesary.83 In a  no rm a l a n a to m ic a l fo rm a tion  of 
th e  child 's skull th e  im p lan t should b e  p la c e d  a t least 5.5 cm  posterio r to 
the  bony e a r c a n a l in o rde r to  assure a  good  position of th e  BAHA in the  
fu tu re.64 The tem p o ra l b one  grows in an  appos itiona l m anner, w h e re b y  
the  im p lan t rem ains in its o rig ina l position.66 As the  skull c o n to u r is p rim arily  
used to d e te rm in e  the  position of the  im p lan t, co n ven tio n a l rad iog raphs 
or CT a re  g e ne ra lly  not requ ired  for a  p reo p e ra tiv e  assessment of the  
child. Besides, CT o ften  requires seda tion  o r g ene ra l anesthesia, w h ich
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exposes these ch ild ren  to  extra  risk.72 Therefo re it is no t g ene ra lly  
re c o m m e n d e d  to  use CT for im p lan t positioning. Patients w ith  syndrom ic 
featu res m igh t b e  an  excep tio n , as has been  repo rted  for Dubow itz 
synd rom e.84
The d e ve lo p m e n t of a  young  ch ild  is d e p e n d e n t on exposure  to speech  
and  la ng uag e , w h ich  requires hea ring .69 W hen  an  im p lan t is lost, it takes 
a  n ew  BAHA im p lan t th ree  to  six m onths to  fully osseo in tegrate . To 
re d u c e  the  period  of ‘non-usage of the  BAHA', a  spa re  im p lan t c a n  be  
p la c e d  during  the  initial im p lan ta tio n  p ro cedu re .62,67,75,81,85 An  a b u tm e n t 
c an  then  b e  p la c e d  d irec tly  a fte r a llo ca tio n  of th e  s leepe r im p lan t. This 
new  a b u tm e n t c a n  b e  lo a d ed  a fte r a  one- to  two-week hea ling  period 
of th e  surg ical w ound . In e xcep tio na l cases, th e  s leepe r im p lan t c a n n o t 
b e  used a n y  m o re  d u e  to tilting of th e  sc rew  or bony  o ve rg row th  caused  
by oppositiona l b one  g row th .67 However, p a rtic u la rly  in the  d e ve lo p in g  
child, the  po ten tia l bene fit of e a rly  lo ad ing  of th e  re p la c e m e n t im p lan t 
ou tw e ighs the  risk of a  useless s leeper. A s leepe r im p lan t c a n  b e  p la c e d  
on the  co n tra la te ra l side in ch ild ren  w ith  b ila te ra l c o n d uc tive  hea ring  loss 
in w hom  a  b ila te ra l BAHA m igh t b e  cons ide red  an  op tion  in the  fu tu re.86 
This is d o n e  b ecause  the  ipsila tera l s leepe r im p lan t is no t used ve ry  often. 
P lac ing the  im p lan t on the  co n tra la te ra l side fac ilita tes b ila te ra l BAHAs in 
the  future. Ye t little is know n of the  long-term fa te  of th e  un lo ad ed  
s leepe r im p lan t. There is o ne  case  repo rt a b o u t a  s leepe r im p lan t th a t 
rem a in ed  un lo ad e d  for 20 years. The im p lan t w as w e ll in teg ra ted  and  
co ve red  w ith  1 m m  bone  w ithou t signs of resorption.87 This suggests th a t 
s leepe r im p lants c a n  still b e  used a fte r lying d o rm an t for a  cons id e rab le  
leng th  of time.
A no th e r m a jo r co nce rn  rega rd ing  BAHA in ch ild ren  is th e  possibility of soft 
tissue reactions a ro und  the  im p lan t.55,62,68,85,88 The p a ed ia tr ic  popu la tion  
relies on carers for p rope r h yg iene  a ro und  the  im p lan t. But ch ild ren  m ight 
not b e  w illing to le t the ir carers c le a n  the  skin a round  the  im p lan t site. 
Also the  te n d e n c y  for hype rtroph ic  skin to occur, pa rtic u la rly  in ch ild ren, 
puts them  m o re  a t g re a te r risk of soft tissue problems. T rad itiona lly this 
p rob lem  w as so lved by surgery w ith  soft tissue reduc tion . H ow eve r 
severa l re c en t studies p ropose in jections w ith  corticostero ids as a 
tre a tm e n t op tion  for h ype rtroph ic  skin (though not in ch ild ren).89,90 
A no th e r op tion  is to  use a  longe r a b u tm e n t (8.5 m m  instead of 5.5 m m ).48 
The short-term results in ch ild ren, (one im p lan t extrusion [out of 16 cases] 
o ve r a  follow-up pe riod  rang ing  from  six months to  six years) a re  
promising, p a rtic u la rly  in a  se lec ted  p a ed ia tr ic  popu la tion . The long-term 
ou tcom es still h a ve  to b e  fully e v a lu a te d .91
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C lin ic a l resu lts
In 1992 the  first s tudy on im p lants in ch ild ren  w as pub lished b y  the  
G o thenb u rg  g roup .92 S ince then  seve ra l o the r clinics h a ve  pub lished the ir 
results.62,64,67,68,70,75,76,81,85,92 The p ed ic led  skin flap  o r g ra ft te c hn iq ue  is still 
th e  o ne  most co m m o n ly  used te c hn iq ue  in ch ild ren. The ove ra ll im p lan t 
loss rang ed  from  5.3% to  26%. Im p lan t loss d u e  to la c k  of osseo in tegration 
or in fec tion  rang ed  from  2.5% to 13.2%. Most losses o c cu r in the  first y e a r 
of follow-up.62,93 Interestingly, ch ild ren  a re  m o re  a t risk of losing the  
im p lan t. The in c id e nce  of skin reactions of Holgers g ra d e  2 or h ighe r p e r 
obse rva tion  ra n g e d  from  1% to 9.4%. The in c id e nce  of tissue revision 
surgery ra n g e d  from  6.3% to  27%.
A b rea kd o w n  of these d a ta  is p resen ted  in C h a p te r 2.2 p a g e  71. This 
s tudy describes the  use of th e  linea r incision te c hn iq ue  a nd  expands on 
long-term c lin ica l e va lu a tio n  in ch ild ren.
BAHA surgery in older adults
In the  lite ra tu re  little is found on the  o u tc o m e  of BAHA surgery in o ld e r 
adults as a  se p a ra te  g roup. This specific popu la tio n  m igh t b e  m o re  a t risk 
of losing an  im p lan t b ecause  of inc reased  bone  resorption, osteoporosis, 
u n fa vo rab le  load ing , ad ve rse  skin reactions, o r inab ility  to c le a n  the  skin 
a round  the  im p lan t.93 Drinias e t a l.93 e v a lu a te d  131 osseo in teg ra ted  
implants, 67 of w h ich  w e re  BAHA im plants, th e  rest be ing  im p lants used 
for a tta c h in g  au ric u la r epithesis. They found th a t a d v a n c e d  a g e  was 
s ign ificantly c o rre la ted  w ith  a  h ighe r im p lan t loss. Blood flow  in the  bone  
a t th e  end  of the  drilled  ho le  as m easu red  by laser D opp le r flow m etry  
w as s ign ificantly less in the  o ld e r adu lt. The authors suggest th a t the  
d ec reased  b lood  flow  m igh t b e  a  risk fa c to r for im p lan t loss.
A specific study to  e v a lu a te  BAHA fitting in the  o ld e r a d u lt is p resen ted  in 
C h a p te r 2.3.
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Patient o u t c o m e  measures
Introduction
An im po rtan t o u tc o m e  of m e d ic a l tre a tm en t, a p a rt from  the  c lin ica l and  
aud io lo g ica l o u tc o m e  measures, is sub jec tive  benefit, w h ich  reflects the  
patients' ow n  v ie w  of the ir hea lth  status. The W orld  Health O rgan iza tion  
has e x te nd ed  the  de fin ition of hea lth  to  e m b ra c e  the  psycho log ica l a nd  
social dom ains. These issues c a n  b e  m easu red  w ith  gene ric  a nd  disease- 
specific va lid a te d  questionnaires. W h ile  g ene ric  instruments e n a b le  
com parisons of hea lth  status, th e y  o ften  fail to  c a p tu re  aspects th a t a re  
im po rtan t to a  specific c lin ica l setting, such as hea ring  im pa irm en t. Thus, 
th e y  m igh t lack  the  sensitivity to  assess the  bene fit in a  pa tien t's  sense of 
well-being a fte r tre a tm e n t.94,95 In o the r words, th e  changes  a re  too  small 
to  b e  d e te c te d  by these instruments.96 In contrast, disease-specific 
instruments assess im pa irm en t of function, in this case  hearing  
im pa irm en t and  co m m un ica tio n . These questionnaires m easu re  not on ly 
disability, bu t also h a n d ic a p  and  a re  the re fo re  m o re  responsive to 
changes  in hea ring  status.
To b e  a c c e p ta b le , a  ques tionna ire  des igned  to  e v a lu a te  a  c h a n g e  in 
hea ring  status should c o ve r severa l aspects:
1. Questions on the patients' opinion about his or her general state of health and 
related quality-of-life questions.
2. The benefit of specific hearing interventions on the general quality of a patient's 
day-to-day life.
3. The effect of the initial and remaining hearing impairment on the individual's 
functioning in daily life and on one's sense of being handicapped.
To a cq u ire  re liab le  d a ta , one's e xp e rie n c e  w ith  im p ro ved  hearing  (a 
new  hea ring  dev ice ) should not b e  too  long, m inim izing reca ll bias. To 
th a t end , p rospec tive  studies should b e  p re fe rred  to re trospec tive  
studies. However, on the  o the r hand , pa tien ts must h a ve  suffic ient 
e xp e rie n c e  to g ive  an  a d e q u a te  response. S ince feelings of g ra titu d e  or 
enthusiasm  should not a ffe c t th e  o u tcom e , it is ad v isab le  to  use a  long 
e va lu a tio n  pe riod  m inim izing the  enthusiasm  bias. To the  best of ou r 
know ledge , no single ques tionna ire  m eets all the  crite ria  m en tioned  
a b o ve . Therefore, in this PhD thesis, severa l well-known v a lid a te d  
questionnaires h a ve  been  used in para lle l.
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BAHA patient outcome 
H is to ry
In o ne  of th e  first studies to b e  ca rried  ou t on sub jec tive  BAHA 
eva lua tio n , pub lished in 1989, the  patien ts w e re  asked not on ly  a b o u t 
a ud iom e tric  im p rovem ents , bu t also for the ir op in ion on bene fit th e y  had  
de rived  from  the  d e v ic e .97 In the  m id nineties, th e  N ijm egen  g roup
Table 3. Overview of questionnaires used in this thesis.
e
py
e
b
ro nsi 
erb nia
m mo 
u d
o
o
e
gn
a
d
e
e
tp
a
h
U
aphab
gbi
gcbi
HHIE-S
HUI3
IOI-HA
NCIQ
Abbreviated 
Profile of Hearing 
Aid Benefit
Glasgow Benefit 
Inventory
Glasgow 
Children's Benefit 
Inventory
Hearing Handicap 
Inventory for the 
Elderly (screening 
version)
Health Utility Index 
(Mark 3)
International 
Outcome 
Inventory for 
Hearing Aids
Nijmegen 
Cochlear Implant 
Questionnaire
Disease
Specific
Disease
specific
Disease
specific
Disease
specific
24
Disease
specific
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24
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Generic 15
Disease 7 
specific
60
Ease of
communication, 
background noise, 
reverberation and 
evasiveness of sound
1-99 Snapshot 
of the 
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Benefit
General, social, 
physical health
-100/ 
+ 100
Benefit
General, emotion, 
physical health, 
learning, vitality
-100/ 
+ 100
Benefit
Emotional 
consequences and 
social/situational 
effects
0-40 Handicap
Vision, hearing, -0.36/ Snapshot
speech, ambulation, 
dexterity, emotions, 
cognition, pain
1.00 of health 
status
Daily use, benefit, 
residual activity 
limitations, 
satisfaction, residual 
participation 
restrictions, impact on 
others and quality of 
life
0-5 Device
use,
satisfactio 
n and 
disability
basic sound 
perception, 
advanced sound 
perception, speech 
production, self­
esteem, activity 
limitations and social 
interactions
0-100 Snapshot 
of the 
situation 
Benefit
4.2
4.3
4.2
4.3
4.2
4.1
4.3
4
3
5
2
8
7
6
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e v a lu a te d  the  BAHA c o m p a re d  to co n ven tio n a l b one  co nduc tio n  and  
a ir co nduc tio n  hea ring  aids.98-101 Am ongst o th e r tools th e y  construc ted  
and  used the ir ow n  instrument, c a lle d  the  N ijm egen  questionna ire . A 
m o re  recen t, w id e ly  used v a lid a te d  ques tionna ire  is th e  G lasgow  Benefit 
Inven to ry (GBI), w h ich  w as first adm in is te red  used in 2001 and  is now  
w id e ly  used.102 Severa l o the r v a lid a te d  questionnaires h a ve  b een  used in 
various specific a nd  g ene ra l BAHA popu la tions.62,80,96,103-116 Tab le  3 gives 
an  o ve rv ie w  of the  questionnaires co ve red  in this PhD thesis
Severa l subsets of questionnaires a re  used d e p en d in g  on the  research 
questions. All of these questionnaires h a ve  b een  previously a p p lie d  in 
BAHA research. The GBI is a  co m m o n  cho ic e  for quality-of-life assessment 
and  has b een  used in the  g ene ra l a d u lt BAHA 
po p u la tio n .102,105,106,112,113,117 The G lasgow  Child ren 's Benefit Inven to ry 
(GCBI) is su itab le  for ch ild ren  a nd  adults w ith  a  m en ta l 
d isab ility.62,109,110,118,119 The A b b re v ia te d  Profile of Hearing  A id  Benefit 
(APHAB) is frequen tly  chosen for pa tien ts w ith  S ingle S ided Deafness 
(SSD), for w ho m  the  BAHA serves as a  trans-cranial CROS d e v ic e .104,116,120-
123
L ite ra tu re  resu lts
In th e  lite ra tu re  th re e  questionnaires h a ve  b een  d e p lo ye d  to assess 
sub jec tive  benefit: th e  G la sgow  Benefit In ven to ry  (GBI) for adults; the  
G lasgow  Child ren 's Benefit In ven to ry  (GCBI) on q ua lity  of life; a nd  the  
A b b re v ia te d  Profile of Hearing A id  Benefit (APHAB) on th e  leve l of 
disability.
Tab le  4 presents the  m e an  GBI scores in series of a d u lt BAHA patien ts 
w ith  b ila te ra l c o n d u c tiv e  or m ixed hearing  loss102,124 a nd  those w ith  
un ila te ra l sensorineural hea ring  loss as w e ll as those using a  BAHA as a 
CROS d e v ic e  (con tra la te ra l routing  of sound).120 For b ila te ra l BAHA users 
the  ad d itio na l BAHA does a d d  som e bene fit a lth o ugh  not statistica lly 
s ign ificant.125
In ch ild ren, th e  GCBI, has been  used to  e v a lu a te  the  bene fit of the  
BAHA. The GCBI was also used previously to e v a lu a te  ch ild ren  w ith  
un ila te ra l hea ring  loss as w e ll as m en ta lly  re ta rd ed  patien ts from  the  
N ijm egen  BAHA c e n te r (Table 4).118,126
The sub jec tive  bene fit w as a lso assessed by m eans of the  APHAB. This 
ques tionna ire  w as adm in is te red  tw ice : o n c e  to o b ta in  a  ‘snapshot' of 
th e  cu rren t s ituation w ith  the  BAHA and  the  second  tim e  to in ves tiga te  
the  una id ed  situation. In the  BAHA lite ra tu re  the  APHAB is mostly a p p lie d
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to  e v a lu a te  un ila te ra l sensorineural hea ring  deafness (SSD) (Table
4) .104,116,120-123
A no th e r instrum ent is the  s im p le ove ra ll ques tionna ire  to m easu re  the  
ou tcom es of hea ring  a id  fitting is the  In te rna tiona l O u tc o m e  Inven to ry  for 
Hearing Aids (IOI-HA). It dea ls  w ith  aspects such as use of th e  hearing  
dev ice , satisfaction, a nd  d isab ility.127,128 The IOI-HA has b een  a p p lie d  to 
e v a lu a te  BAHA bene fit in pa tien ts w ith  un ila te ra l sensorineural hearing  
loss, a fte r six w eeks a nd  a fte r o ne  y e a r  of BAHA use123 (Table 4).
To the  best of ou r know ledge , the re  has not b een  a n y  hea ring  h a n d ic a p  
study (HHIE-s) on BAHA use. A sim ilar questionna ire , th e  Hearing 
H and icap  and  Disability Index (HHDI), has been  adm in is te red  to  patien ts 
w ith  sym m etric  p e rc ep tiv e  hea ring  loss w h o  regu la rly  use a  un ila te ra l a ir 
co nduc tio n  hearing  a id . 129
On a  g ene ric  level, the  HUI3 w ou ld  serve to assess a  g ene ra l s ta te  of 
hea lth  (generic  hea lth- re la ted  q ua lity  of life questionna ire ). The HUI-3 is a 
m ulti-attribute p re fe rence-based  instrum ent to m easu re  g ene ra l health- 
re la ted  q ua lity  of life.80,130,131
Table 4. Overview o f questionnaire outcom e in BAHA literature.
Conventional 
BAHA users
Bilateral BAHA 
user (range)
Unilateral BAHA 
user
BAHA CROS 
user
GBI 103 125 121
Total 31 - 33 38 (33 - 34) 17 - 20
General 37 - 42 50 (43 - 57) 25 - 28
Social 23 - 24 14 (8 - 21) 26 - 31
Physical 11 - 14 18 (11 - 25) 12 - 13
GCBI 127 127
Total 51 34
Emotional 53 31
Physical 38 29
Learning 64 60
Vitality 51 12
APHAB 105, 117, 121, 124
Ease of communication 5.8 - 16.2
Reverberant rooms 15.8 - 26.4
Background noise 15.7 - 33.1
Aversiveness to sound 11.4 - -9
IOI-HA 6 wks ( 1 year)124
Use 4.6 (4.2)
Benefit 3.5 (3.4)
Residual activity limitation 3.9 (3.5)
Satisfaction 4.0 (3.7)
Residual participation restriction 4.2 (4.0)
Impact on others 4.5 (4.4)
Quality of life 4.1 (4.0)
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The N ijm egen  C o c h le a r Im p lan t Q ues tionna ire  (N C IQ )132 c an  p ro v ide  a 
snapshot of th e  cu rren t s ituation rega rd ing  BAHA use.132,133,134 This 
ques tionna ire  is a  disease-specific ‘d isab ility a nd  h a n d ic ap ' instrum ent 
in itia lly des igned  for pa tien ts w ith  c o c h le a r im plants. It is know n to be  
sensitive to hearing- re la ted  quality-of-life issues in patien ts w ith  c o c h le a r 
im p lants a n d  c a n  e lu c id a te  the  cu rren t situation rega rd ing  hea ring  a id  
use. It consists of 60 items in six subdom ains: Basic Sound Pe rcep tion  
(BSP), A d v a n c e d  Sound Pe rcep tion  (ASP), S peech  P roduc tion  (SP), Self­
Esteem (SE), A c tiv ity  Lim itations (AL) a nd  Social In teractions (SI). The 
fo rm e r th ree  subdom ains a re  disability-specific, w h ile  the  la tte r th ree  a re  
hand icap-specific .
To the  best of ou r kno w le d g e  the re  has not b een  a n y  study app ly ing  the  
NC IQ  to  e v a lu a te  patien ts using a  BAHA, However, it has b een  used for 
pa tien ts w ith  o th e r a ud ito ry  im p lants a n d  co n ven tio n a l hea ring  aids.
In the  study repo rted  in c h a p te r 3.1, pa tien ts w ith  c o n d u c tiv e  o r m ixed 
hearing  loss w e re  asked to e v a lu a te  the  BAHA by m eans of the  
In te rna tiona l O u tc o m e  Inven to ry  - Hearing A id  (IOI-HA). O f p a rtic u la r 
interest w e re  the ir responses on age- re la ted  use a nd  p a tien t satisfaction.
The next C h a p te r (3.2) eva lua tes , a  distinct g roup  of BAHA users: ch ild ren  
w ith  un ila te ra l c o n d u c tiv e  hea ring  loss or b ila te ra l c o n d uc tive  hearing  
loss. The G lasgow  Child ren 's Benefit In ven to ry  (GCBI), th e  A b b re v ia te d  
Profile of Hearing A id  Benefit (APHAB) a nd  the  Health  Utility Index M a rk  3 
(HUI-3) w e re  used to assess d isease specific bene fit a nd  g ene ra l qua lity  
of life.
C h a p te r 3.3 dea ls  w ith  bene fit a nd  q ua lity  of life issues for the  o ld e r ad u lt 
BAHA popu la tion . That s tudy e v a lu a te d  134 o ld e r a d u lt BAHA users by 
adm in iste ring  four questionnaires: th e  G lasgow  Benefit In ven to ry  (GBI); , 
A b b re v ia te d  Profile of Hearing  A id  Benefit (APHAB); N ijm egen  C o c h le a r 
Im p lan t Q ues tionna ire  (NCIQ); a nd  the  Hearing H and icap  Inven to ry  for 
th e  Elderly sc reen ing  version (HHIE-S).
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Sc o pe  of this thesis
The ove ra ll o b je c tive  of this thesis is to  co lla te  c lin ica l d a ta  on a  specific 
surg ical im p lan ta tio n  te c hn iq ue  for th e  Bone an cho red  hea ring  a id  
(BAHA) and  p resent it a longs ide  d a ta  on patien ts' opin ions on the  
bene fit a nd  q ua lity  of life th e y  d e rive  from  using a  bone  a ncho red  
hearing  a id  (BAHA). The thesis comprises four chap ters.
The first c h a p te r (or in troduction) gives an  o ve rv ie w  of the  d iffe ren t types 
of surgery to  p la c e  the  im p lan t. It covers the  a p p lic a tio n  of BAHA and  
the  benefit- re la ted  topics found in the  BAHA lite ra ture.
C h a p te r 2 dea ls  w ith  BAHA surgery pe rfo rm ed  w ith  the  linea r incision 
techn ique . In Section  2.1 th e  linea r incision te c hn iq ue  is desc ribed  
extens ive ly and  the  long-term c lin ica l results of a  consecu tive  series of 
BAHA users a re  p resented . Section  2.2 dea ls  w ith  a  specific  and  
cha lleng ing  g roup  of BAHA users, n a m e ly  ch ild ren. It presents the  c lin ica l 
results of th e  linea r incision techn ique . In Section  2.3 th e  linea r incision 
te c hn iq ue  is e v a lu a te d  for o ld e r adults. The em phasis of this section is on 
w o und  hea ling  and  com p lications. In Section  2.4 the  re la tion  b e tw e en  
im p lan t position, soft tissue reac tion , a nd  skin thickness is s tud ied in a d u lt 
BAHA patients.
C h a p te r 3 comprises th ree  studies on p a tie n t re la ted  a ud io lo g ic  benefit 
ou tcom es. In Section  3.1 th e  o ve ra ll b ene fit of BAHA users is stud ied in 
re la tion  to the  patien ts' a g e . Section  3.2 e v a lu a te  the  bene fit of BAHA in 
the  day-to-day lives of ch ild ren  w ith  un ila te ra l c o n d u c tiv e  hea ring  loss, 
as w e ll as the  bene fit to  those w ith  b ila te ra l c o n d u c tiv e  o r m ixed  hearing  
loss, using v a lid a te d  questionnaires. C h a p te r 3.3 e va lua te s  sub jec tive  
bene fit a nd  q ua lity  of life in o ld e r a d u lt BAHA users w ith  m ixed  hearing  
loss.
C h a p te r 4 presents a  g ene ra l discussion. A sum m ary of this PhD thesis in 
English a nd  Dutch, is p ro v ided  in C h a p te r 5.
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A bstract
O b je c tive : To e v a lu a te  the  c lin ica l o u tc o m e  of a  simplified surg ical 
te c hn iq ue  fo r BAHA im p lan ta tion , in terms of im p lan t fa ilu re  and  its 
causes.
Design: Re trospective  analysis.
M ethods: Analysis of a  consecu tive  coho rt of 142 patien ts (150 lo a d ed  
implants) fitted  w ith  th e  BAHA im p lan t b e tw e e n  Janua ry  1, 1997, and  
D e c e m b e r 31, 1999. The simplified surg ical N ijm egen  te chn iq ue  
comprises a  long itud ina l post a u ric u la r incision, extens ive  subcu taneous 
tissue reduc tion , a nd  rem ova l of th e  periosteum . C lin ica l ou tcom es 
w e re  the  ra te  of im p lan t failures, its causes for this, a nd  skin reactions 
a ro und  th e  p e rcu taneous  im p lants classified a cco rd in g  to  Holgers. 
C lin ica l results w e re  c o m p a re d  w ith  o th e r BAHA series.
Results: M e a n  follow-up w as 5.6 ± 2.7 years (range, 0-10.5 yr). Holgers 
g ra d e  2 o r m o re  seve re  skin reactions w e re  seen in 6.5% of the  1,038 
follow-up visits. Extrusion of th e  im p lants occu rred  as a  result o f fa iled  
osseo in teg ration  (N = 3), tra u m a  (N = 5), in fec tion  (N = 1), a nd  (other) 
m ed ica l reasons (N = 5 exp lanations). Total extrusion ra te  w as 9.3%. O n ly  
3% (1 a nd  3) w e re  d u e  to fa iled  osseo in tegration o r in fec tion a round  the  
pe rcu taneous  im p lan t.
C onclus ion: The m od ified  N ijm egen  surg ical te c hn iq ue  is a  sim ple 
s tra igh tfo rw a rd  surg ical p ro ced u re  w ithou t th e  use of a  p ed ic led  skin 
flap. Surgery takes a p p ro x im a te ly  20 minutes. M eticu lous p e rfo rm ance  
of the  p ro ced u re  is cons idered  im po rtan t to  a c h ie v e  op tim a l results in 
th e  long-term. Particu la rly  th e  soft tissue reduc tion  has to  b e  d o n e  w ith  
g re a t ca re . In terms of the  low  rates of im p lan t fa ilu re  and  ad ve rse  tissue 
reactions, th e  N ijm egen  surg ical te c hn iq ue  p ro ved  to  b e  a  good  
a lte rn a tiv e  to  o th e r techn iques.
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In tro d u c t io n
In 1977, a  pe rcu taneous  titan ium  im p lan t w as in troduced  in a  c lin ica l 
e xp e rim en ta l setting to  support a  skin-penetrating bone  co nduc tion  
hea ring  a id  (BAHA) (Entific M e d ic a l systems AB, G o tebo rg , S w eden ).1
The surg ical im p lan ta tio n  te chn iq ue  has g rad u a lly  b een  simplified. The 
o rig ina l 2-stage surg ical p ro ce d u re 2,3 w as re d u c ed  to  a  1-stage 
p ro ced u re  in 1989 a n d  has rem a in ed  th e  surg ical s tanda rd  in adults 
since then .4,5 In the  ea rly  90s, a  simplified surg ical te c hn iq ue  was 
d e ve lo p e d  step by step in N ijm egen .6,7 U ltim ate ly, on ly  a  long itud ina l 
incision rem a ined , instead of th e  previous (semi) c ircu la r incision, to 
fa c ilita te  w id e r subcu taneous tissue reduc tion  a nd  to  a vo id  th e  need  for 
a  th inned  free  skin flap. A th inned  free-skin g ra ft w as a vo id ed , a nd  the  
sometimes-associated skin necrosis of th e  free-skin g ra ft d isap p e a red .6 
Furtherm ore, th e  periosteum  was rem o ve d  w ide ly . The du ra tion  of 
surgery d ro p p e d  to  20 m inutes, a n d  on ly  2 pos tope ra tive  check-ups 
w e re  need ed . Finally, rou tine  follow-up visits w e re  lim ited to  o n c e  a  yea r.
O n e  of the  m a in concerns rega rd ing  the  p e rcu taneous  im p lan t is th e  skin 
reac tio n  a ro und  th e  titan ium  skin-penetrating coup ling .8 Regu la r 
c lean ing  usually p revents skin reactions, a n d  in case  of skin reactions, th e  
use of a  m ed ic a l o in tm en t usually treats these reactions successfully.9 
However, skin reactions c a n  h a ve  a  m ore serious o u tc o m e  such as skin 
o ve rg row th , skin necrosis, im p lan t extrusion, a n d  m o re  seve re  w o und  
infections.10-12 Also, an  in trac e reb ra l abscess has been  repo rted  as a 
co m p lic a tio n  of an  a b u tm e n t c h a n g e .13
The a im  of this study w as to  e v a lu a te  long-term c lin ica l d a ta  rega rd ing  
th e  simplified N ijm egen  surg ical BAHA im p lan ta tio n  techn ique . A tten tion  
is g iven  to  th e  freq uenc y  a nd  d e g re e  of tissue reac tio n  a ro und  the  
im p lan ta tio n  site, extrusion ra te , a n d  m a n a g e m e n t of these 
com p lica tions. The surg ical p ro ced u re  is desc ribed  a nd  illustrated. The 
c lin ica l results a re  p resen ted  a nd  c o m p a re d  w ith  previously repo rted  
results in lite ra ture.
PATIENTS AN D  METHODS
The patient's coho rt consisted of 142 patien ts w h o  w e re  fitted a  titan ium  
BAHA im p lan t b e tw e e n  Janua ry  1, 1997, and  Janua ry  1, 2000.
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Figure 1A-F: Presentation of the surgical technique applied to implant the BAHA 
implant. A; Implantation location, B; Exposure of the periosteum, C; Drilling 
procedure and placement of the fixture under saline irrigation, D; Area of subcutis 
reduction, E; Subcutis reduction procedure, F; Healing cap and position of the 
yanka uer.
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te c hn iq ue  w as used.6 Two surgeons, C.W.R.J. C. a nd  E.A.M. M., 
pe rfo rm ed  th e  sam e surg ical techn ique ; the ir co m b in ed  results a re  
inc luded  in this study.
S u rg ic a l In te rv e n tio n  o f th e  N ijm e g e n  S u rg ic a l B A H A  P ro c e d u re
The surg ical p ro ced u re  in adults is g e n e ra lly  pe rfo rm ed  in d a y  ca re . The 
id ea l site of im p lan ta tio n  is lo c a te d  mostly a p p ro x im a te ly  50 to 55 m m  
posterosuperio rly to  the  e a r  c a n a l on th e  mastoid, le av ing  enough  
space  posterio r to  th e  au ric le  for th e  BAHA transducer. A long itud ina l 
incision of a p p ro x im a te ly  30 m m  is m a d e  (Figure 1A). A fte r sharp 
dissection of th e  subcu taneous tissue, th e  periosteum  is exposed  and  
m obilized (Figure 1B). Next step is th e  drilling p ro ced u re  desc ribed  by 
Tjellström and  G ranström .4 Suffic ient coo ling  is a c h ie ve d  by saline 
irrigation. The im p lan t is p la ced , a nd  th e  im p lan t is contro l- tigh tened  
m a nua lly  (Figure 1C).
Subsequently, subcu taneous tissue is re d u c e d  extens ive ly  o ve r an  a re a  
of a p p ro x im a te ly  2 cm  a round  th e  incision. The skin is s tre tched  b e tw e e n  
2 hooks; th e  fingertip  of th e  surgeon is p la c e d  on to p  of th e  s tre tched  
skin, p rov id ing  th e  best con tro l to  thin the  skin m ax im a lly , first by excision 
and , add itio na lly , by sc rap ing a w a y  th e  rem a in ing  subcu taneous tissue 
g u id ed  by p a lp a tio n  (Figure 1, D a nd  E). Add itio na lly , th e  rem a in ing  
periosteum  is rem oved . The w o und  is c losed w ith  a t least 4 sutures. The 
c a u d a l end  of the  long itud ina l incision is left o pen  for d ra in a g e  (Figure 
1F). During th e  en tire  p rocedu re , suction is d o n e  by a  Y a n kau e r (Tyco 
H ea lthca re , Tu llam ore, Ire land) positioning itself a t this location . During 
c losure of th e  w ound , th e  Y a n kau e r p rovides a  va cuum , a vo id ing  b lood  
re ten tion . The im p lan t is re lo ca ted , th e  skin a t this a re a  is p unc tu red  w ith  
a  pouch, a nd  th e  a b u tm e n t is p la ced . In case  th e  im p lan t is in line w ith  
th e  skin incision, punc tu ring  of th e  skin is no t n eeded . G auze  soaked  in 
an tib io tic  o in tm en t (Terra-Cortril®) (Pfizer BV, C a p e lle  a /d  IJssel, The 
Netherlands) is w ra p p e d  a round  th e  a b u tm e n t a fte r th e  hea ling  c a p  is 
snapped  on. Finally, a  pressure h e a d  dressing is a p p lie d  a round  the  
h e a d  for a t least 3 hours, p re fe rab ly  24 hours (Figure 1G). R em ova l of the  
Terra-Cortril g auze  a nd  hea ling  c a p  is d o n e  in th e  o u tp a tie n t c lin ic a t th e  
first visit a fte r 1 w eek . Further t re a tm e n t consists of th e  ap p lic a tio n  of a n ti­
in f lam m a to ry  o in tm en t (Terra-Cortril®) a ro und  th e  pe rcu taneous  im p lan t 
o n c e  a  day, for 2 weeks. P reo pe ra tive  ora l antib io tics w e re  not used.
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Figure 2: Age in years in categories at the time of surgery, age 
distribution, and age at the time of surgery per implant (N = 150).
In these series, a  to ta l of 15 ch ild ren  w e re  o p e ra te d  in a  2-stage surgical 
p rocedu re . First, th rough  a  long itud ina l incision as previously described , 2 
im p lants a re  p la c e d  w ith  a  c o ve r screw, a n d  th e  skin is c losed  in 2 layers. 
O n e  im p lan t will b e  lo aded ; th e  o th e r will rem a in  subcu taneous as a 
"sleeper." Three months later, th e  second  s tage  is pe rfo rm ed  on one  of 
th e  im p lants as previously described . O n ly  lo a d ed  im p lants w e re  
inc luded  in th e  study.
Table 1: Indication titanium implant (N = 150).
Indication titanium implant n (%)
Acquired conductive / mixed hearing loss 120 (80)
Congenital conductive hearing loss 27 (18)
Unilateral inner ear deafness 3 (8)
Total 150 (100)
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Figure 3: Type of implant loss according to survival time (in months).
Fo llow -Up
In adults, th e  BAHA transduce r w as fitted  a fte r a  re c o ve ry  period  of 6 to  8 
w eeks  to  p ro v ide  suffic ient osseo in tegration. In this period, 2 re turn  visits 
w e re  need ed . The patien ts in itia lly had  to  c h e c k  up a t least o n c e  e ve ry  4 
months. Later, th e  check-up in te rva l was p ro longed  to  6 months, and  
now adays, o n c e  e ve ry  y e a r  is th e  s tandard . Patients had  to  m a ke  an  
o u tp a tie n t c lin ic a p p o in tm e n t for these ye a r ly  check-ups them selves.
Eva lua tion  of th e  tissue reac tio n  a ro und  th e  a b u tm e n t w as d o ne  
a cco rd in g  to  the  classification by Holgers e t a l.8 This w as d o n e  using a 
p re fab ric a ted  ta b le  on a  s tam p  in the  m ed ica l records. Inspection of the  
tem p o ra l b one  a n d  the  a b u tm e n t stab ility on the  im p lan t w as d o ne  
m a nua lly  w ith  th e  use of specific instruments. These eva lua tions  w e re  
d o n e  during e ve ry  o u tp a tie n t clin ic follow-up visit.
S ta tis tic s
To d e te rm in e  the  extrusion ra te , on ly  the  lo a d ed  im p lants a re  no ted . 
W hen  an  im p lan t loss occu rred  w ith in  th e  obse rved  years, th e  
re p la c e m e n t im p lan t w as cons ide ra te  a  n ew  im p lan t. Com parisons of 
c a teg o ric a l va riab les  w e re  m a d e  using [chi]2 tests o r Fisher's e xa c t test. 
Time-to-event analyses w e re  c o n d u c te d  using th e  log-rank test and  
Kap lan-M eier curves. SPSS version 14 (SPSS, Inc., C h ic ago , IL, USA) a nd  
Prism g rap h  p ad  5 (G raphP ad  Software, La Jo lla, CA, USA) w e re  used. 
The leve l of s ign ificance a p p lie d  w as P = 0.05.
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Figure 4: Kaplan Meier survival curves in 149 adults by Tjellström and 
Hakansson5 (follow-up 0 to 5 years) and the current study (150 
adults and children [follow-up 0 to 10 years]). Events were implant 
loss due to failed osseointegration, infection or trauma.
RESULTS
O n e  hund red  fifty im p lants w e re  im p lan ted  in 142 patien ts in 1997, 1998, 
a nd  1999. Fifty-six pa tien ts  w e re  m en, a nd  86 w e re  w om en . The m ean  
a g e  a t im p lan ta tio n  w as 56 years (standard  dev ia tion , ± 20 yr). The a g e  
distribution is p resen ted  in figure 2. O n e  hund red  th irty pa tien ts w e re  
fitted  a  BAHA on 1 side; 14 pa tien ts w e re  fitted  a  BAHA on 2 sides 
(b ila te ra l fitting), 6 of w h ich  w e re  fitted  a  second  BAHA in th e  sam e 3 
years. Eight pa tien ts re c e ived  a  second  im p lan t for b ila te ra l BAHA 
a p p lic a tio n  in m o re  recen t years; these second  BAHA im p lants w e re  
e xc lu d e d  from  this study.
Tab le  1 gives an  o ve rv iew  of the  ind ications for fitting pa tien ts w ith  a 
BAHA. The most co m m on  reasons for fitting a  p a tie n t w ith  a  BAHA in 
those years w e re  ch ron ica lly  in fec ted  ears a nd  m ino r o r m a jo r 
co ng en ita l anom a lies  of th e  ear.
In 133 cases (88.7%), th e  1-staged surg ical te c hn iq ue  w as used. The 
m e an  a g e  of these patien ts w as 51 ± 16 years (range, 15-82 yr). In 15 
cases (10%), a  2-stage surg ical te c hn iq ue  w as used. This g roup  consisted
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Table 2: Life table for BAHA implant in the studies by, Tjellström and 
Hakansson5 and the current study.
Current study Tjellström and Hâkansson5
Follow-up 
period (years) Total No. Implant loss Total No. Implant loss
0-1 y 150 1 149 2
1-2 y 140 0 122 0
2-3 y 134 0 104 1
3-4 y 124 3 68 2
4-5 y 117 2 39 0
5-6 y 110 1
6-7 y 80 0
7-8 y 64 0
8-9 y 39 3
9-10 y 17 0
10-11 y 3 0
m a in ly  of ch ild ren. O n e  a d u lt (49 yea rs  old) w as o p e ra te d  in 2 stages 
b ecause  of m en ta l re ta rda tio n . The m ean  a g e  of th e  ch ild ren  in this 
g roup  a t im p lan ta tio n  w as 9.6 years (range, 4 to  14 yr). O n e  p a tie n t on ly 
und e rw en t a  second-stage p ro ced u re  in this c lin ic b ecause  th e  first 
s tage  w as d o n e  e lsew here. In 1 o the r case, a  second-stage p ro cedu re  
w as d o n e  on a  previously im p lan ted  sleep ing im p lan t.
All 150 im p lants e xc e p t 2 w e re  4-mm im plants. A m e an  of 72 m onths 
(range, 0-125 months) of follow-up for e a c h  titan ium  im p lan t a nd  a 
m e an  of 6.9 ± 4.5 observations p e r im p lan t w e re  found.
Figure 3 shows th e  causes of im p lan t loss (N = 14 [9.3%]). Im p lan t loss was 
spon taneous in 2% (N = 3), w he reas  1 im p lan t w as lost d u e  to  a  Type 4 
skin reac tio n  (0.7%). T raum a caused  im p lan t loss in 5 patien ts (3.3%). All 
lost im p lants w e re  4-mm im plants. Duration until im p lan t loss ra n g e d  from  
5 to  55 months (Figure 3): a v e ra g e  du ra tion  until im p lan t loss w as 27 
months. O n e  spon taneous loss occu rred  in a  4-year-old ch ild  a fte r 7 
m onths of use. The others occu rred  in e ld e rly  persons a g e d  62 a nd  79 
years a fte r 55 a nd  43 months of use, respective ly . No e xp lan a tio n  was 
found  for th e  im p lan t loss. A Type 4 skin reac tio n  caused  the  im p lan t loss 
in a  12-year-old ch ild  a fte r 16 months of use. Survival is shown in Tab le  2, 
w he reas  Figure 4 presents a  survival cu rve .
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Table 3: Clinical data on skin reactions (according to Holgers) and 
revision surgery.
Distribution Most severe skin reaction
N (%) Per observation N (%) Per implant
Types of skin reactions
0 = no irritation 866 (83.4) 74 (49.3)
1 = slight redness 105 (10.1) 36 (24.0)
2 = red and moist tissue 53 (5.1) 27 (18.0)
3 = granulation tissue 11 (1.0) 10 (6.7)
4 = infection leading to removal of 
abutment 3 (0.4) 3 (2.0)
Total 1038 (100.0) 150 (100.0)
Number of adverse skin reactions
0 74 (49.3)
1 36 (24.0)
2 24 (16.0)
3 3 (2.0)
4 3 (2.0)
5 5 (3.3)
7 1 (0.7)
8 1 (0.7)
9 2 (1.3)
10 1 (0.7)
Total 150 (100.0)
Revision surgery
Subcutis reduction
Reduction skin-overgrowth
Second stage 
Total
10 (43.5)
9 (39.1)
4 (17.4)
23 (100.0)
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A to ta l o f 1,038 observations o f the  skin around the  ab u tm e n t w ere 
re co rded  during the  fo llow -up period o f 10,765 months. No abnorm alities 
w ere  found in 866 observations (83.4%). An overv iew  is g iven in Table 3.
Adverse skin reactions w ere  observed in 172 cases; 61% was Type 1 skin 
reactions, 30.8% was Type 2, 6.5% was Type 3, an d  only 1.8% was Type 4 
skin reaction .
Table 3 shows the  adverse skin reactions. There w ere  no episodes o f skin 
reaction  in 74 patients (49%), whereas 76 patients (51%) showed some 
sort o f skin reaction . The most severe tissue reaction  in e a ch  pa tien t is 
presented in Table 3. Type 4 skin reactions w ere  observed only 3 times. 
This (Type 4 reaction) led to  failure o f 1 im p lan t and  to  tem porary 
rem oval o f 2 abutm ents to  a llow  the skin to  heal.
Holgers g rad e  2 skin reactions or higher occu rred  a t some point during 
fo llow -up in a to ta l o f 40 implants (27%). In 8 o f these implants, the  
patients w ere  younger than 16 years. This a c c o u n te d  for 50% o f the  
children in this study (N = 16). In the  o lder patients (N = 134), only 32 
im plants had a Holgers g ra de  2 skin reaction  or higher (24%). The 
d iffe rence  be tw een  the  a g e  groups was significant (P = 0.03).
In the  first 60 months o f im p lan t use, Holgers grades 2 to  4 skin reactions 
arose in the  interval mostly from 11 to  21 months (m edian, 16 months; 
95% co n fid e n ce  interval), whereas Holgers g ra de  1 reactions mostly 
arose be tw een  20 and 58 months (m edian, 39 months; 95% co n fid e n ce  
interval). A fter 60 months o f use, there w ere  no longer any differences in 
o ccu rre nce  be tw een  the groups.
Tissue revision surgery took p la ce  23 times in 20 patients (15%): 8 times 
because o f skin overgrow th, 10 times because o f th ick tissue around the 
abu tm en t, and  4 times as part o f second-stage surgery a fte r 
spontaneous loss or traum a to  the ab u tm e n t (Table 3).
In these 20 patients, second revision surgery was neede d  in 3 cases: 2 
patients ne eded  a second opera tion  to  reduce  the  subcutaneous tissue, 
and  1 pa tien t needed  surgery a fte r spontaneous ab u tm e n t loss and  a 
second ep isode o f tissue overgrow th  around the new  ab u tm en t, bo th  
neede d  revision surgery. A verage interval until the  first tissue reduction 
opera tion  (N = 16) was 39 months (range, 5-86 months). Holgers g rade  2 
skin reaction  or higher was present in 3 cases a t the  tim e o f revision 
surgery, whereas 9 implants had shown Holgers g rad e  2 skin reactions or 
higher a t some tim e during the  period be fore  tissue revision surgery. Thus,
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9 o f the  40 implants th a t had a Holgers g rad e  2 skin reaction  or higher 
also needed  tissue revision surgery. This was a significant d iffe rence  
co m p a re d  w ith the  7 implants in the  g roup w ith the  Holgers g rad e  of 
low er than 2 (N = 110) (P = 0.003). There was no significant d iffe ren ce  in 
the  need for tissue revision surgery be tw een  adults and children.
When th ick skin was persistent or recurrent, an 8.5-mm abu tm en t 
p la cem e n t can  be a useful solution besides revision surgery. This was 
d o ne  in 6 cases, and  all w ere  successful.
DISCUSSION
Since Tjellström e t a l.1 first in troduced  the  BAHA system in 1977, it has 
undergone a d ap tio n  a t several clinics w orldw ide. O ver the  years, the  
surgical p rocedure  has been adjusted. Several BAHA team s have 
reported  their m odifications to  the  tech n iqu e .5,10,14-21 In essence, there 
are 2 m ajor goals: osseointegration and the  prevention o f soft tissue 
reactions. Subcutaneous tissue reduction  prevents soft tissue m ovem ent 
and  subsequently reduces the  de ve lop m e n t o f scar tissue and  infection. 
The aim is to  provide a thin hairless skin site tha t can  a tta c h  itself to  the 
d e e p e r bony layer.
Overall, the  surgical techniques used by several experienced  surgeons 
vary in their m ethods o f soft tissue reduction. The issues are w he ther the 
periosteum should be  rem oved and  w h e th e r a skin g ra ft can  be 
avo ided . Initially, a free re troauricu lar skin g ra ft was used,10,19 w h ich later 
mostly b e ca m e  a loca l skin fla p .16,19 In m ore recen t years, several 
surgeons have m ade  m odifications to  the  surgical p rocedure ; some 
started to  use a de rm a tom e  to  c re a te  the  skin fla p ,10,18 others used 
c ru c ia te  incisions in a c irc le 15 or a c ircu la r incision w ith 4 radia l incisions 
into the  surrounding tissue.17
In N ijmegen, Mylanus and  Cremers6 initially used a linear incision and  a 
re troauricu lar split-thickness skin graft. The main d iffe rence  was the 
longitudinal incision instead o f a round or U-shaped one. The intention 
was to  fac ilita te  m ore extensive subcutaneous tissue reduction  and 
rem oval o f the  periosteum while keeping tissue traum a to  a minimum. 
Since then, a few  add itiona l m odifications have been m ade  to 
d iscontinue the  use o f a free-skin graft.
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Table 4: Overview of the literature on BAHA surgery.
Author Year Location
Mean follow-up in 
N** years ± SD (min - 
max)
Skin reactions
Type of surgery
Complications Implant loss
Holgers
classification
Number / all 
observations
necrosi tissue 
s reduct.
O (%) I (%) T R
%
T&R
loss
N (No. % Loss
lo aded  / tot.
im p lan t im p la
s) nts
BAHA implants N > 100
Current study 2008 Nijmegen 142 5,6 (0 - 10.5)
House and Kurtz11 2007 California 149 NA (0 - 4)
Tjellströme. et al.18 2007 Göteborg 138 1,9 (0.4 - 3.4)
Tjellström and 
Granström10 2006 Göteborg
76
33 0,1 (0 - 0.1)
Reyes at al.9 2000 Göteborg 149#
£  *^** (0 - 8)
Van der Pouw et
al.25 1999 Nijmegen 155 NA (0.7 - 7)
Proops et al.16 1996 Birmingham 188 NA (0 - 9)
Tjellström and 
Hâkansson.5 1995 Göteborg
149
#
2 *^** (0 - 5)
Tjellström and 
Grandstrom 26 1994 Göteborg 100 NA (8 - 16)
Tjellström et al.20 1989 Göteborg 230 4,4 (0 to 11)
Split-thickness flap / 
dermatome
Skin flap
Skin flap dermatome NA
Skin graft Grade > 2 (4 yrs / use)
Skin graft (N= 131) / linear 
inc. (N= 32) Grade > 2
Skin graft NA
Skin graft Grade > 2
Skin graft NA
Skin graft Grade > 2
_ , . 0 67 / 1038 = Grade > 2 6.5%
NA NA
NA NA
NA
2,40%
39 /1382 = 
2.8%
NA
14/806 = 1.7%
NA
42 /1140 = 
3.7%
0
1
NA
8
1
NA
0
0
NA
NA
NA
19
11
NA
NA
NA
6
6
NA
NA
NA
3 (2) 
1
1
(0.7)
4
(0.7) (2.7) 
2 1
(1.4) (0.7)
NA NA
5 5 6.6 150 9.3
0 0 0 149 3.4
0 2 1.4 138 3.6
N
A NA NA
76
33 NA
9 (6) 0 (0) 4 13 11.4 
1 (0.6) 3(1.8)
3
(1.6)14 (7)
4 
(2.7)
5 (5) 0 (0) 5
0 (0)
1 1 
(°.4) (°.4)
5
149 17.4
3 3 163 5.5
0 1.1 188 10.1
11 7.3 149 10.7
0 5 100 10
14 8 230 8.8
0 0 58 3.4
0 0 21 0
0 0 1111
0
0
0 0 63 2
0 0 15 0
0 3 33 6
0 0 67 1.5
1 7 14 7
BAHA implants N < 100
Shirazi et al.12 2006 Maywood
Persaud et al.15 2006 Herts
Lekakis et al.22 2005 Kent
Gillett et al.27 2006 Ashfort
Snyder et al.23 2003 Omaha
Mylanus & Cremers.6 1994 Nijmegen
Holgers et al.8 1988 Göteborg
Tjellström et al.29 1983 Göteborg
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21
11
11
63
15
33
60
14
NA
NA
(1 - 3) 
NA
NA (0.8 - 3.3)
Superiorly based skin flap 
4 thin local skin flaps
Full thickness skin flap 
Split thickness skin graft
NA
NA
NA
NA
NA
(2 - 9) 
NA
local skin graft**
Full thickness skin graft 
according to Brânemark 
(0.8 - 2.1) Linear incision + graft 
(0.3 - 8) Skin graft 
(3 - 5) Skin graft
NA
NA
Grade > 2 
1st visit
NA 
NA 
Grade > 2 
Grade > 2 
NA
NA
NA
2 /11 = 18%
9 /11 = 82%
21 / 63 = 33%
NA
7 / 26* = 21%
8 / 313 = 2.6%
NA
6
0
0
0
0
7
0
0
NA
3
0
0
0
11
0
0
0
NA
2 (3) 
0 (0)
0 (0) 
0 (0)
0 (0) 0 (0) 
1(1,6) 0 (0)
0 (0) 
0 (0) 
0 (0) 
0 (0)
0 (0) 
1(3) 
1(1,5) 
0 (0)
BAHAand auricular prostheses implants 
Tjellström et al.4 1995 Göteborg 214 NA (0 - 5) Skin graft Grade > 2 14 / 806 = 1,74 0 0 0 (0) 1 0 0.4 281 2.5
NA = No data available * Number / patient s 
population
: Number of included patients *** personal communication O = Osseointegration I = Infection T = Trauma R = Other causes for loss or removal # = same
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This m odified N ijm egen surgical tech n ique  has several advantages. First, 
a 2.5 to  to  3-cm  longitud inal incision causes only minimal d istu rbance of 
the  skin a t the  g ra ft site. Second, soft tissue can  be  re duce d  extensively 
(over an area o f approx im ate ly  6 by 4 cm  [18.9 cm 2]) because o f the 
w ide  scope o f the  scalpel and  because o f the  rem oval o f the 
periosteum. Third, it is no longer necessary to  preserve the  periosteum to 
fac ilita te  g ra ft perfusion. Fourth, absence  o f a ped ic led  or free-skin gra ft 
com p le te ly  avoids necrosis. A cco rd ing  to  the  literature, the  periosteum 
was trad itiona lly  left in situ to  m aintain an a d e q u a te  b lood  supply to  the  
skin g ra ft.11,19,22,23 With the  N ijm egen surgical techn ique, the  small 
longitudinal incision causes only minimal tissue d a m a g e  and  does not 
disrupt the  a d e q u a te  b lood supply in the  ou te r layers o f the  skin; 
therefore, the  periosteum can  be  rem oved. No skin necrosis occu rred  in 
the  popu la tion  eva lua ted  in this study. Fifth, in experienced  hands, the  
surgical p rocedure  takes an ave rage  o f 20 minutes. Sixth, the  children in 
ano th e r N ijm egen24 study a tte n d e d  an a ve rag e  o f only 1.8 ± 0.8 ch e ck ­
ups in the  first 4 months a fte r im p lan ta tion , w h ich ind ica ted  qu ick and 
uneventfu l recovery.
In the  literature, w e  focused on larger studies (N > 100) w ith a re latively 
long fo llow -up period. In these studies, overall im p lan t loss was 5.5 to  
17.4%. In this study, w e  found 9.3% im p lan t loss, w h ich  is in line w ith the 
lite ra ture .9,16,20,25
In eva luating  BAHA surgical procedures, however, im p lan t loss due  to  
osseointegration and  in fection are considered to  be d irectly  re la ted to  
the  surgical p rocedure  and  are therefore presented separately. Loss due 
to  fa iled osseointegration ranged from 0.4 to  7%, and  loss due  to  
in fection ranged  from 0.4 to  2.7% (Table 4).5,9-11,14,16,20,26 Im plant loss rates 
due  to  fa iled osseointegration and  in fection in this study on a to ta l o f 150 
im plants w ere  2% and  0.7%, respective ly. These rates w ere  co m p a ra b le  
w ith earlier N ijmegen BAHA team  reports. Of 163 implants, van de r Pouw 
e t a l.25 lost 1 im p lan t (0.6%) because o f fa iled osseointegration and  3 
(1.8%) because o f infection. With respect to  failure due  to  in fection, the  
o u tco m e  o f this N ijm egen study was co m p a ra b le  w ith the  literature.
Overall loss due  to  fa iled osseointegration was re latively rare. 
Nevertheless, im p lan t loss was significantly higher in Birmingham (14 [7%] 
o f the  188; P = 0.024)16 and  in G othenburg  (9 [6%] o f the  149; P = 0,05)9 
than in this N ijm egen series (3 [2%] o f the  150). This m ight suggest tha t the 
long-term  results o f osseointegration w ith the  Nijmegen surgical
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techn ique  m ight even be be tte r than those w ith skin g ra fting  techniques 
in the  literature.5,16 In 1989, on the o ther hand, o f the  230 im plants (0.4%) 
w ith a m ean fo llow -up o f 4.4 years, Tjellström20 reported  only 1 loss due  to  
fa iled osseointegration, w h ich  was not significantly d iffe ren t from the 
current study. An interesting observation in the  Nijmegen study was tha t 2 
o f the  4 im plants w ere  lost because o f in fection, or fa iled 
osseointegration occu rred  in 2 ch ildren a g e d  4 and  12 years. This 
supports the  overall impression th a t children have a higher risk o f im p lant 
loss.
In the BAHA study by Tjellström and Hâkansson5 published in 1995 on their 
skin g ra ft techn ique, they used a life ta b le  to  present their results in 149 
implants: 4 im plants (2.7%) w ere  lost because o f osseointegration and  1 
(0.7%) because o f traum a. The life ta b le  en ab le d  a d e q u a te  com parison 
w ith the  current study, w h ich  revea led  no significant d ifferences (loss due 
to  fa iled osseointegration 3 (2%), in fection  1 (0.7%), and  traum a 5 (3.3%) 
for the  first 5 years. (Figure 4; Table 2). In the  m ore recen t literature, a 
new er surgical techn iqu e  has been presented using a loca l skin flap . The 
fo llow -up is still re la tively short, but the  results seem to  be 
co m p a ra b le .10,11,18 The use o f life tables is re com m e nd ed  to  fac ilita te  
com parisons o f the  techniques.
In the literature, adverse skin reactions have been described several 
times by means o f the  Holgers classification. The literature states a 3.7 to  
8% inc id e nce  o f adverse skin reactions w hen all adverse skin reactions 
(Holgers grades 1-4) are taken into consideration .4,5,9,25 In the  literature, 
however, mostly, Holgers g ra de  2 or higher was used to  ind ica te  
po ten tia lly  dangerous skin infections. Rates ranged  be tw een  1.7% and 
2.8% in the  large studies (N = 142-155, Table 4).5,9,25 M any studies reported  
the  pe rce n ta g e  o f adverse skin reactions a cco rd in g  to  the  to ta l num ber 
o f observed skin reactions.
With respect to  all adverse skin reactions (Holgers grades 1 -4), our results 
show m ore frequent (16.6%) adverse skin reaction . The m ajor part (10.1% 
o f the  tota l) consists, however, o f a G rade 1 (slight redness) reaction .
In the present study, 6.5% o f the  skin reactions w ere  Holgers g rad e  2 or 
higher, w h ich was almost tw ice  as those in the  literature. Comparison of 
the  p e rce n ta g e  adverse skin reactions in earlier and  more recen t periods 
o f this study (and possibly o the r studies) is incorrect from a 
m e thodo log ica l po int o f view. The systematic and  tigh t o u tp a tien t c lin ic 
fo llow -up was, ove r time, a b a n d o n e d  as a result o f the g o o d  o u tco m e  in
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the  Nijmegen series. O ver tim e, the  fo llow -up interval increased from 4 to  
12 months. Next to  this, patients had to  m ake an ap po in tm en t 
themselves, and  there was a te n d e n cy  for patients to  visit the  ou tpa tien t 
c lin ic only w hen problem s occurred . This m ight im ply tha t w e  saw 
re latively m ore adverse skin reactions. Therefore, the  overall num ber o f 
routine check-ups m ay not be such a re liable and precise m easurem ent 
as was presum ed earlier. A g o o d  a lte rna tive  m ight be  to  present the  
d a ta  in terms o f the  highest num ber o f po ten tia lly  dangerous (Holgers 
g rad e  > 2) adverse skin reaction  per im plant. In this study, 40 (26.7%) of 
the  150 im plants had a Holgers g ra de  2 skin reaction  or h igher a t least 
o n ce  during fo llow -up. This was c o m p a ra b le  w ith our 1994 results (21%), 
a lthough tha t popu la tion  was smaller (N = 33) and  fo llow -up was short 
(0.8-2.1 yr).7 The surgical p rocedure  used a t th a t tim e invo lved a linear 
incision w ith a free-skin graft, w h ich  ind ica tes tha t the  new  surgical 
techn ique  is equa lly  as good  w ith regard to  the  o ccu rre nce  o f skin 
reactions.
Tissue com plica tions tha t require revision surgery also re flec t the 
o u tco m e  o f im p lan ta tion  techniques. In the  literature, only a few  BAHA 
team s reported  these com p lica tions .11,12,14,16,27,28 Their inc idences ranged  
from 3 to  17%. The techniques used w ere  d e rm a to m e ,11 a superiorly 
based skin fla p ,12 loca l skin g ra ft,27 and  re troauricu lar skin g ra ft.16,25
In the present study, 18 overgrow n implants ne ede d  revision surgery in 16 
patients (10.7%). This was co m p a ra b le  w ith House and  Kutz11 and  Gillett 
e t al.27 The presence o f an adverse skin reaction  be fo re  most o f the  tissue 
revision surgeries m ight ind ica te  th a t these po ten tia lly  dangerous skin 
reactions p lay a role in the  de ve lopm en t o f th ick skin and  skin overgrow  
around the  abu tm ent, as reported  previously by van de r Pouw e t al.25 It is 
also possible tha t rem oval o f the  periosteum facilita tes the  form ation of 
scar tissue. A helpful solution seems to  be  the  re p lace m en t o f the  5.5-mm 
ab u tm e n t w ith an 8.5-mm one.
In conclusion, the  Nijmegen surgical tech n ique  to  im p lan t BAHA implants 
in the  co rtica l bone  p rodu ced  very favou rab le  results. Meticulous 
pe rfo rm ance  o f the  p rocedure  is considerab ly im portan t to  ach ieve  
op tim a l results in the  long term. Particularly, the  soft tissue reduction  has 
to  be  d o ne  w ith g rea t care. In terms o f the  low  rates o f im p lan t failure 
and  adverse tissue reactions, the  Nijmegen surgical techn iqu e  proved to  
be  a g o od  a lte rna tive  to  o ther techniques. It has several advantages: it 
is re la tive ly simple, avoids skin necrosis an d  requires little time.
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A bstract
O b je c t iv e s :  A re trospective analysis was perform ed to  eva lua te  the  
c lin ical o u tco m e  o f percutaneous bone-anch o re d  hearing aid (BAHA) 
app lica tio n  in ch ildren w ith the  o u tco m e  measures o f im p lan t loss and 
skin reactions.
M e th o d s :  An analysis was d o ne  o f 93 o f the  101 children 16 years o f ag e  
or younger w ho  underw ent the  simplified N ijm egen surgical techn ique  
be tw een  January 1994 and  July 2007.
Results: Twenty-one o f 129 implants (16.3%) w ere  lost or rem oved. In 12 
cases, osseointegration fa iled. The m ajority o f the  im plant losses (86%) 
occu rred  within 1 yea r a fte r surgery. No d ifferences w ere  found 
be tw een  3 a g e  groups or be tw een  im p lan t lengths (seven 3-mm 
implants versus fourteen 4-mm implants). The BAHA implants w ere  less 
stab le in ch ildren than in adults. In 8 cases, Holgers g ra de  4 skin 
reactions w ere  no ted  a t an ave ra g e  (±SD) o f 5.5 ± 4.7 months a fte r 
surgery, ie, s ignificantly sooner than the  m ilder reactions (P = 0.001). In 28 
cases (22%), skin reactions o f Holgers grades 2 to  4 w ere  observed. 
Revision surgery to  re duce  subcutaneous scar tissue was necessary in 22 
implants (17%).
C o n c lu s io n s :  Im plant loss was m ore frequent in ch ildren than in adults. 
The a g e  of the  child and  the length o f the  im plant did not a p p e a r to  
in fluence im p lan t stability. Children should undergo  frequent checkups 
a t the  o u tpa tien t clinic.
BAHA surgery in children
In t r o d u c t io n
A fter initial d e ve lop m en t in G o thenburg ,1 the  bo ne-anchored  hearing 
aid (BAHA) b e c a m e  com m erc ia lly  ava ilab le  in 1987. O ver the  years, 
ind ications for BAHA a p p lica tio n  have  been ex tended  from bilateral 
(mainly conductive ) hearing im pa irm ent to  unilateral congen ita l or 
acqu ired  co n d u c tive  hearing im pa irm ent.2-4 Binaural ap p lica tio n  has 
proved to  be  w orthw hile  in patients w ith b ilatera l hearing im pa irm ent.5-7 
In se lected patients w ith acqu ired  unilateral inner ea r deafness, the  
BAHA m ay provide benefit as a CROS (contra la tera l routing o f sound) 
d e v ice .8 Patients w ith mild de ve lopm en ta l re ta rda tion  are no longer 
exc luded  from BAHA a p p lica tio n  and  are known to  benefit from it.3,4
The minimum a g e  for BAHA im p lan t im p lan ta tion  has not been settled. 
The a pp rop ria te  a g e  is now  considered to  be  3 to  4 years, re la ted  to  the 
presence o f sufficient thickness o f the  cortica l b one .9 The in troduction  of 
the  BAHA so ftband in 2001 provided the  opportun ity  to  postpone the 
tim e o f a c tu a l im p lan ta tion  from 2 to  4 years to  4 or 5 years o f age . In the  
United States, the  m inimum a g e  is 5 years. The BAHA so ftband was 
d e ve lo p e d  to  enab le  ch ildren w ith substantial b ilatera l congen ita l 
con d u c tive  hearing loss to  hear a t a very early age . This ap p lica tion , w ith 
a BAHA fitted  on an elastic h e a db an d , is m ore pa tien t-friend ly than the 
bone  conductors on a steel band  over the  head. This system provides 
children w ith access to  aud ito ry  stimuli be fo re  the  a g e  of 3 years, w hich 
improves the  de ve lo p m en t o f speech and langua ge  skills.10
In this study, a consecutive  series o f 101 children of younger than 16 
years underw ent clin ical eva lua tion  a fte r BAHA ap p lica tio n . The focus 
was on the  o u tco m e  o f a specific surgical tech n ique  in 93 cases tha t did 
not involve the use o f a skin transplant or loca l skin flap.
Patients a n d  m e thods
The BAHA was first im p lem en ted  in this series in June 1988. Since then, 101 
children rece ived  a BAHA. (Figure 1).
In 1994, a new  surgical techn ique  b e c a m e  ava ilab le  in N ijmegen tha t 
d id not involve the  use of a skin graft. This study was perform ed on the  93 
children 16 years o f a g e  or younger, in N ijmegen, w ho  be tw een  January
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1994 and  July 2007 underw ent this new  techn ique . Patient 1 through 6, 
33 and  71 w ere  exc luded , because the  surgical techn iqu e  had inc luded 
a free skin graft. These 8 patients w ere  eva lua te d  separately.
In children of up to  the a g e  o f 10 years, the  N ijm egen BAHA surgical 
p rocedure  was genera lly  perform ed in 2 stages, as was the  initial BAHA 
p rocedure  in adults in the  early days o f BAHA surgery.11 Children m ore 
than 10 years old mostly had a 2-stage procedure . In more recen t years, 
a 1-stage p rocedure  has usually been perform ed. The decision for 
app ly ing  the  1-stage techn ique  in ch ildren over 10 years was based on 
bone  thickness (more than 4 mm) and  the  surgeons' experience. The 
N ijmegen procedure  involved a straight longitud inal posterosuperior 
incision behind the  auricle and  no use of a free  skin graft, as described 
by Van de r Pouw e t al.,12 Mylanus and  Crem ers13 and  De Wolf e t a l.14 
(Figure 2).
In the m ajority o f children, 2 titan ium  im plants w ere  im p lan ted : 1 to  be 
loa d ed  w ith a BAHA and  the  o ther as a “sleeper,” so tha t an 
osseointegrated im p lan t w ou ld  be  ava ilab le  if the  loa ded  im p lan t was 
lost. Surgery was perform ed by tw o  experienced surgeons.
A re trospective review  was m a de  o f the  m ed ica l records of all 93 
children w ho  underw ent BAHA a p p lica tio n  in N ijm egen by the m odified 
surgical techn ique  to  eva lua te  the  outcom es and  com plications. The 
fo llow ing d a ta  w ere  recorded  for use in the analysis: a g e  a t surgery, 
gender, type  o f m a lform ation or syndrom e if present, and  ind ica tion  for
120'
>-
year of implantation
Figure 1: Cumulative number of children 
operated in Nijmegen by year
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Figure 2: Presentation of the soft tissue handling in the Nijmegen 
surgical technique. A; Linear retroauricular incision, B; Exposure of 
implant site with local removal of periosteum, C; Areas of subcutis 
reduction in numeric order, D; removal of subcutis, E; healing cap 
with pressure dressing. (Figures B to E are reprinted with permission of 
Cambridge University Press.)13 Some additional lines and numbers (1­
6) have been added to C-E.
BAHA ap p lica tion . Surgical analysis d a ta  com prised the  typ e  o f surgery, 
num ber o f implants im p lan ted , length o f the  implants, presence o f dural 
exposure, and  tim e interval be tw een  the  first and  second stages o f the  
procedure .
Skin reactions fo llow ing the  new  surgical techn ique  w ere  classified 
a cco rd in g  to  Holgers e t a l.15 A g ra d e  2 or higher reaction  was 
in te rpre ted as an adverse skin re ac tio n .15 Im plant failure was also noted.
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All Patients (age < 1 6 years) 
w ho Underwent operation in 
Nijmegen 
__________|n= 10)__________
Patients included in this
study 219 implants(linear incision technique)
(n = 93)
75 unilateral 
implants 
81%
18 bilateral 
Implants 
19%
129 loaded  implants
75 18
unilateral 18 bilateral rep laced
3-mm implants 4*mm implants
(N = 31/129) (N -  98/129)
24% 74%
7/31 impiantloss 14/98 impiantloss
(33% of tota l loss) (67% of total loss)
Figure 3: Number of loaded implants and sleepers
If an im plant was lost, the  sleeper was considered a new  im p lan t w hen 
the  pa tien t was younge r than 16 years. In this w ay, only loa d ed  implants 
w ere  inc luded in the  study.
Initially, the  patients w ere  fo llow ed up every 4 months. Later, the  fo llow - 
up p ro toco l was ch a n g e d  to  6 months and  finally to  12 months. The 
fo llow -up exam ination inc luded checking  the  levels o f osseointegration 
and  ab u tm e n t stability by means o f a Unigrip to rque driver (Entific 
M ed ica l systems AB, G oteborg , Sweden, Maximum a p p lic a b le  fo rce  of
20
</■)"c0 15-a£
0 10-
E£D~Z 5-
0 11 I I I I i I I I I I i I I I
3 4 5 6 7 8 9 10 11 1213 14 1516
Age at time of surgery (y)
Figure 4: Age distribution at time of implantation 
in 129 implants.
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Table 1 : Specific syndromic diagnosis in 25 of 93 children.
Syndromic Diagnosis No. %
Down syndrome 7 28
Goldenhar syndrome or hemifacial microsomia 6 24
Treacher Collins syndrome 6 24
Grouchy syndrome (del.18q) 2 8
Turner syndrome 2 8
Ectodermal dysmorphia 1 4
Branchio-Oculo-Facial syndrome 1 4
Total 25 100
25 Newton centim eters) or the  surgeons' experience  o f the  maximum 
a p p lica b le  force. The skin reaction  acco rd in g  to  the  Holgers 
classification was no ted .16
S t a t i s t i c a l  a n a ly s e s
Comparisons o f ca te g o rica l variables w ere  m a de  w ith chi-square tests or 
Fisher's exa c t test. T im e-to-event analyses w ere  co n d u c te d  using the  log ­
rank test (M antel-Cox) and  Kaplan-M eier curves. SPSS version 14 was 
used. The level o f s ign ificance ap p lied  was P = 0.05.
Table 2: BAHA indication in 93 children.
BAHA indication N % 
Acquired hearing loss
Chronic otitis media 22 24
Total 22 24 
Congenital malformation
Congenital ear canal atesia 47 51
Treacher Collins syndrome 6 6
Goldenhar syndrome or hemifacial microsomia 6 6
Grouchy syndrome (del. 18q) 1 1
Branchio-Oculo-Facial syndrome 1 1
Total 61 65 
Combination of csom and syndromic features
Down syndrome 7 8
Turner syndrome 2 2
Ectodermal dysmorphia 1 1
Total 10 11
Total 93 100
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Results
The separa te  g roup of 8 out o f the  101 patients whose surgery had 
invo lved a skin g ra ft was fo llow ed-up  for a m ean duration o f 78 months 
(range, 2 to  229 months). Syndromic features w ere  present in 5 o f these 8 
children; in 3 cases these represented the  Treacher Collins syndrome. 
Only 3 implants w ere  lost or rem oved in 3 children: 1 was lost because of 
in fection, 1 was lost because o f traum a, and  1 had to  be  rem oved 
because o f m echan ica l d a m a g e  to  the  inner th read of the  im plant. In 1 
child, tissue revision surgery was perform ed. Holgers g rade  2 or g rea te r 
skin reaction  occu rred  in 4 children.
The new  techn ique  w ithou t skin gra fting  was a pp lied  to  93 patients (47 
boys and  46 girls). A to ta l o f 210 implants w ere  im p lan ted , and  129 w ere  
loaded . The characteristics o f this popu la tion  sam ple are presented in 
figure 3.
The m ean (±SD) a g e  a t surgery was 9.0 ± 3.8 years (range, 3 to  16 years; 
Figure 4). In 71 of the  129 loa ded  implants, the  m ean interval be tw een  
im p lan ta tion  and  load ing was 18.7 ± 7.2 weeks. These d a ta  w ere  missing 
in the  rem aining patients. Twenty-Five o f 129 (19%) o f the  implants w ere  
im p lan ted  in patients w ith syndrom ic features; Down syndrom e had the 
highest p reva lence  (N = 7; Table 1). The indications for BAHA a pp lica tion  
are shown in ta b le  2. Table 3 lists the  types o f incision and  surgical 
m ethods. In 1 child, auricu lar prostheses w ere  im p lan ted  a t the  same 
time, by means o f a question mark-like incision.
Table 3: Operative technique used in 129 implants.
BAHA surgery N %
Surgical method
Two-stage 91 71
One-stage 21 16
Additional 2nd stage on "sleeper" after loss 1st 17 13implant
Total 129 100
Incision used
Linear incision 113 87
Converted incision; square, horseshoe, question 
mark 16 13
Total 129 100
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Table 4: Abutments and implants lost or removed.
CAUSE No. %
Abutment
Skin reaction grade 4 3 42.9
Removed due to deterioration of cochlear function 3 42.9
Spontaneous loss 1 14.2
Total 7 100.0 
Implant
No osseointegration 12 56.2
Skin reaction grade 4 5 23.8
Trauma 3 14.2
Removed because of skin overgrowth 1 4.8
Total 2 1 1 0 0 . 0
In the  group o f 129 implants, 31 im plants (24%) had a length o f 3 mm and 
98 (76%) had a length o f 4 mm. In 69 cases (52%) the  drilled hole e n ded  
in bone, whereas in 52 cases (43%) the  dura was exposed. A sinus was 
visible in 6 patients (5%). These d a ta  w ere  missing in only 9 cases. There 
was no significant d iffe rence  in im p lan t loss due  to  fa iled 
osseointegration or in fection be tw een  the drill holes tha t end ed  in bone 
and  those in w h ich  dural or sinus exposure occu rred . Neither was there 
any significant d iffe rence  found in im plant length and  im p lan t loss. In 92 
implants, primary surgery consisted o f 2 stages. On ave rage , the  interval 
be tw een  the first and  second stages o f the  p rocedure  in these 92 
im plants was 18.47 weeks (range, 8 to  151 weeks). In only 9 cases was the
Cause of Implant loss
□  Spontaneous loss
□  Skinreaction type 4
□  Trauma
■  Re-implantation
,ini,ii,ii,inp inni
0 1 2 3 4 8 9 10 39 50 98 
Time in months until Implant loss
Figure 5: Causes of implant loss according to interval since 
implantation.
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interval be tw een  first and  second stage shorter than 12 weeks 
(consensus s ta tem e n t16), and  not shorter than 8 weeks in any cases. The 
16 lost implants in this g roup all had an in terstage interval o f more than 
12 weeks. The loading tim e was on ave ra g e  23.85 weeks (range, 11 to  
152 weeks). On 9 occasions, the  load ing interval was shorter than the  14 
weeks prescribed in the  consensus s ta tem en t,16 but it was never shorter 
than 8 weeks. The 16 lost im plants in patients 1, 2, 9, 14, 16, 19, 47, 51, 52, 
57, 59, 64, 70, 79, 80 and  85 w ere  all loa ded  a fte r a t least 14 weeks.
The to ta l duration o f fo llow -up tim e was 3,869 months (average, 30 
months; range, 0 to  159 months). A to ta l o f 457 fo llow -up exam inations 
w ere  m ade, w ith an ave ra g e  o f 3.5 ± 3.1 per im plant. On ave rage , 1.8 ± 
0.8 fo llow -up visits occu rred  in the  first 4 months a fte r surgery.
In 17 o f the  93 children, 21 im plants (16.3%) w ere  lost or rem oved by the 
surgeon (Table 4 and  Figure 5). A Holgers g rad e  4 skin reaction  was 
co rre la ted  w ith im plant loss in 5 patients an ave rag e  o f a b o u t 3.8 ± 3 
months a fte r surgery, and  spontaneous loss due  to  fa iled 
osseointegration occu rred  in 12 patients a fte r an ave ra g e  of 10 months 
(range, 0 to  50 months). In 10 o f the  12 cases o f fa iled osseointegrated 
(83%), spontaneous loss occu rred  in the  first 8 months a fte r surgery (Figure 
5). O ne pa tien t experienced spontaneous loss a fte r 39 months o f use, for 
no observable  reason. In ano the r patien t, the  im plant was surgically 
rem oved a fte r 50 months, because the  im p lan t had b e co m e  loose and 
tilted due  to  bone  apposition. In 1 child, the  im plant was rem oved and 
re im p lan ted  a fte r 98 months o f use because o f skin overgrow th. Figure 6 
gives an overv iew  o f the  causes o f im p lan t loss a cco rd in g  to  a g e  a t
Figure 6: Cause of implant loss in three groups at the time of 
surgery.
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Table 5: Life table for BAHA implants.
Follow-up 
period (y)
Current study Tjellström and Hâkansson17
Total No. % Implantloss Total No. %
Implant
loss
0-1 129 100 18 149 100 2
1-2 67 52 0 122 82 0
2-3 49 38 1 104 70 1
3-4 44 34 1 68 46 2
4-5 37 29 0 39 26 0
5-6 29 22 0
6-7 19 15 0
7-8 15 12 0
8-9 10 8 0
9-10 7 5 0
10-11 4 3 0
11-12 3 2 0
12-13 2 2 0
surgery in 3 a g e  groups. No d ifferences in the  to ta l num ber o f implants 
lost or in spontaneous im p lan t loss w ere  found be tw een  the 3 a g e  
groups.
All implants lost because o f fa iled  osseointegration (spontaneous loss), 
traum a, and  in fection (skin reaction  Holgers g rad e  4) are presented in a 
life ta b le  in ta b le  517 and  in a Kaplan M eier survival curve in figure 7.17
Figure 7: Kaplan Meier survival curves for 149 adults by 
Tjellström and Hâkansson17 (follow-up 0 to 5 years) and 
the current study (follow-up 0 to 13 years.) (N = 129). 
Events were implant loss due to failed osseointegration, 
infection or trauma. Confidence interval 95 %.
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9 (2%)8 (2%)
■ 0 = No irritation 
I 1 = Slight redness
■ 2 = Red and moist tissue 
3 = Granulation tissue
Figure 8; Distribution of skin reactions (Holgers classification)
The lost implants com prised seven 3-mm im plants and fourteen 4-mm 
im plants (differences not statistically significant).
In the  g roup w ho  underw ent im p lan ta tion  in 2 stages (109 implants: 92 
w ith primary 2-stage surgery and  17 w ith re im plan ta tion  on a “sleeper 
im p la n t” ) the  m ean fo llow -up was 27 months (range, 0 to  129). A to ta l o f
18 implants (16.7%) w ere  lost in this group. In the rem aining g roup (21 
implants), the  first and  second stages o f the  p rocedure  w ere  perform ed 
simultaneously. The main a g e  in this g roup was 14 ± 2.4 years. During a 
m ean fo llow -up o f 48 months (range, 1 to  159 months), 3 out o f 21 
im plants w ere  lost (14.3%): 2 spontaneously and  1 because o f traum a.
Skin reactions w ere  g rouped  a cco rd in g  to  the  classification o f Holgers e t 
a l.15 No adverse skin reactions w ere  observed in 355 o f 457 observations 
(77.7%; Figure 8). A bou t 55.8% o f the  implants rem ained free o f any tissue 
reaction , and  78.3% had g ra de  0 to  1 skin reactions (Table 6). In the 
fo llow -up period o f 36 ± 46 months, the  skin reaction  was a solitary event
Table 6: Most severe skin reaction per Table 7: Number of adverse skin 
implant (Holgers classification). reactions per implant.
Skin
Reaction No. % Mean (±SD) Interval (mo)
Number of adverse skin
REACTIONS No. %
Grade 1 39 68.4
0 72 55.8 2 6 10.5
1 29 22.5 32 ±34 3 6 10.5
2 14 10.9 33 ±32 4
5
1
3
1.8
5.3
3 6 4.7 41 ± 52 6 1 1.8
4 8 6.2 5.5 ± 4.8 9 1 1.8
Total 129 100.0 Total 57 100.0
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in 68.4% o f the  a ffe c te d  implants. The maxim um num ber o f skin reactions 
per im p lan t was 9, and  the m ean was 1.8 ± 1.5 (Table 7). On ave rage , 
the  first adverse skin reaction  (Holgers g rade  > 2) was no ted  a fte r 27 
months (range, 1 to  117 months). The severe type  o f skin reaction  
(Holgers g rad e  2 to  4) occu rred  w ithin 2 years a fte r surgery in 21 o f the  28 
cases (Figure 9). In the  g roup w ith Holgers g ra de  1, only 11 o f the 28 
(29%) skin reactions arose within 24 months. No significant d ifferences in 
adverse skin reactions (Holgers g ra de  > 2) w ere  found be tw een  the  3 
a g e  groups shown in figure 6.
In this study, 25 im plants w ere  im p lan ted  in ch ildren w ith syndrom ic 
features. No significant d ifferences in ou tco m e  (ie, skin reaction  and 
im p lan t loss) w ere  no ted  be tw een  these children and  those w ithout 
syndrom ic features. In the  patients whose m ed ica l cond ition  inc luded 
bone  m alform ation o f the  skull, 15 im plants w ere  im p lan ted . No 
d ifferences w ere  found be tw een  them  and  patients w ithou t skull 
m alform ations in the  occu rre nce  o f skin reactions or im p lant loss. In 10 
o the r patients, there was some de g re e  o f de ve lopm en ta l de lay. There 
w ere  no d ifferences be tw een  them  and  patients w ithou t deve lopm en ta l 
delays in the  o ccu rre nce  o f skin reactions or im p lan t loss.
Twenty-two im plants (of 129; 17%) in 19 patients ne ede d  revision surgery. 
Tissue revision was perform ed in 13 patients and  in 2 o f them  a second 
revision was perform ed. In 1 o f these patients the  im plant eventua lly  
underw ent re im plan ta tion . In 5 patients the  second-stage surgical 
p rocedure  was perform ed on the sleeper because o f loss o f the  first
Figure 9: Bar chart of time in months until most severe skin reaction 
per implant (N = 57) (Holgers grade 1-4).
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abu tm en t. In 1 o f these patients tissue revision was also required. 
Appositional bone  grow th in one pa tien t also led to  revision surgery.
D isc u ss io n
The first results o f the  BAHA a p p lica tio n  in children w ere  presented in 
1992.18 Since then, several larger studies have been published.19-24 O ne 
o f the  main concerns w ith BAHA a p p lica tio n  is im p lan t loss due  to  fa iled 
osseointegration, traum a, or in fection around the  percutaneous im plant. 
Children run a higher risk than adults.11,18,25,26 Table 8 18,19,22-29 gives an 
overv iew  o f the  literature.
In the present study, 21 im plants (16.3%) w ere  lost, 12 (9.2% of the  129 
implants) o f them  due  to  fa iled osseointegration. It was rem arkable  tha t 
the  first 10 w ere  lost w ithin 8 months a fte r surgery. Our rates o f im p lan t loss 
w ith respect to  fa iled osseointegration and  in fection w ere  co m p a ra b le  
w ith those reported  in the Birmingham and the  London series (Table 8). 
Trauma to  the  BAHA and  its im p lan t is one  o f the  unp red ic tab le  risks 
re la ted  to  BAHA use. Playing foo tba ll was the  cause o f 2 ou t o f the  3 
im p lan t losses in 1 o f the  2 ch ildren w ho  had traum a-re la ted  losses. M c­
D erm ott24 reported  considerab le  im plant loss in children, particu larly in 
ch ildren younger than 5 years (16 o f the  55). In our study however, no 
significant d iffe rence  was found in im p lan t loss be tw een  the 3 d iffe ren t 
a g e  groups.
A large proportion (18 o f the  21 ) was lost w ithin the  first yea r a fte r surgery, 
but spontaneous loss also occu rred  a fte r 3 and  4 years o f use. O ne 
im p lan t was lost for no a p p a re n t reason, and  the  o ther was lost because 
o f appositiona l bone grow th tha t tilted the  im plant so tha t 
osseointegration fa iled.
In the  literature, im p lan t failure rates in children range from 5.3% to  30%.18- 
22,25,26,29 There is considerab le  varia tion in the  num ber o f im plants studied 
per pub lica tion . In com parison w ith the  im p lan t loss rates in children w ith 
only a BAHA in the  larger series (Table 8), the  ou tcom es in this new  study 
are g o o d  and  similar to  the  results o f the  Birmingham series.24 These 2 
series bo th  had a b a n d o n e d  the free skin g ra ft techn ique  and  left the 
original skin in p la ce  w ithou t the  use of a de rm a to m e  (Entific M edica l 
systems AB, G oteborg , Sweden). This find ing confirms tha t g o od  results
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can  be  e xp e c te d  w ith the  surgical techn iqu e  eva lua te d  in this study. The 
in c ide nce  o f im p lan t loss caused by in fection was higher in the  
Birmingham series, and  m ight have  been re la ted  to  the  younger a g e  of 
the  patients or to  preservation o f the  periosteum. Evaluations on new  
and  large series are needed  to  de term ine w hich surgical techn ique  
should take  p recedence .
In 1995, Tjellström and Hâkansson17 reported  im plant loss in 149 
consecutive  BAHA patients in a life ta b le  presentation. (Figure 7, Table 5). 
C om pared  to  our d a ta  on children there was a significant d iffe rence  in 
the  rates o f im p lan t loss (P < 0.0001). This o n ce  aga in  ind icates tha t 
im p lan t loss is m ore likely to  o ccu r in children, especia lly in the  early 
period a fte r im p lanta tion .
In the literature, the  inc idence  o f tissue revision surgery in c ide nce  is 6.3% 
to  26.7% (Table 8). Most studies, however, are relatively small. O f the  182 
observed Birmingham BAHA loa de d  implants, 14 implants neede d  tissue 
revision surgery (7.7%).23 In our series 14 o f the  129 im plants (10.9%) 
neede d  tissue revision surgery a t least once . These rates are 
com pa ra b le . The inc idence  rates o f tissue revision surgery in the  general 
popu la tion  in the  literature vary from 3.2% to  7.4%, ind ica ting  tha t 
ch ildren are m ore a t risk for soft tissue problems th a t require revision 
surgery,12,30,31 particu larly  very young children, as reported  by 
M cD erm ott.24
The ave rag e  thickness o f the  cortica l bone  a t the  a g e  o f 4 years was 
found to  be 2.5 mm (range, 1 to  4 mm), w h ich  is considered to  be  the 
m inimum thickness ne ede d  to  im p lan t a 3-m m im plant. 21,32 Several 
studies suggested tha t im p lant loss was re la ted  to  the use o f 3-mm 
im plants,23 whereas others did not find any re lation be tw een  im p lan t loss 
and  the  length o f the  im p lan t.22,28 In the  current study, 76% o f the 
im plants w ere  4 mm long, and  24% w ere  3 mm long (Figure 3). Analysis 
showed tha t 67% of the  lost im plants w ere  4 mm. No significant 
d iffe rence  in im p lan t loss was found be tw een  the  3-mm and  4-mm 
implants. This study did not confirm  the higher ra te  o f im p lant loss w ith 3­
mm implants, and  is in line w ith tha t of Lloyd e t al.22 Therefore, in our 
view, it does not m a tte r w h ich  length o f im p lant is used in young 
children.
At some centers, the  1-stage adu lt BAHA surgical p rocedure  was 
perform ed in ch ildren w ho  had a bone  thickness o f m ore than 4
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m m .19,26,28 In our series, 21 children w ith a m ean a g e  of 14.4 ± 2.4 years 
had im p lan ta tion  w ith a 1-stage procedure . The ra te  o f im p lan t loss in this 
g roup was 3 out o f 21 (14%), co m p a re d  to  18 out o f 109 (17%) in the  2- 
s tage group. The d iffe rence  was not statistically significant. A 1-stage 
p rocedure  m ay prove to  be  a d e q u a te  in ch ildren o f 10 years o f a g e  and 
o lde r w ho  have a skull thickness o f over 4 mm. None o f the  larger studies 
have shown tha t 1-stage surgery involves ad d itiona l risks in this a g e  
group. Therefore, new  fo llow -up studies are neede d  to  test this 
hypothesis.
In very young children w ho  are cand ida tes  for BAHA ap p lica tion , it is 
crucia l to  their speech and  lan gua g e  d e ve lo p m en t tha t they have 
access to  aud ito ry  stimuli as early as possible, but sometimes 
im p lan ta tion  ca n n o t be  carried out because the  co rtica l layer o f their 
tem pora l bone  is to o  thin. To solve this problem , the  BAHA softband was 
d e ve lo p e d  by the  form er C och lea r C om pany (i.e. Entific) a t request o f 
the  Nijmegen BAHA team  in 2001. The de v ice  comprises the  BAHA sound 
processor c o n n e c te d  to  a soft elastic h e ad b an d . It has been a c c e p te d  
as a g o o d  a lte rna tive  to  BAHA im p lan t im p lan ta tion  in very young 
children.33 Even b ilatera l app lica tio n  has proved possible and  
w orthwhile. The BAHA so ftband is considered to  be a safe and  non­
invasive trea tm en t to  fac ilita te  speech recogn ition  in children w ho  are 
to o  young to  be fitted w ith a percutaneous titan ium  im plant. The a ided  
sound field thresholds w ith the  BAHA so ftband (20 dB) are alm ost equa l 
to  those ob ta in e d  w ith a transcutaneous conven tiona l bone  conductio n  
hearing aid (27 dB).33 Speech and  language  de ve lop m en t are strongly 
fac ilita ted  by the  use o f the  BAHA-softband.10 Nowadays the  BAHA 
so ftband is genera lly  a c c e p te d  as a trea tm en t o f first ch o ice  in children 
younge r than 3 years. A nother deve lop m e n t in BAHA a p p lica tio n  in 
children is the  initiative o f the  Birmingham BAHA team  to  im p lan t a spare 
im p lan t (“ s leeper” ) during the  initial p rocedure , so th a t if the  loaded  
im p lan t is lost, BAHA use can  be  con tinued  rapidly, because an 
osseointegrated im p lan t is a lready in p la ce .22,28,34 In la te r reports there 
was d o u b t a b o u t the  usefulness o f a “s leeper” in children w ith a cortica l 
bone  thickness o f 4 mm or m ore.24 The im p lan t failure rates in the  3 
N ijmegen a g e  groups (3 to  5, 6 to  10 and  11 to  16 years) w ere  equa l. In 
our series, most o f the  children w ere  also im p lan ted  w ith a “s leeper” . The 
p la cem e n t o f a spare im plant is still re garded  to  be  a g o o d  and  pa tien t- 
friendly measure in v iew  o f the  increased risk o f im p lan t loss in children.
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Table 8: Overview of follow-up duration, age a t surgery, skin reactions, tissue revision surgery and implant loss in the literature.
follow-up (y) Age (y) Skin reactions revision Implant loss N (No. %Loss
/
tot.
fixt.
Authors Year Location N.pts. Mean±
SD Range
Mean±
SD Range
Holgers
classification
maximum
Number / all 
observations
tissue surgery 
per patiënt 
in %
O I
%
O&I
loss
T R
%
T&R
loss
of
loaded
fixt.)
Wolf MJF de, 
et al.
Current
study Nijmegen 93 2.2 ± 3 (0 - 13.5) 9.3 ± 3.8 (3 - 16) Grade 2 43 / 457 = 9.4%
14 /129 = 
10.9 12 5 13,2 3 1 3,1 129 16.3
McDermott, AL 
et al. 23 2008 Birmingham 182 NA (4 - 13) 6.8
(2.0 - 
15.1) Grade 3 34 / 182 = 19%*
14 /182 = 
7.7* 8 19 12,6 5 0 2,4 230 14.0
McDermott, AL 
et al.23 2008 Birmingham 39 NA NA 3.3 (2.0 - 4.9) Grade 3 17 / 39 = 44%* 8 / 55 = 14,5 11 0 20 5 0 9 55 30.0
Davids, T et 
al.18 2007 Toronto 40 NA (0 - 10)
3.21 ± 1.65 
7.63 ±
1.55
NA NA NA 3 / 40 = 7.5 1 0 2,5 6 0 15 40 17.5
Lloyd, S et al. 21 2007 London 71 4.5 ± 3.4
(3.6 - 
17.2) 9.6 ± 3.5 (4 - 17) Grade 2 27 / 71 = 37%* 22 / 85 = 25.9 6 3 10,6 5 8 15,3 85 25.9
Yellon, R.F.et
al.27 2007 Pittsburg 13 1.5 (0.1 - 4.4) 5.8
(2.4 - 
14.9) NA NA 4 / 15 = 26.7 2 0 13,3 0 0 0 15 13.3
Priwin, C et
al.22 2005
Gothenburg 
/ Stockholm 41 NA (0 - 21) 8.4 ± 4.6 (1.5 - 16) Grade 2
13/539 = 
2.4% 7 / 44 = 17.1 0 0 0 0 4 9,1 44 9.1
Tietze, L et al.25 2001 Toronto 19 NA (0 - 2) 11.2 ± 4.8 (4 - 18 ) Grade 1 12 / 74 = 16% 2 / 19 = 10.5 0 0 0 1 0 5,3 19 5.3
Zeitoun, H et
al.28 2001 Birmingham 51
3.2 ± 
1.6 (0.5 - 7) 7.6 ± 3.2 (2 - 10) Grade 2 8 / 214 = 3.8% NA 5 0 9,8 3 3 11,7 51 21.5
Granström, G 
et al.26 1997 Gothenburg 37 8 ± 4.2 (1 - 13) 8.7 (2 - 15) Grade 2 12 / 248 = 4.8 NA 3 0 7,5 0 0 0 40 7.5
Papsin, BC et 
al.24 1997 Toronto 32 NA (0.1 - 4.5) 8.9 ± 3.6
(4.1 - 
16.9) Grade 1 26 / 32 = 82%* 8 / 37 = 21,6 3 0 8,1 2 3 13,5 37 21.6
Jacobsson, M 
et al.17 1992 Gothenburg 16 3.3 (0.1 - 144) 9.3 ± 4.6 (3 - 16) Grade 2 1/108 = 1% 1 / 16 = 6.3 1 0 6,3 0 0 0 16 6.3
NA = No data available; O = Osseointegration; I = Infection; T = Trauma; R = Other causes for loss or removal 
* Number / patient
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It also reduces the num ber o f hospital admissions and  enables early 
con tinua tion  o f BAHA use.
A lthough m any studies 18,22,25,26,28,29 reported  skin reactions around the 
ab u tm e n t and  classified them  acco rd in g  to  Holgers e t a l,15 it is d ifficu lt to  
co m p a re  these d a ta  for several reasons. In m any cases, adverse skin 
reactions w ere  expressed as a p e rce n ta g e  o f the  to ta l num ber of 
observed skin reactions.18,22-26,28,35 A Holgers g rad e  of a t least 2 was used 
to  ind ica te  a po ten tia lly  dangerous skin in fection. The inc ide nce  
reported  in a num ber o f studies varied from 1% to 4.8%.18,19,20,21,23,28,29 Five 
out o f these 6 studies w ere  perform ed in G othenburg. In the present 
study, 9.4% o f the  skin reactions w ere  Holgers g ra de  2 or higher, w hich 
was alm ost tw ice  as m any as previously reported  in the  literature. This 
d iffe rence  m ight have been caused by the  increased postopera tive  
check-up  interval a t our clinic. On the  basis o f positive experience  during 
19 years o f BAHA app lica tion , for instance, the  fo llow -up interval a t our 
hospital has g radua lly  ch a n g e d  from 4 to  12 months. Skin reactions are 
usually only no ted  during routine checkups, so events tha t o ccu r a t 
hom e w ithou t a doc to r's  supervision are not recorded . Besides this, in our 
clin ic the  present po licy is for patients to  m ake a fo llow -up a p po in tm en t 
themselves or to  visit us w hen problems occur. So, naturally, relatively 
m ore adverse skin reactions per check-up  are observed. Thus, the  
presentation of adverse skin reactions per to ta l num ber o f routine ch e c k ­
ups m ay not re flect re liable and  precise presentation o f the  d a ta .
An a lte rna tive, and  p robab ly  better, w a y  to  present the  d a ta  m ight be 
to  no te  the  to ta l num ber o f po ten tia lly  dangerous (Holgers g ra de  o f 2 or 
higher) adverse skin reactions observed per im plant. In our series, 22% of 
the  implants had a g ra de  2 (or higher) skin reaction  a t some tim e during 
fo llow-up. As a com parison, M cD erm ott24 reported  skin reactions o f 
Holgers g ra de  3 or m ore in 17% o f their children in 2008. When the la tte r 
classification was ap p lied  to  our series o f children, 15% had a g rad e  3 or 
higher skin reaction  a t some tim e during fo llow -up. Lloyd e t a l.22 found a 
g rad e  2 (or more) skin reaction  in 37% o f their children a t some point 
during fo llow-up. In our study, this ra te  was 22%. It can  therefore be 
co n c lu d e d  tha t our d a ta  on skin reactions seem to  be  co m p a ra b le  w ith 
those reported  in the  recen t literature.
Figure 9 presents de ta iled  inform ation a b o u t the  interval be tw een  
surgery and  the  onset o f Holgers type  2 to  4 adverse skin reactions. This 
inform ation emphasizes the  need for regular checkups a t the  ou tpa tien t
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clinic. Nowadays the  BAHA system is not only ava ilab le  a t university 
m ed ica l centers, but also a t 1 in 3 genera l hospitals in the  Netherlands. 
A lthough w e  en co u rag e  yearly che ck-up  visits a t our ou tpa tie n t clin ic in 
N ijmegen, a small g roup  o f patients prefer to  a tte nd  fo llow -up a t their 
regional hospital. Skin ca re  around the  im p lan t site is now  gradua lly  
becom ing  the  pa tien t's  own responsibility. Obviously, it ca n  be 
questioned w he the r children (a nd /o r caretakers) should be  held fully 
responsible for their own skin care. M oreover, ch ildren run a higher risk o f 
im p lan t loss. Therefore, w e  propose tha t routine fo llow -up tw ice  a yea r 
for a t least 5 years w ou ld  be reasonable in children. M ore frequent 
fo llow -up m ight be  ind ica ted  a fte r a pa tie n t has had a skin reaction  of 
Holgers g rad e  2 or higher.
The surgical p rocedure  used in a large proportion o f the  children in the 
N ijmegen series has been described by d e  Wolf e t a l.14 and  is presented 
in figure 2. In the descriptions o f the  surgical techn ique , most 
authors18,20,22,23,25,26 have referred to  Tjellström e t a l,1,17,36,37 w h o  first 
in troduced  the  use of a free post-auricular skin graft. Later, Tjellström 
c h a n g e d  his techn iqu e  to  the  use of a U-flap and, most recently, a 
specia lly designed de rm a tom e  to  p roduce  a th inned ped ic le  skin flap. 
Overall, various techniques are used by experienced  surgeons to  reduce  
the  am oun t o f soft tissue. The Birmingham BAHA team  a d a p te d  their 
techn ique  avo id ing  using a skin transplant. They preferred the  th inned 
pe d ic le  flap, such as described by Proops.31
The Nijmegen surgical techn ique  can  be  used in ch ildren and  adults. It 
has several advantages, such as m inimal tissue d isturbance, extensive 
soft tissue reduction , the  a vo id a n ce  o f necrosis, a 20-m inute procedure , 
and  an ave ra g e  o f only 1.8 ± 0.8 postopera tive  checkups.
In conclusion, our series o f ch ildren had a higher in c ide nce  o f im p lant 
loss than adults, in a c c o rd a n c e  w ith the literature. Im plant loss in children 
occu rred  a fte r a shorter period o f BAHA use. The stability o f the  im plant 
d id not a p p e a r to  be in fluenced by the  a g e  of the  child or the  length of 
the  im plant. It is im portan t th a t children undergo frequent checkups, 
because po ten tia lly  dangerous skin reactions arose a t least o n ce  in one 
quarte r o f the  implants.
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A bstract
Objective: We evaluated the clinical outcom e measures of implant 
loss and skin reactions in older-adult users of percutaneous bone- 
anchored hearing aids (BAHAs).
Methods: We performed a retrospective analysis on 224 older-adults 
(at least 60 years of age) who underwent implantation of 248 implants 
with the simplified Nijmegen surgical technique between January 1995 
and May 2007.
Results: During a mean follow-up of 39 months (range, 0 to 144 
months), 16 out of the 248 implants were lost (6.5%). The causes were  
failed osseointegration in 9 cases, trauma in 6 cases, and implant loss in 
irradiated bone 1 case. There were no losses due to infection. Implant 
loss was not significantly correlated with age. In 40 implants (16.9%), 
severe skin reactions of Holgers grade 2 or more were observed. Skin 
revision surgery was performed around six implants (2.4%). None of the 
patients had an 8.5-mm abutment to overcome severe skin reactions.
Conclusion: The outcom e of BAHA surgery in older-adults was 
favourable. The rate of Implant loss was com parab le  with that in the  
overall population of BAHA recipients. There were low risks of severe skin 
reactions or developing thick skin around the implant.
BAHA surgery in older-adults
In t r o d u c t io n
About 30 years ago, the bone-anchored hearing aid (BAHA, Cochlear 
Bone Anchored Solutions AB in Göteborg, Sweden) was developed. It 
comprises a bone conduction hearing aid connected to a 
percutaneous titanium implant in the temporal bone.1,2 The BAHA was 
first app lied to patients with significant bilateral conductive or mixed 
hearing loss in whom conventional solutions had fa iled.1,3,4 As a result of 
its success, the indications have been extended. Children have been  
included, as well as patients with moderate mental retardation.5-9 Other 
indications for BAHA treatment are unilateral inner ear deafness (BAHA- 
cros [contra lateral routing of sound])10 and unilateral acquired and  
congenita l conductive hearing impairment.11-14 The BAHA-softband was 
first in troduced in 2001 as a transcutaneous device for infants and  
toddlers who were candidates for BAHA implantation.15
Over the years, the surgical technique used to implant the percutaneous 
implant and handle the soft tissue has been simplified. In adults and  
children (of older than 10 years); the two-stage technique has been  
reduced to one stage. The applica tion of a free skin graft has been  
abandoned. Nowadays, a ped icled thinned skin flap is used, or a simple 
longitudinal incision with maximal subcutaneous and periosteal tissue 
reduction.4,16-19 In general the aim is to achieve a thin hairless skin site 
(fixed to the bone) around the percutaneous titanium implant to 
minimize skin reactions.
Depending on the BAHA implant centre and the duration of follow-up, 
the rates of implant loss varied from 3.5 to 17.4% in adults4,11,16,19-24 and  
from 5.3% to 30% in children.6,7,25-33 The cause of the w ide variation in 
outcomes is still not well understood. Children are more vulnerable to 
implant loss and differences have been found between age groups.26,29 
Skin care around the BAHA implant is a difficult issue in children, because  
it is not always possible for them to perform skin care adequate ly. The 
same might also app ly to the older-adult population due to various age- 
related problems, such as visual impairment, decreased mobility of the 
fingers or hands, lack of assistance.
In the literature, da ta  on older-adult BAHA users are scarce.34 Therefore, 
to investigate whether this group of BAHA users might be at more risk of 
implant loss and adverse skin reactions, we retrospectively analyzed the
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clinical outcomes in older-adult patients who received implants by the 
Nijmegen linear incision technique.
Patients a n d  m e t h o d s
Patients
The study cohort comprised 224 consecutive patients 60 years of age or 
older (111 men and 116 women) who had undergone implantation of a 
BAHA in Nijmegen between January 1, 1995, and May, 1 2007. The mean 
(±SD) age a t implantation was 65 ± 6.5 years (range 60 to 87 years).
Surgical technique
Older-adult BAHA users were included in this retrospective study if they 
had undergone implantation by the simplified Nijmegen one-stage linear 
incision technique. This surgical technique consisted of a longitudinal 
incision of approximately 3 cm, 50 to 55 mm posterosuperiorly to the ear 
canal. After removal of the periosteum, the titanium implant was p laced  
accord ing to the one-stage technique described by Tjellström et al.21 
Subcutaneous tissue was reduced extensively over an area of 
approximately 2 cm  around the incision. After wound closure, a pressure 
dressing provided hemostasis.19 This linear incision surgical technique has 
been described by Mylanus et al.35, Van der Pouw et al.23 and De Wolf et 
al.19 Over the years, three surgeons have been involved in the 
technique. Their combined results are presented below.
Case analysis
Data were obta ined from the medical files of the 224 older-adult BAHA 
users on age, gender, indication for a BAHA, type of implant (3 or 4 mm), 
type of ending of the drilled hole, possible (post) operative  
complications, implant failure, time of failure, skin reactions (Holgers 
grade),36,37 and the duration of follow-up. The Holgers classification 
comprises five grades: 0) no irritation, 1) slight redness, 2) red and moist 
tissue, 3) granulation tissue, 4) infection leading to removal of the 
abutment. A grade 2 or higher reaction was interpreted as an adverse 
skin reaction. In the literature, several reasons were mentioned for 
implant failure, such as failed osseointegration, infection, trauma, non-
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Table 1: Postoperative wound healing complications.
Postoperative complications N (%)
None 234 94.4
Minor wound dehiscence 10 4.0
Moderate wound dehiscence 2 0.8
Small skin lesion 1 0.4
Haematoma 1 0.4
Total 248 100.0
use because of progressive sensorineural hearing loss, and improved  
hearing after conventional ear surgery.1'16'19'20'22'38'39 Pain rarely was given 
as the reason to remove the implant.40'41 Clinical outcomes were divided  
into 5-year subgroups accord ing to the age of the patient at 
implantation.
Statistics
Comparisons of categorica l variables were made using chi-square tests 
or Fisher's exact test. Time-to-event analyses were conducted using the 
log-rank test and Beslow test and Kaplan Meier curves. SPSS version 16 
(SPSS' Inc.' Chicago ' Illinois) and Prism Graph Pad 5 (GraphPad Software' 
La Jolla' California) were used. The level of significance) was 0.05.
Results
Between January 1 ' 1995 and May 1' 2007' 224 older-adult patients had 
received 248 implants. In 12 patients' BAHAs had been p laced bilaterally 
(N = 25). In 1 case' one of the bilateral BAHA implants had been p laced  
by means of a skin graft technique; therefore' this implant was excluded  
from the analysis.
Chronic otitis media ' ie' the conventional indication' was the cause of 
the hearing impairment in 202 patients (90.2%). Unilateral sensorineural 
hearing impairment was the indication in 21 patients (9.0%). A BAHA had 
been p laced to ach ieve directional hearing in one patient (0.4%) with 
congenita l unilateral conductive hearing impairment and in another 
patient (0.4%) with unilateral acquired conductive hearing impairment 
due to trauma.
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Figure 1 : Type of implant loss due to failed osseointegration and 
trauma and duration until implant loss.
During surgery, the drilled hole had ended in bone in 198 cases (80%), in 
the dura in 22 cases (9%) and in a sigmoid sinus in 18 cases (7%). Only 10 
observations were missing (4%). All the implants were 4 mm except for 1.
Mean follow-up of each titanium implant was 39 months (range, 0 to 144 
months), with a mean of 4.8 ± 3.6 observations per implant.
Table 1 shows the postoperative wound healing complications. Minor 
wound dehiscence was the most common complication. It took an 
average of 6.4 weeks (range 2 to 10 weeks) of treatment to c lear up. 
Moderate wound dehiscence occurred in two patients and had taken 
considerably longer to treat (35 and 19 weeks, respectively). The small 
skin lesion had healed within 3 weeks.
Figure 1 shows the causes of implant loss (N = 16, 6.5%) and the durations 
until implant loss. Failed osseointegration was the major cause in 9 of the 
16 patients. Trauma was the cause in 6 cases. One patient lost two  
implants because of trauma. Another patient lost an implant because of 
failed osseointegration after 45 months of use and lost the replacement 
because of trauma after 32 months. After this loss, she received a 
second replacement. A patient who had been treated with local 
radiotherapy to intra-cerebellar metastases from large cell lung 
carcinoma lost one implant. Although 1 Holgers grade 4 skin reaction  
occurred, no implants were lost due to infection in this group of older- 
adult BAHA users. None of the patients with lost implants had 
perioperative complications. Figure 2 shows a Kaplan Meier survival 
curve of all the lost implants. The-time-to event analysis did not show any 
significant correlations between implant loss and age.
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Figure 2: Survival curves of implant loss in older adults 
(N = 248 implants), consecutive adults (N = 150 
implants)19 and children (N = 129 implants)26 Events 
were implant loss due to failed osseointegration, 
infection and trauma.
The abutment had been removed in only 2 cases: one after 20 months of 
use because of chronic pain and the other after 4 months for 
psychological reasons following a period of neuralgic pain. Two other 
abutments were lost because of trauma, and another one becam e  
loose and was lost in association with Holgers grade 4 skin reaction. The 
implants themselves were not lost, however.
During the total investigation period of 9669 months, 1180 observations 
had been made. In the majority of observations (1046; 88.6%) no 
abnormalities were found (Table 2). To ach ieve a more clinically oriented  
presentation of the data, we noted the grade of the worst skin reaction  
per implant during follow-up. In 167 of the 248 implants (67.3%), no 
adverse skin reactions were observed. In 40 implants (16.9%), Holgers
Table 2: Clinical data on skin reactions and revision surgery.
Holgers grade
Distribution 
N (%)Per observation
Most severe skin reaction 
N (%)Per implant
0 = no irritation 1046 (88.6) 167 (67.3)
1 = slight redness 83 (7.0) 41 (16.5)
2 = red and moist tissue 37 (3.1) 27 (10.9)
3 = granulation tissue
4 = infection leading to removal of abutmentTotal
13 (1.1)
1 (0.01)
1180 (100.0)
12 (4.8)
1 (0.4)
248 ( 100.0)
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Table 3: Number of adverse skin reactions (per implant).
Implants
N %
0 167 67.3
1 58 23.4
2 11 4.4
3 5 2.0
4 2 0.8
5 3 1.2
6 1 0.4
10 1 0.4
Total 248 100.0
grade 2 or higher was observed. More details are presented in tab le 2 
and 3. There were no significant differences between the age groups in 
the occurrence of the worst skin reactions (Table 4 and 5).
Revision surgery of the skin surrounding the implant was performed for 6 
implants (2.4%) in 5 patients (Table 6). In one of these patients, revision 
surgery was performed tw ice. The 3 lost abutments were rep laced by 
means of second stage surgery. In this older-adult population, no 8.5-mm 
abutments were used in the initial surgical procedure, or later to  
overcome severe skin reactions.
D isc u ss io n
BAHA implant loss can be the result of failed osseointegration, infection  
around the percutaneous implant, surgical removal because of severe 
pain a t the implant site or trauma.16,18-20,22,38,40,41 Children are the most 
vulnerable to failed osseointegration and trauma. In children 5 to 10
Table 4: Skin reactions per observation (Holgers grade) per age group.
Total no. of observations
Skin reaction Holgers grade Severe skin reaction
0 1 2 3 4 2 - 4
Age (Y) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
60 - 64 398 (33.7) 342 (85.9) 36 (9.0) 15 (3.8) 4 (1.0) 1 (0.3) 20 (5.0)
9656 321 (27.2) 294 (91.6) 17 (5.3) 7 (2.2) 3 (0.9) 0 (0) 10 (3.1)
7 o 7 4 236 (20.0) 209 (88.6) 16 (6.8) 8 (3.4) 3 (4.3) 0 (0) 11 (4.7)
75 - 79 148 (12.5) 141 (95.1) 2 (1.4) 4 (2.7) 1 (0.7) 0 (0) 5 (3.4)
8 o 8 4 70 (5.9) 53 ( 75.7) 12 (17.1) 3 (4.3) 2 (2.9) 0 (0) 5 (7.1)
9858 7 (0.6) 7 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 1180 (100.0) 1046 (88.6) 83 (7.0) 37 (3.1) 13 (1.1) 1 (0.01) 51 (4.3)
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Table 5: Worst skin reaction per implant (Holgers grade) per age group.
Total no. of observations
Skin reaction Holgers grade Severe skin reaction
0 1 2 3 4 2 - 4
Age (y) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
60 - 64 76 (30.6) 45 (59.2) 15 (19.7) 12 (15.8) 3 (3.9) 1 (1.3) 16 (21)
9656 61 (24.6) 42 (68.9) 12 (19.7) 4 (6.6) 3 (4.9) 0 (0) 7 (11.5)
7 o 7 4 56 (22.8) 38 (67.9) 10 (17.9) 5 (8.9) 3 (5.4) 0 (0) 8 (14.3)
75 - 79 35 (14.1) 29 (82.9) 1 (2.9) 4 (11.4) 1 (2.9) 0 (0) 5 (14.3)
8 O 8 4 17 (5.7) 10 (58.8) 3 (17.6) 2 (11.8) 2 (11.8) 0 (0) 4 (23.5)
9CO5CO 3 (1.2) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 248 (100) 167 (67.3) 41 (16.5) 27 (10.9) 12 (4.8) 1 (0.4) 40 (16.9)
years of age, the rate of implant loss was 40%.42 To the best of our 
knowledge, no clinical da ta  are available specially on older-adult BAHA 
users. Drinias et al.34 reported on a series of 131 implants that included 29 
implants in older adults (60+ years); 25 out of these 29 implants were  
BAHA implants, and 4 were auricular prosthesis implants. During a total 
follow-up of 3 to 17 years, implant loss was 20% (6 of 29).34 This incidence  
was greater than that reported in the literature on the general BAHA 
population.
To gain greater insight into BAHA use in older-adults, we analyzed the 
outcom e of 224 older-adult patients who had received 248 implants with 
the Nijmegen linear incision technique.19,23,35 Special attention was paid  
to the risk of losing an implant and adverse skin reactions that might 
have resulted from difficulties with cleaning the skin around the implant.
The most common reasons for implant loss in this population were failed 
osseointegration and trauma. Infection around the implant and the 
medical reasons reported in the literature were not among the causes of
Table 6. Implant loss and complications per age group.
Total no. ofimplants
Total no. of lostimplants
Lost to failed osseointegrat ion or irradiation Lost due to trauma Duration until loss
Minor and moderate wound dehiscence
Tissuereductionsurgery Follow-up
Age(Y) N (%) N (%) N (%) N (%) Months N (%) N (%) Months (range)
60 - 64 76 (30.6) 7 (9.2) 5 (6.6) 2 (2.6) 4 - 55 1 (1.3) 1 (1.3) 45.7 (0-143)
65 - 69 61 (24.6) 4 (6.6) 1 (1.6) 3 (4.9) 2 - 47 6 (9.8) 4 (6.6) 43.1 (0-144)
7 o 7 4 56 (22.8) 2 (3.6) 1 (1.8) 1 (1.8) 3 - 129 4 (7.2) 1 (1.8) 33.0 (0-133)
9757 35 (14.1) 1 (2.9) 1 (2.9) 0 (0) 43 1 (2.9) 0 (0) 37.1 (0-96)
80 - 84 17 (5.7) 2 (11.8) 2 (11.8) 0 (0) 70 - 76 0 (0) 0 (0) 25.1 (0-85)
85 - 89 3 (1.2) 0 (0) 0 (0) 0 (0) 0 0 (0) 0 (0) 8.7 (0-21)
Total 248 (100) 16 (6.5) 10 (3.6) 6 (2.4) 12 (4.8) 6 (2.4)
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implant loss.
The rate of implant loss in this study was 6.5% (10 out of the 248 implants). 
Time-to-event analysis did not reveal any significant correlation between  
the outcom e and age.
In a previous study by the first author, the rate of implant loss was 9.3% 
(14 out of the 150) in a consecutive series of 150 implants p laced  
between January 1, 1996 and December 31, 1999.19 All ages were  
represented in the population (56 ± 20 years [SD]), and the mean follow- 
up was 30 months (range, 0 to 159 months). In the current population, 
the mean follow-up was 39 months (range, 0 to 144 months), which  
indicates that the rate of implant loss was com parab le with earlier 
studies and not disproportionally high in older adults as was previously 
mentioned by Drinias et al.34
Figure 2 shows the present clinical da ta  on implant loss due to failed 
osseointegration and trauma in the form of a Kaplan-Meier survival curve  
and includes previously published data  from our clinic on implant loss 
(failed osseointegration, trauma and infection) in the consecutive series 
of 150 implants19 and a pediatric series of 129 implants.26 There was no 
significant difference in the occurrence of implant loss between the 
current study and the consecutive series of adults and children (P > 0.09). 
However, a significant difference in implant loss was found between the 
pediatric series (N = 129) and the older adults in the current study (N = 
248; P < 0.001). This finding once again confirms that children are at more 
risk of implant loss.
In the literature, the overall rates of implant loss in the general population  
ranged from 3.4% to 17.5%; 0.4% to 13.6% of losses were due to failed  
osseointegration. These populations contained adults and children (age  
range 2 to 89 years). Mean follow-ups ranged from 1.9 to 6.7 
years .4,16,20,22,23,38,39
In the current study, tota l rate of implant loss was 6.5% (16 out of the 248); 
3.6% of losses (10 out of the 248) were due to failed osseointegration. The 
mean follow-up was 3.3 years. These outcomes are consistent with those 
reported in the literature. More research is needed to further determ ine  
the risk factors for BAHA implant loss in the older adults.
Skin reactions around the implant are another major fac to r in the clinical 
outcom e of BAHA surgery. In general, the rate of skin reactions around  
the percutaneous implant might be influenced by the surgical soft tissue
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technique applied. At our clinic, these outcomes were also negatively  
influenced by extended intervals between the outpatient check-ups, 
which were due to the tendency of the patients to postpone their visits 
until they experienced problems around the implant.
In this study, 167 of the 248 implants (67.3%) remained free from any skin 
reaction. During the 1,180 observations, 51 (4.3%) implants had Holgers 
type 2 to 4 skin reactions (Table 2).
A significant difference in the incidence of severe skin reactions was 
seen between the current study and the earlier Nijmegen BAHA studies 
on the consecutive series of patients in which the incidence of severe 
skin reactions was 6.5% (67 out of the 1,038 observations)19 in the adults 
and 9.4% (43 out of the 457 observations) in the children (P = 0.003 and P 
< 0.001 ).26 In the current study, the incidence of the highest grade skin 
reaction per implant was 16.9% (40 of the 248), whereas in the 
consecutive series, the incidence was as high as 26.7% (40 of the 150). 
The significant difference in severe skin reactions between the current 
study and the consecutive series (P = 0.01) indicates that older-adults 
had less-severe skin reactions around the implant and fewer events of 
severe skin reactions than the overall population studied a t our clinic.
However, in the literature, incidence rates of severe skin reactions per 
observation (Holgers grade 2 to 4) ranged from 1.7% to 6.5% in studies on 
over 100 cases.4,19,22,23,38,39 Thus, the older adults in our study had 
com parab le  results.
Interestingly, tissue revision surgery was only performed around 6 implants 
in 5 patients in the current population, ie, 2.4% of all the implants. This is a 
large difference compared to the previous Nijmegen publication on 
BAHA surgery in which tissue revision surgery was performed on 19 cases 
in the consecutive population of 150 implants (12.6%; P < 0.001).19
In the literature, the incidence of tissue revision surgery ranged from 3.2% 
to 12.6% in the overall BAHA population.16,19,20,23,38 The incidence of 
revised surgical reduction of subcutaneous tissue was particularly high in 
the two more-recent studies on the skin flap technique: 14 of the 177 
(7.4%) and 11 of the 149 (7.9%), respectively.20,38 These differences were  
significant (P = 0.04). Thus the older adults in this study were at less at risk 
of developing hypertrophic skin that required revision surgery around the 
implants. This finding can be explained by the normal ageing processes 
in the dermis: irreversible degeneration of tissue.43 None of our 
population had a higher 8.5-mm abutment, although its application
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might have reduced the number of surgical revisions even further. More 
research on this specific top ic is needed to draw reliable conclusions.
Besides long-term tissue complications, short-term complications also 
occurred. With the use of the simplified linear incision technique, 
however, local skin necrosis did not occur in this population. Nevertheless 
there were 12 cases of minor or moderate wound dehiscence around 
the implant (4.8%). Diabetes mellitus was present in two of these patients. 
It can be speculated that an important cause of wound dehiscence in 
specific populations is removal of the stitches a t a relatively too early 
stage. In general, stitches are removed within 7 days, probably too early 
in the older-adult population with other general health problems.
These short-term complications of minor of moderate wound dehiscence  
around the implant were not observed in the other Nijmegen studies on 
the linear incision technique.19,23 In that technique, the exact location of 
the implant related to the incision line is determ ined during surgery. It 
can be p laced in the incision line or just beside it. In the latter case, the 
incision line is sutured and a small hole is punctured for the abutment at 
the implant site. It is possible that the occurrence of wound dehiscence  
was influenced by the location of the implant in relation with the incision 
in some of the older-adult patients with wound healing issues, such as 
those associated with diabetes mellitus. However, this hypothesis could  
not be tested retrospectively from the patient files. No additional surgery 
was needed in these patients.
In the literature, very few da ta  are availab le on postoperative wound  
healing problems besides skin necrosis. Incidences ranged from 1% to  
10.5% with the skin flap technique and reach 3% with the 
derm atom e.18,20,38,44,45 It should be emphasized that one of the 
advantages of the linear incision technique is the prevention of skin flap  
necrosis. However, special attention must be paid to the wound healing 
process in older-adult BAHA patients.
In conclusion, BAHA surgery in older-adults had a favourable outcome. 
The rate of implant loss was similar to that in the overall BAHA population. 
The incidence of severe skin reactions was very low. There was less risk of 
developing hypertrophic skin around the implant, but a slightly increased 
tendency towards postoperative wound healing problems occured.
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A bstract
Objective To evaluate the e ffect of implant location and skin thickness 
on the frequency and degree of adverse skin reactions around the  
abutment.
Design Retrospective multivariate analysis of implant position related to  
skin thickness and clinical variables.
Setting Tertiary referral center.
Patients Random sample of 248 patients with bone-anchored hearing 
aids.
Interventions Bone-anchored hearing aid implant p lacement by means 
of the linear incision technique.
Mean Outcome Measures Type and number of skin reactions and  
implant loss.
Results The mean (SD) distance from the external auditory ear canal to  
implant was 48.8 (8.0) mm (range, 29-84 mm). The mean skin thickness 
was 5.5 (1.9) mm. Severe skin reactions (Holgers grade, 2-4) were seen in 
46 of the 248 patients (18.5%). Implant loss occurred in 4 patients (1.6%). 
Three implants were lost owing to failed osseointegration (1.3%), and  
another implant was removed because of deterioration of coch lear 
function (0.9%). No implant was lost as a result of infection.
Conclusion Implant location and skin thickness were not correlated with 
implant loss or the frequency or degree of adverse skin reactions around  
the abutment.
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In t r o d u c t io n
Brânemark et a l.1 first described the principle of osseointegrated 
implantation in the denta l region. On the basis of osseointegration 
between bone and titanium, a new hearing device was introduced, the 
bone-anchored hearing aid (BAHA).2 Tjellström et al.3 initiated the first 
clinical app lica tion of a BAHA device coupled to a skin-penetrating, 
bone-anchored titanium implant (anchored to the temporal bone of the  
skull). The implant in the skull enables sound vibrations to be transmitted 
to the coch lea via bone conduction. Since 1987, the BAHA system has 
been successfully introduced in many countries. In the Netherlands, the 
BAHA program was established at the University Medical Center in 
Nijmegen in 1988. In patients with conductive or mixed hearing loss, the  
BAHA has been a well-established treatment for over 25 years.4-5
One of the main concerns in BAHA surgery is to achieve a stable implant 
with a zone of reaction-free skin around the percutaneous abutment. It 
has been reported that movement of the tissue around the 
percutaneous implant it is a risk fac to r for skin reactions.6 Surgical thinning 
of the skin around the abutment reduces the chance of epithelial debris 
or crusts being trapped between the abutment and the skin and acting  
as foreign bodies.
Regular cleaning is the most effective way to prevent skin reactions. If 
skin reactions occur, they can usually be treated successfully with a 
m edicated ointment. Skin reactions should be avoided because they 
can have a more serious outcome, such as skin overgrowth, implant 
extrusion, and severe wound infection.7-9 The probability of losing an 
implant as a result of adverse skin reactions is fairly low. However, if left 
untreated, a skin reaction may eventually lead to implant loss or 
w ithdrawal.10 Also, preexisting skin impairment, such as dermatoses, thick 
skin, previous radiotherapy, and poor hygiene, can impair the clinical 
outcom e.6,11-12 Other factors that might influence the long-term results 
are soft-tissue reduction during BAHA surgery and the implant location  
on the skull, which might also influence soft tissue in the long term. We 
evaluated the e ffect of the implant location and skin thickness on the 
frequency and degree of adverse skin reactions around the abutment.
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M ethods
Patients
Patients who were scheduled for their regular (yearly) follow-up visit to 
the BAHA outpatient clinic were invited to partic ipate in the study. 
Inclusion criteria were; age older than 17 years, implant using the 
Nijmegen linear incision technique, unilateral application, and at least 1 
year of BAHA use. Patients with syndromic features and skull deformities 
were excluded. The patients were informed about the study, including  
the skin thickness measurement using a needle and the lateral skull 
radiograph. A random sample of 248 patients agreed to partic ipate in 
the study. They had undergone implantation during the period of 
January 1, 1992, through December 31, 2006.
BAHA surgery
All the patients had received their BAHA using the Nijmegen linear 
incision technique. In general, the Nijmegen linear incision technique  
consists of a longitudinal incision approximately 3 cm long, 50 to 55 mm 
posterosuperiorly to the ear canal. After removal of the periosteum, the  
titanium implant was p laced accord ing to the 1-stage technique  
described by Tjellström and Granström.13 Subcutaneous tissue was 
reduced extensively over an area of approximately 2 cm around the 
incision. After wound closure, a pressure dressing provided hemostasis. 
The handling of the soft tissue is described by de Wolf et a l.14 and was 
not modified during the study period.
Skin thickness measurements
Skin thickness a t the implant site was estimated by using a needle to  
penetrate the skin up to the bone on the contralateral side a t the 
matching position (relative distance of the implant from the ipsilateral rim 
and pinna). The procedure was performed by 2 otolaryngologists 
(E.A.M.M. and M.K.S.H.). Measurements were recorded as the number of 
millimeters the needle penetrated the skin during the regular checkups.
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Implant position
A standardized digital lateral conventional radiograph of the whole skull 
(Siemens, Erlangen, Germany), taken of the ipsilateral side of the implant, 
was used to determ ine the position of the implant on the skull. The side of 
the implant was always positioned nearest to the x-ray de tec to r to avoid  
differences in the magnification factor. The distance from the upper 
center of the external auditory ear canal to the implant was measured 
using the ruler function in a radiological program, with the Frankfurter 
horizontal plane (FHP) as a baseline (adopted at the 1884 Craniometrical 
Conference in Frankfurt am Main, Germany, c ited in 1958 by Moorrees 
and Kean15). It consists of a straight line between the most superior point 
on the upper margin of the external auditory ear canal and the most
Figure 1: Frankfurt Horizontal Plane (FHP) coordinates of the implant (x- and y- 
coordinates) used to measure the distance from the upper centre of the external 
auditory ear canal to the implant (l) X indicates distance from the upper centre of 
the external auditory ear canal (EAEC) to implant along the FHP; and Y, the 
distance from the upper centre of the EAEC to implant vertically perpendicular to 
the FHP.
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inferolateral point in the orbital cavity (Figure 1). The position of the  
implant was recorded as x- and y-coordinates (horizontal and vertical, 
respectively) using the FHP as the x-axis.
Case analysis
Data were retrieved from the medical records. These include age, sex, 
indication for a BAHA, surgical method, type of implant (3 or 4 mm), type  
of abutment (5.5 or 8.5 mm), type of tissue at the end of the drilled hole, 
implant loss, duration until loss, skin reactions (according to the 
classification published by Holgers et a l.,16 hereinafter Holgers 
classification), time of implantation, and duration of follow-up.
Follow-up
The tissue reactions around the abutment were evaluated accord ing to 
the Holgers classification: grade 0, no reaction; grade 1, reddish 
discoloration of the skin around the implant; grade 2, red and moist 
surface of the skin around the implant; grade 3, formation of granulation  
tissue around the implant; and grade 4, extensive soft-tissue reaction that 
requires implant removal or leads to implant loss.16 The state of the skin 
around the implant was also observed. Thick skin around the implant was 
noted when it was level with the top of most of the abutment. At each  
follow-up visit, the implant stability was checked manually with a torque  
wrench. All these data  were entered into the medical files by means of a 
standardized stamp. Initially, the patients a ttended the checkups a t least 
once every 4 months. Later, the interval was prolonged to 6 months, and  
currently, once a year is the standard interval.
Statistical analysis
Comparisons of categorica l variables were m ade using multivariate 
correlation tests, 1-way analysis of variance, and independent sample t 
tests. Time-to-event analyses were conducted using Kaplan-Meier 
curves. The analyses controlled for age a t surgery, sex, duration of follow- 
up, and tissue type a t the end of the hole drilled for the abutment. SPSS 
software (version 16; SPSS Inc, Chicago, Illinois) and Prism Graph Pad 5
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(GraphPad Software, La Jolla, California) were used to perform statistical 
analysis. The level of significance was set at P = 0.05.
Results
Description o f population
Our population comprised 100 men and 148 women with a unilateral 
percutaneous titanium implant. The mean (SD) age at implantation was 
52.5 (14.7) years. Figure 2 shows the age distribution. Implants had been 
p laced on the left side (N = 128) and on the right side (N = 120). 
Indications for BAHA fitting were bilateral acquired conductive or mixed 
hearing loss (N = 209 patients [86.7%]), congenita l conductive hearing 
loss (N = 8 [3.8%]), and unilateral inner ear deafness (N = 31 [12.5%]). The 
latter group comprised 30 cases of acoustic neurinoma and 1 case of 
intracranial rhabdomyoma. The etio logy of the hearing loss in 1 patient 
(0.4%) was trauma. A total of 12 patients were classified as having 
mental retardation.
A 1-stage surgical procedure had been used to p lace 247 implants 
(99.6%). In 1 patient, the second stage (abutment p lacem ent and tissue 
reduction) was performed separately.
Figure 2: Age at time of surgery per implant (N = 248 patients) and 
number of implants.
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During surgery, the drilled hole had ended in bone in 213 cases (85.9%), 
at the dura mater in 21 cases (8.5%), and in the sinus in 8 cases (3.2%). 
Only 6 observations were missing (2.4%). All of the implants were 4 mm 
except for 1. In 2 cases, the length of the implant was not noted in the  
medical records. All the abutments were 5.5 mm except for 1. This 
patient did not report any adverse skin reactions or thick skin. The mean  
duration of follow-up was 67.7 (39.4) months (range, 12 to 215 months) 
with a mean of 7.4 (4.9) observations per implant.
Implant location measurements on the lateral radiographs
The mean (SD) distance from the upper center of the external auditory 
ear canal to the implant was 48.8 (8.0) mm (range, 29.0 to 84.0 mm), the 
mean distance of the x-component was 44.8 (8.5) mm (range, 22.0 to  
82.0 mm), and the mean distance of the y-component was 18.6 (10.6) 
mm (range, -13.0 to 48.0 mm). Figure 3 shows a lateral representation of 
the scatter of implant positions.
In patients with congenita l atresia (N = 8), the mean distance of the y- 
com ponent was 21.3 mm. Compared with the mean distance of the y-
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Figure 3: Scatterplot of the implant locations. The coordinates (0,0)
= external auditory ear canal (EAEC); x = distance from the upper 
center of the EAEC to implant along the Frankfurt horizontal plane 
(FHP); y = the distance from the upper center of the EAEC to 
implant vertically perpendicular to the FHP.
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com ponent in the other patients (18.5 mm) this was not a notable  
difference. Their x-component was 46.3 mm compared with the other 
patients, which was not clinically significant. The mean distance  
between the upper center of the external auditory ear canal and  
implant was 51.5 mm. This d ifference (0.3 mm) was not clinically 
significant com pared with those of the other patients. The measurements 
in the patients with congenita l atresia did not notably a ffect the  
distances in the total group of patients. In the patients who had 
undergone translabyrinthine schwannoma surgery, the x-component of 
the implant location did not differ from that in the patients who  
underwent "regular" BAHA surgery.
Implant loss
A total of 4 of the 244 implants (1.6%) were lost: 3 owing to failed  
osseointegration (1.3%) and 1 that was removed owing to deterioration  
of coch lear function (0.9%). No implants were lost as a result of infection. 
Statistical analysis did not show any relationship between implant loss 
and the distance from the upper center of the ear canal to the implant, 
the mean distance of the x-component, and the y-component.
Skin reactions
Skin reactions were observed in 130 patients (52.4%): in 84 patients the 
most severe skin reaction was Holgers grade 1 (33.9%), in 32 patients this 
was Holgers grade 2 (12.9%), in 12 patients this was grade 3 (4.8%), and  
only 2 patients had a grade 4 skin reaction (0.8%). In this group, 46 
patients (18.5%) had a skin reaction that required treatment (classified as 
Holgers grade 2 to 4). This type of reaction occurred only once in 33 of
Table 1: Clinical data on skin reactions and revision surgery.
Skin reactions Distribution Per observation
N (%)
Most severe skin reaction Per implant
0 = no irritation 1505 (84.7) 118 (47.6)
1 = slight redness 206 (11.6) 84 (33.9)
2 = red and moist tissue 52 (2.9) 32 (12.9)
3 = granulation tissue
4 = infection leading to removal of abutmentTotal
12 (0.7)
2 (0.1) 
1777(100.0)
12 (4.8)
2 (0.8)
248 (100.0)
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Table 2: Frequency of Skin Reaction and Most Severe Skin 
Reaction Around the Implant.
Frequency of skin reactions follow-up
Total number (%) of adverse skin reactions per implant
Total number (%) of Holgers 2-4 skin reactions per implant
0 118 (44.5) 202 (81.5)
1 68 (27.2) 33 (13.3)
2 27 (13.1) 9 (3.6)
3 15 (5.9) 2 (0.8)
4 7 (3.1) 2 (0.8)
5 7 (2.8)
6 2 (1)
7 4 (1.7)
Total 248 (100.0) 248 ( 100.0)
the 46 patients (71.7%) (Table 1 and Table 2).
The mean intervals in months between implantation and the skin 
reactions were 42.5 months for grade 1, 37.8 months grade 2, 37.8 
months for grade 3, and 76.5 months for grade 4 (Table 3). The mean 
interval until the first skin reaction, irrespective of the grade, was 24.3 
months (range, 0-129 months).
The distance from the upper center of the external auditory ear canal to  
the implant was not correlated with Holgers grade 1 to 4 skin reactions or 
the total number of skin reactions. Furthermore, there was no correlation  
between skin reactions or implant loss and the x- and y-components of 
the distance from the upper center of the ear canal to the implant.
Skin thickness, measurements observations and  revision surgery
In 204 patients (82.3%), skin thickness was measured on the side 
contralateral to the percutaneous implant. Skin thickness varied from 2.0 
to 11.0 mm, with a mean (SD) thickness of 5.5 (1.9) mm. Analyses did not
Table 3: Interval Between Implantation and Skin Reaction.
Time to skin reaction type
Implants
No range Mean (SD)
1 111 0 to 179 42.5 (34.0)
2 37 0 to 119 37.8 (35.5)
3 12 1 to 127 37.8 (39.8)
4 2 48 to 105 76.5 (40.3)
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show any statistically significant correlations between skin thickness and  
implant loss (P = 0.58), or skin reactions of Holgers grades 1 and 2 (P = 
0.48 and 0.65, respectively; there were too few cases of Holgers skin 
reactions of grades 3 and 4 for statistical comparison), or with the total 
number of skin reactions (P = 0.39). There was no significant correlation  
between skin thickness and the vertical com ponent (y) (P = 0.57). 
However, skin thickness was significantly correlated with the horizontal 
com ponent (x) (0.2 mm; P < 0.002) and the mean distance from the 
implant to the ear canal (0.2 mm; P < 0.001).
Next to the measurements of the thickness of the skin a t the contralateral 
side to the implant, the state of the skin level around the abutment was 
recorded during follow-up in 192 patients. Thick skin, that is, skin reaching  
to the top of the 5.5-mm abutment, had been noted in 81 patients 
(42.2%), with a mean rate of 2.4 observations (range, 1 to 12 
observations). Only 40 patients (16.1%) had 1 single observation of thick 
skin. The latter once-only events accoun ted for 49.4% of all the 
observations of thick skin. The mean (SD) interval until the first observation 
of thick skin was 47.0 (33.6) months. In most of the cases, the thick skin 
was treated successfully with antibacteria l and steroid ointment or 
watchful waiting.
Tissue reduction surgery was performed on 23 implants (9.4%) a t a mean 
period of 34 months after implantation (range, 4 to 119 months) when 
thick skin persisted. One patient required 1 subsequent tissue reduction  
surgery.
D isc u ss io n
We evaluated the e ffect of the implant location and skin thickness on 
the frequency and severity of skin reactions around the abutment. To 
evaluate this correlation, the position of the implant (the mean distance  
from external auditory ear canal to the implant) was measured (48.3 
mm). This corresponds with the ideal site accord ing to the Nijmegen 
BAHA surgical procedure because it leaves enough space to 
accom m oda te  the BAHA transducer behind the auricle.14 No correlation 
could be found between implant location and the frequency and  
severity of skin reactions in this study.
To our knowledge, no previous studies have investigated a possible 
correlation between implant location and skin reactions. Eeg-Olofsson et
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al.,17 however, described the position of the implant in relation to the  
external auditory ear canal. Their study was set up to determ ine the 
extent to which bone dam pened sound transmission to the cochlea. 
They found that moving the vibrating stimulus closer to the cochlea  
increased the velocity a t the coch lear promontory. Combined with the  
results of our study, the ideal implant site in terms of optimal sound 
transmission and low incidence of skin reactions would be as close to the  
coch lea as possible.
It should be noted that skull dimensions can vary among individuals. Skull 
dimensions also change with advancing age (eg, progressive decrease  
in the height of the neurocranium).18-19 Patil and Mody20 described  
significant differences in 10 cephalometric dimensions between men 
and women. In the current study, we adjusted the statistical analyses for 
sex and age to address the differences in skull dimensions.
In BAHA surgery, special attention must be given to the handling of the 
soft tissue in order to obtain thin hairless skin with optimal reduction of 
mobility. The soft-tissue reduction technique used results in a gentle slope 
of the soft tissue in an area of approximately 15 to 20 cm2 around the 
percutaneous implant, depending on the length of the incision. At the 
basis of the abutment, postoperatively the skin thickness varies from 
approximately 1 to 1.5 mm. Unfortunately, because skin thickness 
measurements a t the implant location were not performed in a structural 
manner, a prospective analysis was not possible.
Implant loss is one of the major clinical outcom e measures in BAHA 
surgery. In our study, the total implant loss was 1.6% (4 of the 248 
implants). Recent studies by the Nijmegen BAHA team reported a 9.3% 
implant loss (14 of 150 implants) in a consecutive series of 142 patients 
who had undergone BAHA surgery and in 6.5% (14 of 248 implants) in 224 
elderly patients who had undergone BAHA surgery.14, 21 In the literature, 
implant loss caused by failed osseointegration ranged from 0.4% to 7%, 
whereas loss caused by infection ranged from 0.4% to 2.7%.5, 7, 9-1°,22-23 The 
mean (SD) duration of follow-up in the current study was 78.4 (48.3) 
months (range, 12 to 220 months) com pared with a range of 6 to 141 
months in the literature.5,7,10,22 Rates of implant loss in these Nijmegen 
series are substantially lower than those described in literature.
An explanation for the differences in implant loss might lie partly in the 
exclusion of children from this study. Compared with the adult skull, the 
infant skull is less thick and has fewer minerals content and more water
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content. This is believed to be one of the causes of the higher risk of 
failed osseointegration in the younger population.7 In the study by 
Proops,22 implant loss occurred in 19 of 188 patients (10.1%); 10 of these
19 (52.6%) occurred in children. In the Nijmegen consecutive series of 
children,24 implant loss in children also accoun ted for a relatively large 
part of the percentage. Overall implant loss in the Nijmegen series was 
16.3% (21 of 129).24
Another major clinical outcome measure in the follow-up after BAHA 
surgery is skin reactions. Our da ta  showed that 46 of the 248 patients 
(18.5%) had a severe skin reaction (Holgers grade, 2 to 4) a t least once  
during follow-up. In this group of patients, 33 (71.7%) had a severe skin 
reaction only once. The rates of severe skin reactions in the current study 
conform with those in the literature (3.4% to 39.6%).5,10,16,25-27 These data  
are also in line with those of previous studies performed within the BAHA 
program a t the University Medical Centre. de Wolf et a l.14 found an 
incidence of 26.7% (40 of 150) in a consecutive series of patients with 
BAHA implants.
Besides implant location, another potentially relevant variable is skin 
thickness. Measurements found in this study varied from 2.0 to 11.0 mm, 
with a mean (SD) thickness of 5.5 (1.9) mm. No correlations were found  
between skin thickness and implant loss, Holgers grade 1 to 4 skin 
reactions, the y-component, or the total number of skin reactions. 
Measurements of the skin thickness were taken on the side contralateral 
to the implant. Skin thickness was significantly positively correlated with 
the x-component and the distance between the implant and the ear 
canal (0.22 mm, P < 0.002; and 0.24 mm, P < 0.001, respectively). Thus, 
the greater the distance between the implant and the ear canal, the 
thicker the skin. The procedure used for skin thickness measurements was 
based on the assumption that the skin is of equal thickness on both sides.
In conclusion, no correlations were found between the distance from the 
superior part of the external auditory ear canal to the implant nor 
between the horizontal and vertical positions of the implant and the type  
and number of skin reactions. Skin thickness measured on the 
contralateral side was not correlated with the type and number of skin 
reactions. Comparatively, implant loss was not correlated with the  
distance from the superior part of the upper center of the external 
auditory ear canal to the implant, the position of the implant, or skin 
thickness.
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A bstract
Objective: To study age-related patient satisfaction with the bone- 
anchored hearing aid (BAHA) compact.
Methods: A retrospective postal questionnaire, the International 
Outcome Inventory for Hearing Aids (IOI-HA), was sent to 211 BAHA 
Compact users. Questionnaire responses from 135 BAHA users were 
analyzed related to age, sex, years of BAHA experience, and the 
hearing thresholds (pure-tone average) at the aided side. Age ranged 
from 18 to 77 years.
Results: The IOI-HA showed that the BAHA Compact was greatly 
appreciated by almost all of the users: most patients stated that they 
were using the device for most of the day; it helped them to hear better 
and it reduced the number of situations in which hearing impairment 
was problematical. The cumulative score on the questionnaire was 
negatively influenced by age ([rho] = -0.191, P = 0.05). Furthermore, 
increase in sensorineural hearing loss (SNHL) component was associated 
with decrease in total IOI-HA scores (Spearman [rho] = -0.193, P < 0.05). 
A significant correlation was found between age and the SNHL 
component (Spearman [rho] = 0.525, P < 0.001).
There were no significant differences in the levels of difficulty with 
placing the BAHA on the implant or with handling the BAHA between 
the age groups. Cleaning the skin around the implant causes the most 
difficulties in the youngest age group (p < 0.02).
Conclusion: The BAHA Compact enhances participation in various 
domains of communication. Differences in patients' satisfaction seemed 
to be correlated with the SNHL component rather than age.
Age-related use and benefit of the BAHA compact
In tro d u c t io n
The bone-anchored hearing aid (BAHA) was introduced in 1977 by 
Tjellström et al.1 Since then, it has been applied widely at many other 
clinics all over the world. The BAHA system can be used to treat patients 
with conductive or mixed hearing loss who are unable to use a 
conventional hearing aid, for example, because of otitis media or aural 
atresia.2,3 During the years, the indication for BAHA application has 
expanded, including bilateral application, application in patients with 
unilateral congenital or acquired conductive hearing impairment, or as 
a Contralateral Routing of Sound (CROS) device.4-8 In recent years, 
quality of life (QOL), benefit, and satisfaction aspects after BAHA 
placement have received increased attention.6,9-16 To the best of our 
knowledge, there are no previous studies on age-related BAHA use and 
patient's satisfaction. In the present study, opinions were gathered in 
retrospect using the International Outcome Inventory for Hearing Aids 
(IOI-HA). The Dutch version of the IOI-HA was evaluated by Kramer et 
al.17 Since its development, the IOI-HA has been used in several studies 
on the use of hearing aids, particularly in older adults.18,19 It has also been 
used in BAHA studies on unilateral or bilateral conductive hearing loss.20 
The present study analyzed the audiological and questionnaire data 
from a group of experienced BAHA Compact users with conductive or 
mixed hearing loss. The BAHA Compact was the most frequently applied 
BAHA at our clinic between 2000 and 2007. Indications comprised 
conductive hearing loss or mixed hearing loss with a sensorineural 
component up to 35 dB. Furthermore, all patients fulfilled the indication 
criteria as listed in the consensus statements21 at the time of 
implantation, for example, for these patients; the BAHA was the only 
alternative owing to either aural atresia or chronic otitis media. Larger 
sensorineural hearing loss (SNHL) components require the more powerful 
BAHA Intenso or Cordelle.21 However, because this group was fairly 
limited in size and mainly comprised older patients, the Cordele users 
were excluded from the current comparison. To provide insight into age- 
related patient satisfaction and benefit, the respondents were divided 
into 3 age groups: 1) aged 18 to 40 years, 2) 41 to 60 years, and 3) older 
than 60 years.
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Table 1 : patient data per age category.
Age Categories (years)
18-40 41-60 >60 Total
Questionnaires sent 49 87 55 211
Questionnaires received 29 64 42 135
Response rate 58% 73% 77% 73%
Mean Age 30 51 67 52
Years of Baha experience (SD) 4.5 (1.6) 4.3 (1.8) 4.6 (1.8) 4.4 (1.7)
Indication for Baha
Bilateral cond. / mixed loss 18 49 33 100
Unilateral cond. / mixed 5 10 8 23loss
Unilateral cond. / mixed 6 5 1 12loss other ear deaf 1
PTAbc(0.5, 1, 2, 4) (SD) 15 (9) 21 (11) 28 (9) 22 (11)
PTAbc(1, 2, 4) (SD) 16 (10) 23 (12) 31 (11) 24 (13)
Air bone Gap (SD) 45 (11) 37 (13) 32 (12) 37 (13)
PATIENTS AND METHODS
Patien ts
The IOI-HA was sent to 211 consecutive BAHA Compact users who were 
older than 18 years and had conductive or mixed hearing loss. 
Questionnaires were returned by 135 patients. It was possible to contact 
30 (55%) of 55 non-responders. They all stated that they were still using 
the BAHA. To provide insight into age-related patient satisfaction and 
benefit, the respondents were divided into 3 age groups: 1) aged 18 to 
40 years, 2) 41 to 60 years, and 3) older than 60 years. Mean age was 52 
years (range, 18 to 77 yr). An overview of questionnaire responses and 
patients' hearing thresholds is presented in Table 1.
M e th o d s
Patients were asked to fill in the IOI-HA, an internationally applied 
questionnaire designed to evaluate the effectiveness of hearing aid 
treatment. The IOI-HA is a brief questionnaire that consists of 7 questions 
on use (Use), benefit (BEN), residual limitation in activity (RAL), satisfaction 
(SAT), residual participation restriction (RPR), impact on others (loth), and 
QOL related to, in this case, the BAHA Compact (Appendix 1). To answer
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each of these questions, the patient selected 1 of the 5 possible 
responses that roughly covered the whole range from "no benefit" to 
"very much benefit." The validated Dutch version of the IOI-HA was 
used.17,22
The questionnaire outcomes were related to age, sex, and the pure-tone 
average bone-conduction (PTAbc). The focus was on age because 
bone-conduction thresholds deteriorate with increasing age, which may 
compromise the potential (subjective) benefit of the BAHA Compact. 
Some extra questions concerning everyday use of the BAHA were 
added to the IOI-HA as well as questions concerning potential difficulties 
with placing the device on the implant, handling the device, and 
cleaning the skin around the implant (response format: everyday use 
and difficulties placing [yes, no]; handling the device [yes, sometimes, 
no]). The IOI-HA results are compared with those in the literature on other 
types of hearing aids.
Statistics
Comparisons of categorical variables (the IOI-HA domains and the extra 
questions on "everyday use," "placement," "operation," and "cleaning") 
were made using Fisher's exact test. Correlations between the IOI-HA 
outcome and demographic factors were evaluated using Spearman 
[rho]. SPSS version 16 (SPSS, Inc., Chicago, IL, USA) was used.
r e s u lts
The means and standard deviations (SDs) on each of the 7 domain 
scores of the IOI-HA are presented in table 2. Missing data are also
Table 2: Descriptive statistics for each of the seven domains of the 
IOI-HA in the total study group (N = 135).
Responses No responses Mean SD
1 USE 135 0 4.59 0.9
2 BEN 130 5 4.17 1.0
3 RAL 129 6 3.95 0.9
4 SAT 135 0 4.31 0.9
5 RPR 130 5 4.01 0.9
6 loth 132 3 4.40 0.7
7 QOL 130 5 4.37 0.9
Total IOI-HA
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presented; ranging from 3 (2.2%) to 6 (4.4%). Figure 1 presents mean data 
per domain and age group and the results of each of the 7 questions 
separately. "USE" shows that approximately 80% of the patients in the 2 
younger subgroups were using their BAHA for more than 8 h/d. In the 
patient group older than 60 years, approximately 70% were using the 
BAHA for more than 8 h/d. "BEN" shows that 96.4% of the patients in the 
youngest subgroup experienced at least moderate benefit with the 
BAHA in the situations where they most wanted to hear better; 89.2% of 
them even indicated "quite a lot" or "very much benefit." In the 41 - to 60- 
year-old age group, these outcomes were 91.9 and 82.3%; in the patient 
group older than 60 years, these outcomes were 87.5 and 67.5%.
In response to "RAL," concerning "difficulty understanding speech despite 
the use of the BAHA," less than 8% of the patients were still experiencing 
significant problems, whereas most had only moderate problems or no 
difficulties. Interestingly, the patients who responded with "very much 
difficulty understanding speech" were 60 years or older (3 patients). 
Within this group, there were 2 patients who responded "quite a lot of 
difficulty." Moreover, 6 (9%) of the 64 patients from the middle-aged 
group responded with "quite a lot of difficulty."
"SAT" represents patient satisfaction with their BAHA. Nearly all of the 
patients considered the BAHA to be worth the trouble. Only 1.6% 
reported that the BAHA was not worth the trouble (all in the 41- to 60-yr- 
old age group). The patients in the group older than 60 years seemed to 
be more conservative in their reports regarding satisfaction: 45.2% 
indicated the "very much worthwhile" domain compared with 54.7 and 
72.4% scored by the other groups.
More than 70% of the patients indicated that their BAHA did not restrict 
their participation in activities (RPR), or that it only restricted them slightly. 
Only 2.6% of the patients in the group older than 60 years felt very much 
restricted in the things they could do because of the BAHA.
Although more than 90% of the patients in the 2 youngest age groups 
stated that other people were only slightly or not at all bothered with the 
patient's hearing problems (loth), 20% of the patients in the group older 
than 60 years indicated bother at a moderate or above average level. 
This suggests that the older BAHA users are more inclined to think that 
others are bothered by their hearing limitations.
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Figure 1: Patients' responses to each of the IOI-HA questions. USE; Most patients use the 
Baha for more than 8 h/d, BEN; Approximately 90% of the Baha users report at least 
moderate benefit, there was a tendency that the 2 youngest age groups report more 
benefit. RAL; most patients reported only moderate to no residual limitations in activity. 
SAT; the patients from the group older than 60 years seemed to be more conservative 
in their reports regarding satisfaction. RPR; most patients report slightly or no restrictions 
in participation in activities. However, the older adults report the most restrictions. loth; 
the older Baha users are more inclined to think that others are bothered by their 
hearing limitations. QoL; although most reported greater enjoyment of life owing to the 
Baha, the patients from the group older than 60 year were least inclined to indicate the 
last domain ‘very much better'.
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Responses to the QOL question show that, although most reported 
greater enjoyment of life because of the BAHA, the patients in the group 
older than 60 years were least inclined to indicate the domain "very 
much better." Almost 44% of the patients in the group older than 60 years 
reported "very much better" QOL with the BAHA compared with almost 
60 and 55% in the 2 younger age groups.
In response to the extra questions, more than 95% of the patients in each 
age group reported that they did not have any difficulty placing the 
BAHA on the implant. Nor did they have any problems with handling the 
BAHA (not shown). Interestingly, only 41% of the youngest age group 
reported that they did not have problems cleaning the skin around the 
implant compared with 66 and 63% in the other 2 age groups (Figure 2). 
Thus, cleaning the skin around the implant caused the most difficulties in 
the youngest age group (P < 0.02). However, there were no significant 
differences between the 3 age groups in the level of difficulty with 
placing the BAHA on the implant or with handling the BAHA. A separate 
analysis of the oldest patients in this study (age > 70 yr, N = 8) revealed 
that only 1 of them reported problems with placing the BAHA on the 
implant, none reported problems with handling the BAHA, and only 3 
reported that they sometimes had problems cleaning the skin around 
the implant.
To identify correlations between the demographic factors (patients' age 
and SNHL component) and the questionnaire responses, Spearman [rho] 
correlation coefficients were calculated. Correlations at the P < 0.05 
level were considered significant.
Figure 2: Results for the extra question; "Do you have problems with 
the cleaning of the implanted screw?"
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The cumulative IOI-HA score was significantly negatively influenced by 
age ([rho] = -0.191, P < 0.05). A larger SNHL component was associated 
not only with a poorer score on domain 6 (Ioth, [rho] = -0.212) but also 
with the total IOI-HA score (Spearman [rho] = -0.193, P = 0.026). The 
significant correlation between age and the average SNHL component 
that was found (Spearman [rho] = 0.525, P < 0.001) suggests that it is not 
age per se that is related with IOI-HA but rather the (age-related) SNHL 
component.
DISCUSSION
The IOI-HA questionnaire was developed as a brief useful tool to 
compare the outcomes of hearing aid fitting. It can also be used to 
evaluate individual performance with a hearing aid.17,23 The approach of 
this study was to use it to compare different subgroups with the same 
hearing aid, for example, age-related benefit. In the IOI-HA, hearing aid 
users were asked to evaluate the previous 2 weeks of their hearing aid 
use, that is, to provide very recent retrospective data. Thus, the IOI-HA 
can be considered to represent a "snapshot" of the situation. Because of 
this setup, the recall bias was assumed to be negligible.
The overall response rate, defined as the ratio between the number of 
questionnaires received and sent, was 71%, which is favorable 
compared with the literature.17,18,23-25 Furthermore, a large proportion of 
the non-responders could be contacted. Their reasons for not answering 
the questionnaire were diverse, but they all stated that they were using 
the BAHA on a daily basis and were satisfied with it. This indicates that our 
results are a good estimate of the outcome in the whole group. Table 1 
shows that the response rate in the 18- to 40-year-old age group was 
lower than the response rate in the 2 other age groups. Nevertheless, the 
18- to 40-year-old age group is large enough to be considered of value.
The IOI-HA outcome in this study showed that almost all users 
appreciated their BAHA Compact: they were using it for most of the day; 
it was clearly helping them to improve their hearing; it reduced the 
number of situations in which hearing loss was problematic; it was 
considered to be worth the trouble; limitations due to hearing loss were 
no longer present or had diminished; and it was having a positive impact 
on the enjoyment in life for most of the patients.
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Subdivision into age groups provided more insight into the responses to in 
the IOI-HA domains. Some differences in patients' benefit were found 
between the age groups, but in most cases, they were not substantial. 
The patients in the age group from 18 to 40 years were experiencing 
more benefit than those in the age group older than 60 years. 
Differences between the 18- to 40-year-olds and the 41- to 60-year-olds 
were less pronounced. Another interesting finding was that there was no 
general effect of age on ease of handling the BAHA. Thus, patients of all 
ages were capable of handling and placing the BAHA. Interestingly, the 
youngest age group reported more difficulty with cleaning the skin 
around the implant. This supports the assumption that older BAHA users 
are at least comparably capable of using and taking care of the implant 
and the BAHA.
There seemed to be a link among the level of appreciation of the BAHA, 
the degree of SNHL, and age. Although the BAHA provides access to 
sound, threshold deterioration with age will result in poorer speech 
recognition. Thus, (sensorineural) hearing loss, rather than age, is 
probably the major cue. It should be mentioned that these correlations, 
although significant, were relatively weak.
The IOI-HA has also been used to evaluate hearing devices.17,18,23 
However, most of these studies comprised patients with pure SNHL, fitted 
with conventional air-conduction hearing aids. The patients' types and 
severity of hearing impairment differed largely; therefore, no valid 
comparison could be made.
In conclusion, the BAHA Compact enhances participation in various 
domains of communication in patients with conductive or mixed hearing 
loss with an SNHL component between 0 and 44 dB. Differences in 
patients' satisfaction seemed to be correlated with the SNHL component 
rather than age.
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A ppend ix  1
USE; "Think about how much you used your BAHA over the past two 
weeks. On an average day, how many hours did you use the BAHA?"
□ Not at all □ <1 h/day □ 1-4 h/d □ 4 - 8 h/d □ >8 h/d
BEN; "Think about the situation where you most wanted to hear better, 
before you got your BAHA. Over the past two weeks, how much has the 
BAHA helped in those situations?"
□ Not at all □ Slightly □ Moderately □ Quite a lot □ Very much
RAL; "Think again about the situation where you most wanted to hear 
better. When you use your BAHA, how much difficulty do you STILL have 
in that situation?"
□ Very much □ Quite a lot □ Moderately □ Slightly □ Not at all
SAT; "Considering everything, do you think your BAHA is worth the 
trouble?"
□ Not at all □ Slightly □ Moderately □ Quite a lot □ Very much
RPR; "Over the past two weeks, with your BAHA, how much have your 
hearing difficulties affected the things you can do?"
□ Not at all □ Slightly □ Moderately □ Quite a lot □ Very much
Loth; "Over the past two weeks, with your BAHA, how much do you think 
other people were bothered by your hearing difficulties?"
□ Not at all □ Slightly □ Moderately □ Quite a lot □ Very much
QOL; "Considering everything, how much has your BAHA changed your 
enjoyment in life?"
□ Worse □ No change □ Slightly better □ Quite a lot □ Very much
better
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A bstract
Purpose: To evaluate the benefits of a bone anchored hearing aid 
(BAHA) in the daily lives of hearing impaired children.
Design: Retrospective questionnaire study
Setting: Nijmegen Medical Centre, Nijmegen, the Netherlands.
Patients: Thirty-eight BAHA users wit a minimum age of 4 years at BAHA 
fitting and 1 to 4 Years of use, divided into groups with bilateral 
conductive or mixed hearing loss and either normal cognition or mental 
disability and a group with unilateral conductive hearing loss.
Methods: Scores on the Glasgow Children's Benefit Inventory, 
Abbreviated Profile of Hearing Aid Benefit, and Health Utility Index Mark 3.
Results: The Glasgow Children's Benefit Inventory showed a subjective 
overall benefit of +32, +16 and +26 in the 3 groups (on a scale from -100 
to 100). The Abbreviated Profile of Hearing Aid Benefit also showed an 
overall mean benefit in the groups. On an individual level, a clinically 
significant benefit was reported by more children in the group with 
bilateral hearing loss and normal cognition (7 patients [70%]) than in the 
unilateral hearing loss group (4 patients [27%]). Overall mean health 
utility scores and disability index scores on the Health Utility Index Mark 3 
were comparable among the 3 groups.
Conclusions: Overall, BAHA fitting can be considered effective and 
beneficial in children with bilateral or unilateral hearing loss.
Benefit and quality of life in children with a BAHA
INTRODUCTION
Since its introduction over 30 years ago, the bone anchored hearing aid 
(BAHA) has become an established treatment option for auditory 
rehabilitation in patients with chronic conductive or mixed hearing loss.1-3 
When the BAHA was first introduced, it was mainly fitted in adults.4 In 
1992, Jacobsson et al.5 reported the use of the BAHA in children. This was 
followed by reports from other BAHA teams describing their clinical 
findings on the surgical and audiological aspects of BAHA fitting in 
children.5-16 Gradually, the BAHA has been recognized as first-line 
therapy in children with bilateral conductive hearing loss (BHL) who are 
still too young to undergo microsurgery of the middle ear.3'17 Infants with 
hearing impairments can be fitted with the BAHA softband during their 
very early years of life.18,19 This facilitates hearing earlier in life, particularly 
in the bilaterally impaired. For unilaterally impaired children, this benefit is 
disputed. In children with congenital unilateral conductive hearing loss 
(UHL), the BAHA provides a valuable way of creating binaural 
hearing.3,17,20,21 For these subgroups, however, the audiological outcome 
varies.
In addition to doing a clinical evaluation, some research groups have 
used non-validated questionnaires to gain insight into patient satisfaction 
regarding their day-to-day use of the BAHA.22-24 In such studies, quality of 
life questionnaires (QOL) are typically used as supplements to other 
research. More recently, the QOL and treatment benefits have been 
addressed by means of validated questionnaires in adults25 and 
children.11,21,26-29 In the pediatric population, these QOL studies have 
examined different causes and pathological processes of disorders. For 
example, studies have been conducted among children with diverse 
types of unilateral hearing impairment, both acquired and 
congenital21,26,28; bilateral acquired or congenital conductive hearing 
impairment21; and Down syndrome.27,30,31 In 2008, McDermott et al.29 
evaluated QOL in a cross-sectional study of children with unilateral or 
bilateral conductive hearing loss using the Glasgow Children's Benefit 
Inventory (GCBI). They concluded that the BAHA significantly enhanced 
the general well-being of the children. It is essential, though, to obtain 
and analyze QOL data on the effects of the BAHA fitting for each type of 
hearing loss, particularly for unilaterally impaired children, in whom it is 
not yet clear how to predict treatment success. To the best of our
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knowledge, only one study (Priwin et al.21) has evaluated the subjective 
benefits and QOL in separate groups of children with BHL or UHL.
The ideal tool for evaluating the subjective effects of hearing aid fitting in 
day-to-day life should assess several aspects. First, it should assess the 
effect of the impairment on an individual's auditory functioning in daily 
life and the benefit the person experiences with regard to his or her 
disability when using the hearing aid. Second, the tool should accurately 
evaluate the hearing aid's contribution to the general quality of a 
patients' day-to-day life. Third, the patient's opinion about his or her 
general state of health (ie, QOL) should also be assessed.
To obtain reliable data in retrospective evaluations, recall bias should be 
minimized. To do so, the interval between the evaluation and the device 
fitting should not be too long. In contrast, it is important that the patient 
have had sufficient experience with the hearing device to give 
adequate responses and to minimize bias caused by initial enthusiasm. 
Recall bias and questionnaire completion can be managed by having 
the parents and the child fill out the questionnaires together.
To our knowledge, none of the questionnaires that were recently made 
available address the disability, handicap, benefit, and quality of life 
simultaneously. Moreover, no study on BAHA use in children has 
addressed these items simultaneously. To address this lack of data, 3 well- 
known, validated questionnaires were used in this study.
The aim of this study was to evaluate the effect of the BAHA on the day- 
to-day lives of children with UHL and BHL by means of validated 
questionnaires.
Patients a n d  methods
Patients
A total of 38 out of 134 children fitted with a BAHA in Nijmegen, the 
Netherlands, were included in this study. The inclusion criteria were a 
minimum age of 4 years at BAHA fitting and 1 to 4 years of BAHA use. 
Parents were asked to fill out the questionnaires with their child to 
emphasize the opinion of the child.
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To adequately evaluate the questionnaire results, the population was 
divided into two groups, those with BHL and those with UHL.
fWithin the BHL group, subgroups of children with normal cognition (BHL- 
NC) and children with mental disability (BHL-MD) were defined because 
mental disability might influence patient outcomes. In the UHL group, all
Table 1: Daily use questionnaire responses
Question Response bhl-n c BHL-MD UHL
(N = 10) (N = 6) (N = 15)
Are you still using your BAHA? Yes 10 (100) 6 (100) 15 (100)
Not anymore 0 0 0
Over the past 2 wk, how many hours a Not worn the BAHA 0 0 0
day did you use your BAHA on
average? < 1 0 0 0
1-4 0 1 (17) 2 (13)
4-8 1 (10) 1 (17) 6 (40)
> 8 9 (90) 4 (67) 7 (47)
Do you consider your BAHA to be No 0 1 (17) 1 (7)
worth the effort? A little 0 0
Moderately 2 (20) 1 (17) 4 (27)
Much 2 (20) 3 (50) 4 (27)
Very much 6 (60) 1 (17) 6 (40)
Do you find it difficult to place your Yes 0 1 (17)
b a h a ? No 10 (100) 5 (83) 15 (100)
Can you handle your BAHA well? Yes 10 (100) 4 (67) 14 (93)
No 0 1 (17) 1 (7)
Are you familiar with the extra options Yes 2 (20) 2 (33) 4 (27)
on your BAHA (for example, the audio
connection)?
No 8 (80) 4 (67) 11 (73%)
Do you find it difficult to clean the skin Yes 0 1 (17) 2 (13)
around the implant? Sometimes 2 (20) 2 (33) 6 (40)
No 7 (70) 3 (50) 7 (47)
What do you think about the quality of Very good 2 (20) 1 (17) 2 (13)
sound from your BAHA?
Good 6 (60) 2 (33) 9 (60)
Reasonable 2 (20) 3 (50) 3 (20)
Bad 0 0 1 (7)
Very bad 0 0
Would you recommend the BAHA to a Yes 9 (90) 4 (67) 10 (67)
friend with the same type of deafness?
No 1 (10) 2 (33) 5 (33)
Would you (parent / caregiver), be Yes 7 (70) 3 (50) 11 (73%)
prepared to pay (3000 euros) yourself, 
to have your child fitted with a BAHA?
No 2 (20) 3 (50) 4 (27)
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children had normal cognition and a congenital origin of their unilateral 
hearing loss. Audiological data were also obtained.
Methods
This retrospective questionnaire study used the following four tools: 1) a 
"daily device use” questionnaire (a nonvalidated questionnaire 
designed for this study to evaluate the BAHA in daily situations [Table 1]),
2) GCBI,32 3) the Abbreviated Profile of Hearing Aid Benefit (APHAB)33 
and 4) the Health Utility Index Mark 3 (HUI-3) .34,35
The GCBI retrospectively measures the health-related quality of a child's 
day-to-day life after an otorhinolaryngologic intervention, such as BAHA 
fitting. It is, therefore, considered to be a disease-specific QOL 
instrument. The questionnaire is comprised of 24 questions that are 
divided into four domains: emotion, physical health, learning, and vitality. 
The GCBI outcome is quantified with a score between -100 to 0, which 
reflects a diminished QOL, and a score between 0 to +100, which reflects 
an improved QOL.
The APHAB assesses auditory functioning in daily life and is a hearing 
disability-specific questionnaire. A reduction in hearing disability 
achieved by fitting a hearing aid (in this case, a BAHA) is measured by 24 
questions subdivided into four subscales: ease of communication (EC), 
reverberation (RV), background noise (BN), and aversiveness of sound 
(AV). The APHAB has a scoring scale from 1 to 99, with a higher score 
indicating more frequent problems. The APHAB was completed twice by 
the study participants, with the first questionnaire based on the current 
situation and the second one based on the previous situation without the 
BAHA. To define clinical significance on an individual level for each 
subdomain, a difference of at least 22 points was considered to be 
statistically significant.36 An overall difference in the scores of more than
10 points for a given subdomain (i.e., EC, RV and BN) was also 
considered to be statistically significant.36 Data collected by Cox from a 
normative group of young controls with normal hearing were used for 
comparison.36
The HUI-3, a generic, multi-attribute preference-based instrument used to 
measure general health-related QOL. This is one of the few general QOL 
questionnaires that is able to capture changes in quality of life as a result 
of hearing aid fitting.37-39 The HUI-3 consists of the following eight
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subdomains: vision, hearing, speech, ambulation, dexterity, emotion, 
cognition and pain. In the HUI-3, there are two types of score: the single­
attribute utility and the multi-attribute utility. The single-attribute utility 
score varies from 0 (highest degree of impairment or disability) to 1.00 
(no impairment). The multi-attribute utility score varies from -0.36 (most 
disabled) to 1.00 (perfect health), whereas 0 corresponds to death.35'40-42 
In this study, the HUI-3 was used to provide a "snapshot” of the current 
health status of the subgroups. In addition, the HUI-3 can also be used to 
assess a handicap index.43 This index has the following four categories: 
no disability (1.00), mild disability (0.89 to 0.99), moderate disability (0.70 
to 0.88) and severe disability (< 0.70).
Statistical analysis
The unpaired, 2-tailed t-test and the Krusskal-Wallis test were used to 
compare the mean values on the different domains of the GCBI to 
determine a difference between the benefits experienced by the BHL- 
NC group and the BHL-MD group. A P value of less than 0.05 was chosen 
as the level of significance, which corresponded to P = 0.025 for the 2­
tailed t-test. Correlations between demographic factors and the 
questionnaires and interquestionnaire correlations were tested with 
Spearman rho. SPSS version 16 (SPSS, Inc., Chicago, Illinois, USA) and Prism
Table 2: Descriptive Population data.
BHL-NC 
(N = 10)
BHL-MD 
(N = 6)
UHL
(N = 15)
Congenital origin of hearing loss, No. (%) 8 (80) 2 (33) 15 (100)
Age a t implantation, mean (range), y 7 (5-13) 11 (4-16) 7 (4-12)
Age at questionnaire, mean (range), y 10 (6-15) 12 (6-17) 9 (5-16)
Bilateral BAHA users, No. (%) 5 (50) 3 (50) NA
Conventional bone conductor use before BAHA, No. (%) 5 (50) NA NA
PTAbcmean (SD), dB HL 4 (8) 23 (9) 10 (10
PTAac mean (SD), dB HL 49 (11) 61 (15) 56 (17)
Air-bone gap, mean (SD), dB HL 45 (15) 34 (13) 46 (14)
Type of mental disability, No. (%)
Down syndrome NA 3 (50) NA
Grouchy syndrome NA 1 (17) NA
Unknown NA 2 (33) NA
Abbreviations; BAHA, bone-anchored hearing aid; ac, air conduction; bc, bone 
conduction, BHL, bilateral conductive hearing loss; HL, hearing level; MD, mental 
disability; NA, not applicable; NC, normal cognition; PTA, pure-tone average; UHL, 
unilateral conductive hearing loss.
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Graph Pad 5 (GraphPad Software, La Jolla, California, USA) were used 
for analysis.
Results
Patients
The response rate to the questionnaires was 82% (31of 38 children). Non­
responders (N = 7) were contacted by phone. Reasons for non­
participation were diverse. Mean age at implantation was 7 years
Figure 1: Duration of bone anchored hearing aid (BAHA) use per 
day in the three study groups. BHL indicates bilateral conductive 
hearing loss; MD, mental disability; NC, normal cognition; and UHL, 
unilateral hearing loss.
(range 4-15 years). Age at the time of the questionnaire was 10 years (6­
17 years). Eighteen patients (58%) were male and 13 (42%) were female. 
Descriptions of the subgroups (BHL-NC, BHL-MD and UHL groups) are 
given in table 2.
The bilateral hearing loss (BHL) group
A total of 16 children responded to the questionnaire: 10 in the BHL-NC 
group and 6 in the BHL-MD group.
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Figure 2: Responses to the question, "Do you consider your BAHA to 
be worth the effort?" BAHA indicates bone anchored hearing aid; 
BHL, bilateral conductive hearing loss; MD, mental disability; NC, 
normal cognition; and UHL, unilateral conductive Hearing Loss.
The "daily device use" questionnaire
In the BHL-NC group, 9 children (90%) were using the BAHA for more than 
8 hours a day (Figure 1). Most children in this group (8 [80%]) reported 
that the BAHA was worth the effort (Figure 2). There were no reports of 
problems with placement or handling of the BAHA, and only 2 of 9 
children (22%) experienced occasional problems with cleaning around 
the implant (Figure 3). See table 1 for more details. In the BHL-MD group 
(N = 6), the answers were more varied (Table 1).
Figure 3: Responses to the question, "Do you find it difficult to clean 
the skin around the implant?" BHL indicates bilateral hearing loss; 
MD, mental disability; NC, normal cognition; and UHL, unilateral 
hearing loss.
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The Glasgow Children's Benefit Inventory (GCBI)
An overview of the GCBI scores is given in table 3 and Figure 4. In the 
BHL-NC group, 8 children reported benefits from using the BAHA. 
However, 2 children (20%) were having problems in at least one of the 
subdomains. The BHL-MD group had lower overall scores on the GCBI. 
Three children had negative scores on the GCBI.
Although the overall mean scores of the BHL-MD group were lower than 
those of the BHL-NC group, there were no significant differences 
between these groups for any of the subdomain scores.
Table 3: Mean questionnaire results per subdomain and study group
Questionnaire subdomain scores (mean, (SD) BHL-NC BHL-MD UHL
GCBI Total 32 (25) 16 (34) 26 (22)
Emotion 40 (32) 20 (36) 27 (30)
Physical 11 (16) -1 (38) 16 (19)
Learning 47 (33) 29 (40) 40 (28)
Vitality 31 (20) 10 (32) 19 (17)
APHAB I ase of Communication, unaided 50 (17) NA 30 (16)
Reverberation, unaided 63 (23) NA 53 (13)
Background Noise, unaided 73 (24) NA 53 (22)
Aversiveness to Sound, unaided 22 (24) NA 26 (20)
I ase of Communication, aided 18 (22) NA 20 (18)
Reverberation, aided 29 (9) NA 33 (14)
Background Noise, aided 35 (20) NA 26 (15)
Aversiveness to Sound, aided 40 (27) NA 37 (26)
I ase of Communication, benefit 38 (21) NA 14 (15)
Reverberation, benefit 34 (21) NA 21 (18)
Background Noise, benefit 38 (26) NA 27 (24)
Aversiveness to Sound, benefit -19 (30) NA -10 (18)
HUI-3 Vision 1.00 (0.00) 0.82 (0.4) 1.00 (0.01)
Hearing 0.80 (0.10) 0.69 (0.20) 0.85 (0.11)
Speech 0.91 (0.12) 0.54 (0.14) 0.90 (0.12)
Ambulation 1.00 (0.00) 0.86 (0.11) 1.00 (0.0)
Dexterity 1.00 (0.0) 0.61 (0.45) 1.00 (0.0)
Emotion 1.00 (0.03) 1.00 (0.04) 1.00 (0.02)
Cognition 0.97 (0.06) 0.71 (0.23) 0.92 (0.11)
Pain 1.00 (0.07) 0.96 (0.09) 1.00 (0.00)
Multiattribute Utility 0.83 (0.14) 0.26 (0.25) 0.82 (0.12)
Abbreviations: APHAB, Abbreviated Profile o f Hearing Aid Benefit; BHL, bilateral 
conductive hearing loss; GCBI, Glasgow Children's Benefit Inventory; HUI-3, Health 
Utilities Index Mark 3; MD, mental disability; NA, not applicable; NC, normal cognition; 
UHL, unilateral conductive Hearing Loss.
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The Abbreviated Profile o f Hearing Aid Benefit (APHAB)
To determine the amount of benefit derived from using the BAHA, the 
patients were asked to fill out the APHAB retrospectively, thereby taking 
their situation before BAHA fitting into account. A dotted line at the 10- 
point level and the norm scores are shown in figure 5. The mean group 
scores on subdomains EC, RV and BN were all above the 10-point level. 
Individual data, however, showed that 7 patients (70%) experienced a 
significant overall clinical benefit. None of the patients reported a 
clinically significant deterioration in their hearing when using the BAHA. 
Four of these 7 patients had not been using a hearing aid previously, and 
3 of them had used a conventional bone conductor. No differences 
were seen between these two groups.
Only 3 of 6 caregivers for the children in the BHL-MD group responded to 
the APHAB questionnaire. One of them remarked that the questions were 
too difficult for the child to answer. Therefore, all the APHAB data from 
this group were excluded.
Health Utility Index mark 3 (HUI-3)
The scores on each of the 8 subdomains are presented in table 3. In the 
BHL-NC group, the mean (SD) scores ranged from 0.80 (0.10) to 1.00 
(0.00). The overall mean utility score was 0.83 (0.14). The disability scale 
categorized patients as having no disability (N = 1; [10%]), mild disability
GCBI subdomain
m BLH-NC Group
□  BLH-MD Group
□  UHL Group
Figure 4: Total Glasgow Ghildren's Benefit Inventory (GCBI) and 
subdomain scores per group. A positive score (0-100) represents 
benefit; a negative score represents deterioration in quality of life. 
BHL indicates bilateral hearing loss; MD, mental disability; NC, 
normal cognition; and UHL, unilateral hearing Loss.
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(N = 2; [20%]), moderate disability (N = 6 [60%]), or severe disability (N = 
1[10%]).
In the BHL-MD group, the mean scores were considerably lower. Ranging 
from 0.54 (0.14) to 1.00 (0.04), with a mean utility of 0.26 (0.25). The lower
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Figure 5: Mean (SD) benefit scores on the Abbreviated 
Profile of Hearing Aid Benefit (APHAB) subdomains ease 
o f communication (EC), reverberation (RV), background 
noise (BN), and aversiveness of sound (AV). BHL indicates 
bilateral hearing loss; NC, normal cognition; and UHL, 
unilateral hearing Loss. There was significant benefit for 
the majority o f the children in the BHL-NC group (scores 
above the 10-point line). In the UHL group, there was a 
significant benefit seen for BN on a subdomain-specific 
level (the majority o f the scores are above the 22-point 
line).
scores were mostly due to comorbid conditions and lower scores for 
dexterity, speech and cognition. In this group, all children were classified 
as having severe disability on the disability scale.
80
-60
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Findings across questionnaires
Within the BHL-NC group, there were no differences in the GCBI, APHAB 
and HUI-3 scores between the following groups: the unilateral BAHA users 
and the bilateral BAHA users; BAHA users with congenital causes and 
those with acquired causes; and those who previously used 
conventional hearing aids and those who did not. A negative correlation 
was found between the age at BAHA fitting and the scores on the GCBI, 
which indicated that the younger the child was at the time of BAHA 
fitting, the greater the benefit that could be experienced (rho = -0.68, 
P=0.02).
There were no interquestionnaire correlations between the domains or 
subdomains of the questionnaires used. However, a trend was seen 
between the learning subdomain of the GCBI and the BN subdomain of 
the APHAB (rho = 0.6, P = 0.06).
The Unilateral Hearing Loss (UHL) group  
"Daily device use" questionnaire responses
In the UHL group (N = 15), 7 children (47%) were using their BAHA devices 
for more than 8 hours a day, and 6 children (40%) were using them for 4 
to 8 hours a day (Figure 1, Table 1). The BAHA was considered to be 
either worth the effort or very much worth the effort by 10 (67%) of the 
patients surveyed (Figure 2, Table 1).
GCBI Responses
An overview of the GCBI scores is given in table 3 and figure 4. The results 
were comparable with those found in the BHL-NC group, although 3 
children (20%) reported problems in at least one of the subdomains.
The Abbreviated Profile o f Hearing Aid Benefit (APHAB
Only 4 children (27%) experienced a significant overall benefit (scores of 
10+ for each subdomain) from using the BAHA, according to the results 
of the APHAB. Significant deterioration did not occur. A significant 
benefit was seen in 4 children (27%) for subdomain EC, 7 children (47%)
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for subdomain RV and 8 children (53%) for subdomain BN. The age at the 
BAHA fitting was negatively correlated with the subdomain BN (rho -0.54, 
P=0.02), which indicates that patients experience a greater benefit when 
the BAHA is fitted at an early age. None of the other subdomains 
showed significant correlations with age.
Health Utility Index mark 3 (HUI-3)
The mean (SD) scores on the HUI-3 subdomains ranged from 0.85 (0.11) 
to 1.00 (0.0). The overall mean utility score was 0.82 (0.12). The disability 
scale categorized patients as having no disability (N = 2 [13%]), mild 
disability (N = 3 [20%]), moderate disability (N = 8 [53%]) or severe 
disability (N = 2 [13%]).
Findings across Questionnaires
The learning GCBI subdomain showed a statistically significant 
correlation with the APHAB benefit of BN (rho = 0.53, P = 0.04).
The unaided APHAB RV subdomain score was positively correlated with 
the GCBI overall subdomain (rho = 0.71, P = 0.003), the emotion 
subdomain (rho = 0.66, P = 0.008), the learning subdomain (rho = 0.54, P = 
0.04) and the "vitality” subdomain (rho = 0.53, P = 0.04). This suggests that 
patients, especially those experiencing problems hearing in large rooms 
(e.g., lecture halls, theatres or classrooms) because of reverberation, 
might experience some benefit from use of the BAHA.
D iscussion
This study aimed to evaluate the effect of BAHA fitting on the day-to-day 
lives of children with either unilateral or bilateral conductive hearing loss. 
Different questionnaires were used to measure different outcomes.
The response rate in our study was 82%, which is comparable with 
response rates reported in the literature (73% to 87%).11'22'29'44 This high 
level of participation was mostly due to an active recruitment method 
that consisted of multiple reminder letters and telephone calls. To avoid 
enthusiasm bias as much as possible, we included children who had 
been using their BAHA for at least one year. To complete the
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retrospective questionnaires, parents and children had to recall their 
situation before the BAHA was fitted, which was as long as four years 
ago. This may have posed a limitation for the study; however, the choice 
of four years as the upper limit for duration of the BAHA allowed for a 
study population (large enough) to sufficiently evaluate the level of 
benefit. The parents were asked to answer the questions based on the 
child's opinion as much as possible. All parents stated that they could 
sufficiently recall their child's situation before the BAHA was fitted. 
Therefore, the answers were considered to be reliable. The minimum age 
for inclusion in the study was four years, the age at which Dutch children 
go to nursery school, where their abilities are tested more completely 
than at younger ages.
In this study population, there were 6 children with mental disabilities. The 
literature shows that patients with disabilities do indeed derive benefit 
from the BAHA.27'30 However, to evaluate this specific patient group, their 
findings need to be analyzed separately. Three of the 6 parents were 
unable to respond to the APHAB on behalf of their child. As a result, the 
APHAB was determined to be too difficult to use in this population and 
the data from the APHAB was excluded for this group.
It was not possible to draw any firm conclusions regarding comparisons 
of the BHL-NC and the BHL-MD groups because the number of 
participants was too small. Nevertheless, some of the children in the BHL- 
MD group derived more benefit from the BAHA than the previous device, 
whereas others did not. The very low scores on the HUI-3 could be 
explained by co morbidities related to mental disability and/or physical 
handicap. Overall, the study population was relatively small and, 
therefore, more research on this specific BAHA population is needed to 
draw more firm conclusions.
The BHL group
The BAHA is considered to be the best option for children with bilateral 
conductive hearing loss (our BHL-NC group) (consensus statements, Snik 
et al.3). In general, these children derive a great benefit from the BAHA in 
everyday situations. Our findings support those of other publications on 
the use of the BAHA in pediatric populations.11,22,29
Overall, the GCBI revealed a general benefit of BAHA use in the BHL-NC 
group. There was a particularly large benefit on the learning subdomain,
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which underscores the impact of the BAHA on hearing impaired 
children's education. High scores were also seen for the emotion 
subdomain, which is an encouraging finding for a child's development.
We found that a younger age at the time of BAHA fitting correlated with 
higher scores on the GCBI, which emphasizes the need for early hearing 
aid fitting in children with bilateral hearing loss.
Figure 6 shows the scores from all children who participated (N = 31) 
compared to findings reported in the recently published literature. In a 
retrospective study, McDermott et al.29 evaluated data from 84 children 
who had been fitted with a BAHA during a period of 15 years. The GCBI 
scores for all subdomains reported in their study were significantly higher 
than the scores reported herein (P< 0.01). One explanation for this 
discrepancy may be the differences in the study populations. In our 
study, about 19% of study participants had syndromic features 
compared with 48% in the population studied by McDermott et al. Their 
approach to these patients, who require additional treatment for their 
particular comorbidities, involved an integrated program of evaluation 
and rehabilitation. It is possible that this program created additional 
subjective treatment benefit for these patients, which was reflected in 
the scores of the GCBI.
Figure 6: Mean (SD) Glasgow Children's Benefit inventory (GCBI) 
scores for each subdomain for the current study's total population 
(N = 31) compared to the total population evaluated by 
McDermott et al.29 (N = 84). The scores for the current study 
population are significantly lower for all subdomains (P < 0.01).
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- BHL-NC group aided 
• UHL group aided
Figure 7: Aided scores (SDs) on the Abbreviated Profile of Hearing 
Aid Benefit (APHAB) subdomains ease o f communication (EC), 
reverberation (RV), background noise (BN), and aversiveness of 
sound (AV) for the bilateral hearing loss-normal cognition (BHL-NC) 
and unilateral hearing loss (UHL) groups. The scores on subdomains 
EC, RV and BN all fall around the 80th percentile, indicating that 
80% of the normal-hearing normative group experience less 
problems in these listening situations.
Mean scores on the APHAB showed a significant treatment benefit in the 
majority of children in the BHL-NC group (Figure 5, Table 3). The scores on 
the subdomains EC, RV and BN all fell around the 80th percentile line for 
normal hearing subjects33, which indicates that 80% of the normative 
group with normal hearing experienced fewer problems in these listening 
conditions than the current population (Figure 7). These findings 
emphasize that, although the BAHA provides benefit in the majority of 
cases, there is still residual disability compared to normal hearing 
children.
In the BHL-NC group, the HUI-3 results also support the fact that there is 
still a residual disability when the BAHA is used. In the current study, the 
overall mean multi-attribute utility score on the HUI-3 was 0.83 (0.14), 
which correlates with a moderate disability score. Table 3 shows that a 
large part of the deviation from perfect health in preference scores can 
be attributed to the hearing and speech domains, which is not surprising 
because speech relies heavily on auditory input. The HUI-3 score in the 
BHL-NC group indicated comparable a general QOL compared with 
previous reports in the literature.45
The results found in children with BHL show an interquestionnaire trend 
between the benefit of the BAHA in listening conditions with background 
noise and the beneficial effect of the BAHA on learning capabilities (rho 
= 0.6, P = 0.06). Thus, the beneficial effects of BAHA use, especially in
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noisy environments, may also explain its positive effect on learning in 
these children.
UHL group
According to the consensus statements, the BAHA is also an important 
treatment option for children with UHL.3 However, it is still unclear what 
the predictor for success is in this group. Kunst et al.20 studied 10 children 
and 10 adults with UHL. The BAHA had a beneficial effect on speech 
recognition in a noisy environment in a setup with spatially separated 
speech and noise sources, although this result could be attributed to 
effectively lifting the acoustical head shadow.
Priwin et al.21 did not find any benefit from the BAHA during directional 
hearing tests in a group of 6 children with congenital UHL. In some cases, 
directional hearing even deteriorated when the BAHA was used.
Overall, there is no clear evidence to date that a BAHA is beneficial to all 
children with UHL.17 To gain more insight into the mechanisms of how 
patients derive benefit from the BAHA in this patient group, we 
evaluated the subjective measurements of the BAHA in 15 children with 
congenital UHL. On the daily device use questionnaire, the UHL group 
reported that the BAHA was worth the effort in general. However, they 
did not seem to be using the BAHA all day, and they were not overly 
impressed by the sound quality. Furthermore, only 67% of the children 
with UHL would recommend the BAHA to peers compared with 90% in 
the BHL group. Some of the patients with UHL responded that they used 
the BAHA only in the classroom, which has also been reported in other 
studies.21 The BAHA has proved to be particularly beneficial in speech 
recognition tests in the setting of noise in patients with UHL. Therefore, the 
BAHA might be particularly beneficial in the school environment for these 
children, which is the most important time of the day.17'21'46'47
In this study, children with UHL and a BAHA showed a similar benefit, as 
measured by the GCBI, as the children with BHL and a BAHA. However, 3 
of 15 children with UHL had a negative score on 1 of the subdomains. 
These disappointing results emphasize the importance of performing a 
trial with a headband to predict which children will benefit most from a 
BAHA in different listening conditions, including both at home and in 
school. Previously, Kunst at al.26 used the GCBI to study 10 children with
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Figure 8: Mean (SD) Glasgow Children's Benefit Inventory (GCBI) 
scores for each subdomain for the current study's unilateral 
hearing loss group (N = 15) compared with the children with 
unilateral conductive hearing loss (N = 10) in a study by Kunst et 
al.26 Both studies showed comparable results.
UHL recruited from this clinic. The scores for the subdomains were 
comparable to those from our study (Figure 8).
On the basis of the fact that the study subjects scored highest on the 
learning subdomain, it can be concluded that, in children with a 
unilateral air-bone gap, the BAHA is particularly beneficial in educational 
settings.
Only 4 patients in the UHL group (27%) derived a significant benefit 
overall from the BAHA, according to the APHAB assessment made with 
the criteria defined by Cox.36 Their poor results could be attributed to a 
low score of 27% on the EC subdomain compared to 47% and 53% on 
the RV and BN subdomains. These findings indicate that the BAHA does 
not lead to a significant benefit in all domains assessed by the APHAB in 
children with UHL. Hypothetically, patients with a congenital, unilateral 
air-bone gap use their normal contralateral ear to compensate for their 
impaired ear, which would undermine the benefit of the BAHA. The 
relatively positive results seen in the subdomains RV and BN might be due 
to the synergistic effect of binaural hearing and lifting the head shadow, 
respectively.
The results of the APHAB reiterate that it is of the utmost importance for 
children with UHL to undergo a trial period with the BAHA on a 
headband or softband to establish whether or not the BAHA will provide 
optimal treatment.
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The HUI-3 and disability scores in the UHL group were comparable with 
the scores in the BHL-NC group. For this population, therefore, the BAHA 
has a beneficial effect, although a residual moderate disability remains. 
It is difficult to assess the benefit of a BAHA in this population; therefore, a 
preoperative screening for disability conducted in reverberated rooms 
using the APHAB might be a valuable way to assess potential additional 
benefits.
C o n c lu s io n
This study further supports the finding that the BAHA is beneficial for 
children with BHL. Children with normal cognition and those with mental 
disability gave positive subjective reports about the BAHA. Subjective 
evaluations by the children with UHL were more varied than those by the 
children with BHL. In children with UHL, the decision to use a BAHA should 
be made on an individual basis with the aid of a trial period of at least 
two weeks, which allows the child to use the BAHA in a variety of settings, 
particularly in a school environment. Overall, the BAHA was particularly 
beneficial for a child's learning, which may be largely due to its 
beneficial effects in noisy surroundings.
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A bstract
Objective: Benefit and quality-of-life analysis in the older adult bone- 
anchored hearing aid (BAHA) users.
Study Design: Retrospective evaluation.
Methods: Four questionnaires (Glasgow Benefit Inventory [GBI], 
Abbreviated Profile of Hearing Aid Benefit [APHAB], Nijmegen Cochlear 
Implant Questionnaire [NCIQ], and the Hearing Handicap Inventory for 
the Elderly screening version [HHIE-S]) were used.
Results: The response rate was 80%, mean age was 75 years (range, 62 
to 93 yr), and mean pure-tone average at frequencies of 500, 1,000,
2,000, and 4,000 Hz for bone conduction was 42 to 13 dBHL. More than 
80% of the patients were using their BAHA for more than 8 hours a day. 
To obtain a snapshot of current BAHA use, the NCIQ, HHIE-S, and the 
APHAB were used. The NCIQ showed good disability and handicap 
results (score range, 49 to 64). The HHIE-S showed that 60% of the 
patients had a mild to moderate handicap. The APHAB aided scores 
ranged from 39 to 58%. Mean benefit scores of the Glasgow Benefit 
Inventory were positive in 112 of the 134 patients (84%). The APHAB 
showed clinically significantly more benefit with the BAHA than with the 
previous aided or unaided situation. A trend could be seen, the higher 
the pure tone average at frequencies of 500, 1,000, 2,000, and 4,000 Hz 
for bone conduction, the smaller the mean benefit scores on the 
questionnaires.
Conclusion: Bone-anchored hearing aid users aged 60 years or older 
were able to place and handle the device very adequately and clean 
the skin around the implant. Most patients reported comparable or 
increased general benefit and good quality of life with the BAHA.
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INTRODUCTION
In 1965, Brânemark et al.1 began using osseointegrated titanium implants 
to fit dental prostheses. This led to the development and fitting of the first 
bone-anchored hearing aids (BAHAs) by Tjellström et al.2 in Göteborg, 
Sweden, in 1977. In the spring of 1982, the first 10 patients were fitted with 
a BAHA.3 The BAHA is mostly used by patients with conductive or mixed 
hearing loss who are unable to wear a conventional air conduction 
hearing aid (ACHA) mostly due to chronic otitis. For these patients, the 
BAHA is usually the only remaining option.
In June 1988, the first patients were implanted with a BAHA in Nijmegen, 
the Netherlands. Two decades later, 1,076 patients have been fitted with 
a BAHA in Nijmegen. Most of these patients were adults with the 
previously mentioned "conventional" indication. However, within these 
1,076 (28%) patients, 297 were 60 years or older, and 168 were 
considered suited for inclusion in this study. The sensorineural hearing loss 
component is known to increase with age. In general, sensorineural 
hearing loss affects 25 to 40% of the population 65 years or older. The 
prevalence increases dramatically with age: 40 to 60% in the 75+ age 
group and more than 80% in the 85+ age group.4 It is possible that BAHA 
users who originally had pure bilateral conductive hearing loss will 
experience more problems as the sensorineural component becomes 
more prominent with aging. Thus, the BAHA might become less suitable 
for these persons over the years.
Important outcomes of medical treatment nowadays are subjective 
benefit and the patient's own view of their health status. These issues can 
be measured with 3 types of validated instrument: generic, disease- 
specific, and domain-specific. Generic instruments enable comparisons 
of health status but often fail to capture aspects that are important to a 
specific clinical setting such as hearing impairment. Thus, they seem to 
lack sensitivity to assess the gain in quality of life after changes in 
treatment5'6, or change is too small for them to detect.7 In contrast, 
disease-specific instruments can assess impairment of function, in this 
case, hearing impairment. They not only assess disability but also give an 
indication of handicap and are therefore more likely to be responsive to 
changes in hearing impairment. The third category of instruments is 
domain-specific, which means that they can measure, for example, pain 
and depression.
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A recent study by Bagai et al.4 on older adults with hearing impairment 
has shown that the patients who were not using their conventional 
hearing aid were more likely to report sadness and depression, worry and 
anxiety, paranoia, decreased social activity, emotional turmoil, and 
insecurity than those who were using their hearing aid. The same 
problems might arise in patients of all ages if their hearing aid does not 
work properly or is not suited to the type of hearing loss. Hearing 
impairment has commonly been associated with functional disability 
and emotional, social, and behavioral problems.8 Disabilities can be very 
severe even when audiologic testing shows that the hearing loss is 
relatively mild. For older adults, a BAHA can be suitable provided that 
the cochlear function is adequate. However, their cochlear function is 
likely to deteriorate with aging, which would cause additional hearing 
problems. It is possible that precisely these older patients, with mixed 
hearing loss, will derive benefit and improvements in quality of life from 
BAHA fitting.
The purpose of this study was to evaluate subjective benefit and quality 
of life in older adult BAHA users with mixed hearing loss.
MATERIALS AND  METHODS
Patients
All consecutive patients 60 years or older were identified who had been 
fitted with a BAHA for the conventional indication between April 1990 
and April 2007. After exclusion of the patients who had died, 
questionnaires were sent to the 168 suitable candidates who had 
bilateral conductive or mixed hearing loss and had used the BAHA for at 
least 1 year. A response rate of 80% (N = 134) was achieved after several 
reminders. Reasons for nonparticipation (N = 34) were 18 patients had 
moved and could not be contacted, 8 were not interested in the study, 
2 had dementia, and 6 patients had stopped using their BAHA (3 due to 
chronic pain at the implant site, 1 because of implant loss due to 
trauma, 1 had deteriorating health, and 1 had not experienced sufficient 
benefit).
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Table 1: Descriptive Population data.
Descriptive Population data (N = 134)
Age 75 years (range 62-93 years)
men 56 (42%)
women 78 (58%)
PTAbc 42 ± 13 dB HL
Bilateral BAHAs 11 (8%)
Indication
Bilateral mixed hearing loss 98 (73%)
Mixed hearing loss in one 
ear, other ear deaf
36 (27%)
Mean duration of BAHA use 6 years (range 1-18 years)
< 1 year of use 11 (8%)
< 5 years of use 67 (50%)
Previous HA
no BAHA (N = 13, 10%)
age 67 ± 6 years
PTAbc 38 ± 16 dB HL
air bone gap 33 ± 12 dB HL
ACHA (N = 81, 60%)
age 68 ± 6 years
PTAbc 36 ± 11 dB HL
air bone gap 32 ± 12 dB HL
BCHA (N = 40, 30%)
age 69 ± 6 years
PTAbc 45 ± 15 dB HL
air bone gap 35 ± 13 dB
Methods
The patients were sent 5 different questionnaires. One concerned "daily 
use" and satisfaction with the BAHA. Satisfaction was defined as a 
positive response to 2 of 3 of the following aspects: recommendation to 
a peer, being prepared to pay for the BAHA yourself, or choosing the 
BAHA again (Table 1). The other 4 questionnaires comprised widely 
accepted and validated instruments.
Three of the questionnaires (Abbreviated Profile of Hearing Aid Benefit 
[APHAB], the Hearing Handicap Inventory for the Elderly-Screening 
version [HHIE-S]9'10, and the Nijmegen Cochlear Implant Questionnaire 
[NCIQ]11) were used to obtain a "snapshot" of the current situation 
regarding BAHA use.12'13 Two questionnaires were used to assess 
subjective benefit: the Glasgow Benefit Inventory (GBI) and the APHAB.
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The APHAB, developed by Cox and Alexander12, is a disease-specific 
"disability" questionnaire with 24 items scored in four 6-item subscales. 
Three of the subscales address speech understanding in various 
everyday environments: ease of communication (EC, under relatively 
favorable conditions), listening under reverberant conditions (RV, 
communication in reverberant rooms such as halls or churches), and 
listening in background noise (BN, in settings with high background noise 
levels). The fourth subscale measures the negative reactions to 
environmental sounds: aversiveness of sounds. Responses can be given 
on a 7-point scale.
The HHIE-S, developed by Lichtenstein et al.9 and Ventry and Weinstein10, 
is a "handicap"-specific screening tool for elderly subjects with hearing 
loss. It consists of 10 items and 2 domains: emotional consequences and 
social/situational effects, with 3 response categories: "yes" (4 points), 
"sometimes" (2 points), and "no" (0 point). Scores can range between 0 
(no handicap) and 40 (maximum handicap). The HHIE-S was adapted 
for use in the BAHA-aided situation. A score of 0 to 8 points meant a 
probability of 13% that the hearing impairment was forming a handicap 
(no handicap). With a score of 10 to 24, there was a 50% probability of 
mild to moderate handicap, and with a score of 26 to 40, there was a 
probability of 84% of severe handicap.10,14
To assess more detailed information on hearing related disability a third 
questionnaire was added. The NCIQ, developed by Hinderink et al.11, is a 
disease-specific "disability and handicap" questionnaire initially designed 
for patients with cochlear implants (CIs). This questionnaire is known to be 
relatively sensitive to hearing-related quality-of-life issues in patients with 
CIs. It consists of 60 items on 3 domains: physical, psychologic, and 
social. These can be subdivided into 6 subdomains: basic sound 
perception (BSP), advanced sound perception (ASP), speech 
production, self-esteem, activity limitations (AL), and social interactions. 
The former 3 subdomains are disability-specific, whereas the latter three 
are handicap-specific. The response format is a 5-point Likert scale and a 
"not applicable" option. Scores can range between 0 and 100 (optimal). 
For use in the present BAHA population, the NCIQ was adjusted by 
excluding 3 of the questions on speech production and 1 question in the 
social interactions domain because they refer specifically to the use of 
signs, shouting, and communication with deaf persons in CI users. The 
resulting questionnaire was expected to be sensitive in BAHA patients,
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but this was the first time that it has been applied to a BAHA in this 
population.
The 2 questionnaires used to assess subjective benefit were the GBI and 
the APHAB. The GBI is a retrospective generic quality-of-life questionnaire 
developed by Robinson et al.15 to measure outcomes after 
otorhinolaryngologic procedures. It is sensitive to changes in "health 
status" that result from an intervention, and it enables comparisons 
between different interventions. Three domains are covered by 18 items, 
12 related to general improvement, 3 to social improvement, and 3 to 
physical improvement. Responses can be given on a 5-point Likert scale. 
Scores range from -100 (maximum lack of benefit), to 0 (no benefit), to 
+100 (maximum benefit).
The APHAB can also be used to assess benefit if pre-intervention and 
post-intervention data are available. Differences in benefit score on 
each of the EC, RV, or BN subdomains of more than 10 points are 
considered to be clinically significant with a chance occurrence of only 
4%.13 On a subdomain-specific level, a difference of 22 points is 
considered to be clinically significant.13
Demographic characteristics of the patients (age; years of BAHA use; 
previous type of hearing aid [none/air conduction/bone conduction]; 
and the most recent measured pure-tone average at frequencies of 500,
1,000, 2,000 and 4,000 Hz for bone conduction [PTAbc] and air-bone gap) 
were used to analyze statistical correlations. Inter-questionnaire 
correlations were also calculated.
Statistics
The statistical analyses were performed using the SPSS 16.0 system (SPSS, 
Inc., Chicago, IL, USA). Spearman [rho] was used to correlate the 
variables to the outcomes of the questionnaires. Only statistically 
significant correlations of 0.4 or more were regarded to be clinically 
significant. Linear regression analyses were used to perform inter­
questionnaire analyses.
RESULTS
This population comprised 134 BAHA users 60 years or older. Descriptive 
data are presented in table 1. The interval in years between the most 
recent audiologic test and the questionnaires taken was 2.3 ± 1.9 years.
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Table 2: The "daily use" questionnaire.
Question Response N (%)
Are you still using the BAHA?
How many hours per day have you 
been using the BAHA on a regular 
basis over the past two weeks?
In general, is your current BAHA worth 
the effort?
Do you have difficulties placing the 
BAHA?
Can you handle the BAHA controls 
well?
Are you familiar with the extra 
application options?
Do you have difficulties cleaning skin 
around the implant site?
How do you judge the sound of the 
BAHA?
Would you recommend the BAHA to 
a friend with the same hearing loss as 
yours?
If you had to pay for the BAHA (3000
euro) yourself, would you still have it 
fitted?
Would you, based on your experience 
with the BAHA, choose the BAHA 
again?_________________________________
Yes 131 (98%
No 3 (2%
Not worn the BAHA 2 (2%
Less than one hour a 1 (1%
day
1-4 hours a day 14 (10%
4-8 hours a day 8 (6%
More than 8 hours a 109 (81%
day
No 2 (2%
A little 4 (3%
Moderately 22 (16%
Much 26 (19%
Very much 78 (58%
Yes 13 (10%
No 120 (90%
Yes 126 (94%
No 8 (6%
Yes 46 (34%
No 83 (62%
Yes 12 (9%
Sometimes 25 (19%
No 96 (72%
Very good 16 (12%
Good 61 (46%
Reasonable 47 (35%
Bad 8 (6%
Very bad 1 (1%
Yes 121 (90%
No 12 (9%
Yes 95 (71%
No 35 (26%
Yes 123 (92%
No 8 (6%
Daily Use
Responses to the questionnaires (Table 2) showed that 131 of the 134 
patients (98%) were currently using their BAHAs; 81% were using their 
BAHAs for more than 8 hours a day. Reasons for no longer using the 
BAHA were problems with skin disease (psoriasis), unexplained 
dysfunction of the hearing aid, and illness of the spouse. These 3 patients 
had stopped using their BAHA less than 14 months before the study after
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Figure 1: Mean NCIQ results in the conventional BAHA group 
(n=134) subdivided into Basic Sound Perception (BSP), Advanced 
Sound Perception (ASP), Speech Production (SP), Self-Esteem (SE), 
Activity Limitations (AL), and Social Interactions (SI). And a 
comparison with the literature.
4, 7, and 11 years of use, respectively. Their responses were included in 
the analysis.
The general questionnaire showed that the BAHA had been fairly well 
accepted. Most of the patients did not have any difficulties with putting 
their BAHAs on (90%), cleaning the skin around the implant (72%), or 
handling the BAHA (94%). Satisfaction with the BAHA (81%) was reflected
100
APHAB
Figure 2: Mean scores in the aided condition (N = 134) 
plotted against a norm group with linear air conduction 
hearing aids Cox.13 On the subdomains EC, RV and BN, 
the mean BAHA scores fell on the 80th percentile, thus 
80% of the norm group had fewer problems.
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Figure 3: Severity o f handicap (HHIE-S) plotted against PTAbc 
categories.
in the responses to recommend the BAHA to a peer (90%), willingness to 
pay for the BAHA (71%), and choosing the BAHA again (92%). An 
overview of the data is given in table 2.
Current Status o f BAHA Use
The NCIQ, APHAB, and HHIE-S provided a "snapshot" of current BAHA use 
in terms of disability and handicap. Higher scores on the NCIQ mean 
better outcomes. Lower outcomes in the APHAB and HHIE-S reflect milder 
handicap.
The disability-specific scores on the BAHA-aided subdomains of the 
APHAB are presented in table 3. Figure 2 shows the mean scores in the 
aided and unaided conditions plotted against those of a norm group of 
older ACHA users studied by Cox (gray lines).13
Interestingly, the HHIE-S showed higher levels of handicap in the 
social/situational setting than in the emotional setting (111 of the 134; 
83%) for most patients; 14 patients (10%) had comparable levels of 
handicap in the 2 settings, and only 9 patients (7%) had more severe 
emotional than situational handicap. This handicap scale showed that in 
the BAHA-aided condition, 23 patients had "no handicap" (17%), 80 
patients had mild to moderate handicap (60%), and 31 patients (23%) 
had severe handicap.
The following demographic variables were used in the analyses: age at 
administration of the questionnaires, duration of BAHA use in years, PTAbc, 
and air-bone gap. Spearman [rho] showed that there were no clinically
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significant correlations (all correlations were < 0.4) between these 
variables and the outcomes of the questionnaires. However, trends were 
seen between the sensorineural hearing loss component and the 
subdomains BSP and ASP of the NCIQ (r = -0.36 and -0.37, respectively; P 
< 0.000). This indicates that sound perception benefit in the BAHA-aided 
condition might depend on the sensorineural hearing loss component. A 
trend in PTAbc was also seen on the HHIE-S (r = 0.34, P < 0.000), which 
might indicate that the level of handicap depends on the sensorineural 
hearing loss component (Figure 3).
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Figure 4: Mean GBI scores subdivided into 
total, general, social and physical benefit (N =
134).
Benefit in the BAHA-Aided Condition
On the GBI, the higher the score, the greater the benefit. A total of 112 of 
the 134 (84%) patients had a positive mean GBI score. These outcomes 
are shown in table 3 and figure 4.
On the APHAB, patients were asked to fill in the questionnaire 
retrospectively and according to the current situation with the BAHA. In 
this population, 45 of the 134 patients (34%) reported significant overall 
benefit with the BAHA compared with their previous situation. 
Deterioration was reported by 2 patients (2%), whereas 87 patients (64%) 
had not experienced any significant difference.
The data were also divided into subgroups according to the previous 
aided or unaided situation (no HA, ACHA, or BCHA). Benefit scores for 
these subgroups are presented in table 3. In the ACHA and BCHA
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Table 4: Linear regression results o f the NCIQ subdomains BSP, ASP, 
and SP explaining the total score on the HHIE-S.
B SE B Beta
Step
1
(Constant) 38.63 2.45 15.77 0.00
Advanced sound 
perception
-0.25 0.05 -.58 -4.79 0.00
Basic sound 
perception
-0.01 0.05 -.03 -0.25 0.81
Speech
production
-0.08 0.04 -.18 -2.00 0.05
Step (Constant) 38.67 2.43 15.91 0.00
2
Advanced sound 
perception
-0.26 0.04 -.60 -6.85 0.00
Speech
production
-0.09 0.04 -.18 -2.06 0.04
Note R2 = 0.51 for step 1; A R2 = 0.00 for step 2
groups, 2 patients experienced clinically significant deterioration after 
changing from an ACHA (1%) or a BCHA (3%) to the BAHA.
Inter-questionnaire Correlations
In response to the "snapshot" questionnaires on the current aided 
condition, the subdomains EC and BN in the APHAB showed clinically 
significant correlations with all the subdomains of the NCIQ (r = 0.44 to 
0.64; P < 0.00). The subdomain RV in the APHAB showed correlations with 
BSP, ASP, and AL in the NCIQ (r = 0.44 to 0.47; P < 0.00). The total 
handicap score on the HHIE-S correlated with the aided scores on the
Table 5: Linear regression results o f the EC, RV, and BN subscales of 
the APHAB explaining the variance in the HHIE-S scores.
B SE B Beta
Step
1
(Constant) 1.226 2.108 0.582 0.562
Ease of
communication 0.088 0.037 -0.203 2.375 0.019
aided
Background noise 
aided
-0.168 0.036 -0.417 -4.686 0.000
Reverberation aided -0.065 0.040 -0.130 1.615 0.109
Step
2
(Constant) 3.291 1.687 1.951 0.053
Advanced sound 
perception
-0.101 0.036 -0.234 2.783 0.006
Speech production -0.188 0.034 -0.468 -5.569 0.000
Note R2 = 0.42 for step 1; A R2 = -0.012 for step 2
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APHAB (EC, BN, RV; r = 0.47 to 0.59; P < 0.00) and all the subdomains in 
the NCIQ (r = -0.5 to -0.77; P > 0.00). Linear regression showed that the 
subdomains BSP, ASP, and speech production of the NCIQ, representing 
disability, explained 51% of the total score on the HHIE-S (Table 4). The 
APHAB-aided subscales EC, RV, and BN explained 42% of the variance in 
the HHIE-S scores (Table 5).
Inter-questionnaire correlations between the "Benefit" questionnaires 
were clinically significant for the total and general scores on the GBI and 
the subdomain scores EC, RV, and BN on the APHAB (r = 0.40 to 0.52; P < 
0.00).
DISCUSSION
Nowadays, the BAHA, developed in 1977, is accepted worldwide. It is 
regarded as the gold standard for patients with chronic otitis or middle 
ear malformations who cannot be treated with a conventional air- 
conduction hearing aid. This study concentrated on the benefit and a 
"snapshot" evaluation of the effect of the BAHA in older adults by 
measuring certain quality-of-life aspects (remaining disability, remaining 
handicap, benefit, and satisfaction) using different questionnaires.
To gain insight into the satisfaction of this population, several items were 
addressed in the first general questionnaire. Satisfaction was defined as 
a positive response to 2 of 3 of the following: recommendation to a peer, 
paying for the BAHA yourself, or choosing the BAHA again. This revealed 
that 95 patients (71%) were satisfied.
The questionnaire data also showed that 131 patients (98%) were still 
using their BAHA, and that 109 of them (81%) were using it for more than 
8 hours a day. Most of the patients did not have any difficulties handling 
the BAHA (N = 126; 94%) or cleaning the skin around the implant (N = 96; 
72%). Only a very small percentage of the patients (N = 2; 1.5%) felt that 
the BAHA was not worth the effort or that the sound quality was poor (N 
= 9; 7%). Overall, these results indicated that the BAHA was functioning 
well in the daily lives of these older adults. The NCIQ, APHAB, and HHIE-S 
were used to make the "snapshot" evaluation.
The disability scores on the APHAB showed the best results on the EC 
subscale. Patients only experienced problems 38% of the time (Figure 2). 
This indicates that the BAHA enables good performance in what is
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qualified as the most important situation: communication with others. In 
reverberant conditions and situations with background noise, the 
patients reported less favorable results in terms of problems in 58% and 
57% of the cases, respectively. An explanation for these poor results may 
be that 92% of this population was fitted with only 1 BAHA. Listening with 
bilateral BAHAs might be of specific value in these conditions.
The aided scores reported in the APHAB were comparable with those in 
a norm group described by Cox and Alexander12 and Cox13 (Figure 2). 
Their norm group consisted of mostly elderly conventional hearing aid 
users with mild-to-moderate sloping or flat bilateral hearing loss who had 
been using their device for at least 1 year for 4 or more hours a day. 
When the mean scores from the BAHA population fell on the 50th 
percentile line, this means that the 2 populations were experiencing 
comparable hearing problems. However, in this BAHA population, the 
mean scores on the subdomains EC, RV, and BN fell on the 80th 
percentile, which indicated that 80% of the norm group was 
experiencing fewer problems. An explanation for the poorer scores on 
the subdomains RV and BN might be that in our BAHA population, only
11 of the 134 patients (8%) were fitted bilaterally compared with 42% in 
the population studied by Cox and Alexander.
The HHIE-S gives an indication of the subjective severity of their 
handicap. Our results showed that in the BAHA-aided condition, almost 
80% only had a mild level of residual handicap. A trend was seen (Figure
3) that with increasing sensorineural hearing loss, the severity of the 
handicap also increased. However, in some cases, there was not always 
a linear relation between the severity of the hearing loss and the 
subjective handicap (Figure 3). In the literature, HHIE-S scores (13 points) 
from patients with a unilateral air-conduction hearing aid (N = 98) were 
comparable with the scores from our population.8
In this BAHA population, the NCIQ scores ranged from 49 to 65 points, 
which means that the patients were able to function or hear on a 
"regular" to "usual" basis in different situations. This can be considered as 
a good outcome in these patients (Figure 1). Although the NCIQ was not 
designed for BAHA patients, and no other studies have used it for this 
purpose, the results of this first application showed that the NCIQ can 
also be used to obtain data from a BAHA population. Its various 
subdomains gave more specific indications in which direction the 
problem or benefit lay with the BAHA. The NCIQ results can be
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Table 6: NCIQ comparison between cochlear implant and BAHA.
NCIQ
Current study 
(N = 134, mean 
age 75 ± 6)
Hinderink et al. 11 
(N = 45, mean age 50 ± 
16)
Damen et al.16 
(N = 37 mean 
age 55 ±16)
2009 BAHA+ 2000 CI+ 2004 CI +
BSP 49 ± 24 64 ± 24 ** 61 ± 25*
ASP 58 ± 22 54 ± 20 54 ± 20
SP 65 ± 10 82 ± 18** 83 ± 18**
SE 59 ± 15 67 ± 16** 67 ± 19**
AL 59 ± 20 73 ± 16** 74 ± 20**
SI 64 ± 19 71.9 ± 14.5* 64 ±15
Means and standard deviations of the different subdomains of the NCIQ. 
Significant changes between BAHA and cochlear implant are indicated with an 
asterisk (Unpaired t-test) *p<0.05; **p<0.01
compared with the CI outcomes obtained 1 year after the intervention in 
the earlier studies by Hinderink et al.11 and Damen et al.16 Data are 
presented in table 6 and Figure 1. This questionnaire is known to be 
relatively sensitive to changes in hearing-related quality-of-life issues in 
patients with CIs.11 Although CIs and BAHAs work on different principles, 
the NCIQ questions address general hearing-related issues. Therefore, it 
can be argued that it is also suitable for BAHA users. The poorer 
outcomes in the BAHA users might be explained by differences in 
lifestyles (coping strategies) between the 2 patient groups. The 
explanation for this is that it was expected that the postintervention 
scores in the CI patients would be poorer (going from total deafness to 
moderate/severe hearing impairment) than in the patients who 
changed their previous non-optimal hearing device for a BAHA (going 
from moderate hearing impairment to moderate/mild hearing 
impairment). Apparently, CI users can cope more easily with remaining 
disability than BAHA users. Subjective perceptions of disability levels play 
a role. To obtain NCIQ reference values for BAHA patients, it is 
recommended to use this questionnaire in other populations of BAHA 
users.
Patient characteristics such as PTAbc and the air-bone gap did not show 
any clinically significant correlation with the "snapshot" outcome of these 
questionnaires. In the case of the air-bone gap, this was not a surprise 
because the BAHA bypasses the air-bone gap.17 However, the 
sensorineural hearing loss component showed a negative trend on the 
subdomains BSP and ASP on the NCIQ (r = -0.36 and -0.37; P < 0.000). This 
indicates that poor sound perception with the BAHA might be due to a
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Figure 5: GBI comparison with the literature. Mean results on the 
general, social and physical subdomains.
large sensorineural hearing loss component and illustrates the limitations 
of BAHA fitting in patients with more severe sensorineural hearing loss.
In general, retrospective benefit assessments, for example, using the GBI 
or APHAB, give rise to difficulties. One of the major drawbacks is that 
patients sometimes have to recall how their situation was several years 
ago.
In the present population, most patients had been using their BAHA for a 
long period of time. Recollection of the problems experienced before 
the BAHA was fitted may have weakened over time and caused recall 
bias, thus changing the results. To obtain the best results and thereby 
avoid recall bias, a group should have been chosen whose maximum 
duration of use was 1 year. In our study, this would have applied to a 
group of 11 patients (8%). The data were reanalyzed twice, once with 
only the patients with a follow-up of 1 year and once with the group with 
a follow-up of up to 5 years. This analysis showed only minor differences 
in overall benefit scores between these 2 subgroups and the total 
population. The mean scores on the GBI and APHAB in the 1-year group, 
the 5-year group, and the total population were 18 ± 16, 23 ± 21, and 23 
± 22 (GBI) and 12 ± 25, 19 ± 23, and 17 ± 23 (APHAB), respectively. The 
most accurate way to evaluate health-related quality of life and 
subjective benefit is to administer the questionnaires before BAHA fitting 
and to repeat these measurements after certain intervals, which will 
avoid recall bias. However, such an assessment procedure had not been 
followed.
The GBI was used to examine the subjective benefit of BAHA use. In this 
population of older adults, it produced positive results on all the
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subdomains, which indicates that the patients were experiencing benefit 
from their BAHAs. In the literature, 3 studies evaluated the subjective 
benefit of BAHA use by means of the GBI.18-20 Figure 5 presents the results. 
The subjective benefit outcomes in the subgroups "mastoid disease" and 
"otitis media" have been combined to facilitate adequate comparison. 
The current data were the poorest. Reasons might be the relatively long 
follow-up in our study (although recall bias is unlikely because duration of 
follow-up has little effect on the GBI score) or enthusiasm bias in the other 
studies owing to persisting feelings of gratitude during the relatively short 
follow-up. In our population of older adults, the sensorineural hearing loss 
might have been more profound and therefore possibly weakened the 
benefit that can be provided by a BAHA.
The APHAB was also used to assess the subjective effect of the BAHA in 
the present older population. It was chosen to compare the BAHA to the 
previous hearing aid (no HA, ACHA, BCHA). In the "no HA" subgroup, 54% 
of the patients reported significant overall benefit. In the other 2 
subgroups (ACHA or BCHA), these percentages were 32 and 30%, 
respectively. These data showed that in approximately one third of our 
older adult patients, the BAHA was providing greater audiologic benefit 
than their previous situation, and it had also brought relief from the 
chronic otitis (ACHA) or pressure pains (BCHA).
Inter-questionnaire analysis of the "snapshot" questionnaires showed 
clinically significant correlations between the EC and BN subdomains in 
the APHAB and all the subdomains in the NCIQ. In addition, subdomain 
RV in the APHAB was correlated with subdomains BSP, ASP, and AL in the 
NCIQ. This indicates that these 2 questionnaires assess comparable 
disability issues. The significant correlations can be regarded as 
validation of the study setup. Correlations were found between the total 
handicap score in the HHIE-S, the aided scores on the APHAB (disability), 
and all the subdomains in the NCIQ. This suggests that any remaining 
subjective handicap was closely associated with the subjective level of 
disability.
In conclusion, our older BAHA users were able to place and handle the 
device very adequately and clean the skin around the implant. They 
also reported good quality of life when using the BAHA. Most were 
experiencing comparable or increased general benefit from the BAHA 
despite their age-related hearing deterioration.
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DISCUSSION
C l i n i c a l  o u t c o m e  m e a s u r e s
This thesis addresses tw o aspects of BAHA surgery and  BAHA use. First, 
c lin ica l outcom es such as im plan t loss and  skin reactions around the im plan t 
are discussed in v iew  of a specific  surgical techn ique  focusing on children, 
adults and  o lde r adu lt user groups (C hapter 2). Second, the am oun t of 
benefit and  the quality  o f life ga ined  from the BAHA d e v ice  was are 
e va lua ted  in these groups.
An overv iew  o f the literature on BAHA puts its d e ve lo p m en t into 
perspective. Initially, a free re troauricu lar skin g ra ft was used with subcutis 
reduction  to c re a te  hairless skin a t the im plan t site. The m obility o f the free 
skin g ra ft was reduced  through an extensive reduction  o f the subcutaneous 
tissue. However, the use o f a free skin g ra ft was g radua lly  a b a n d o n e d  as it 
e nha n ce d  the risk o f skin necrosis and  donor site m orbid ity. A m anually 
perform ed p e d ic led  skin flap  g radua lly  rep la ce d  it. In o rder to  simplify this 
techn ique , a d e rm a tom e  was used to  p ro duce  an approp ria te  skin flap . 
The skin fla p  techn ique , w ith or w ithou t the use o f a de rm atom e, has since 
been used extensively in BAHA im p lan t surgery. Parallel to this deve lopm en t, 
the N ijm egen BAHA team  devised the linear incision techn ique , w hich is 
now  used by an increasing num ber o f im plan t teams.
C hap te r 2.1 describes the linear incision techn ique  and a retrospective 
eva lua tion  o f a consecu tive  series o f N ijm egen BAHA patients. This study 
shows tha t the linear incision offers an a c c e p ta b le  a lte rna tive  to o ther 
techniques w ith respect to im p lan t loss and adverse tissue reactions. The 
linear incision techn ique  has several advan tages. It causes minimal 
d is tu rbance o f the cutis. Disruption o f the b lood  supply to the cutis is in 
princip le  less severe than w hen perform ing a free skin g ra ft or a dissection of 
the skin w ith a de rm a tom e . Therefore, extensive reduction  o f subcutaneous 
tissue and  periosteum m ay have  a less de trim enta l e ffe c t on vascularisation. 
M oreover, It does not disrupt the b lood  supply to the ou te r layers o f the skin. 
Thus, there is little risk o f necrosis. The periosteum can  then be  excised safely 
and  subcutaneous soft tissue can  be  reduce d  sufficiently. This p rocedure  
takes on a ve rag e  20 minutes in skilled hands. In very recent literature, others 
have e va lua te d  the linear incision te chn ique  as well. Mudry co m p a re d  the 
skin fla p  and  the linear incision techn iques with respect to  the short-term skin 
healing process.1 In the linear incision group, he found less need for revision 
surgery and  less frequent unforeseen post- opera tive  contro l visits. This study 
dem onstra ted  statistically lower risks o f skin problem s w ith the linear incision
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te ch n iq u e .1 Van de  Berg et al. co m p a re d  the free auricu lar skin graft, a 
p e d ic le d  skin flap , the d e rm a tom e  techn ique , and the linear incision 
te chn ique .2 They found tha t the linear incision techn ique  was associated 
w ith significantly few er m ajor com p lica tions than the p e d ic le d  skin fla p  and  
the de rm a tom e  techn ique  in a fo llow -up period o f approx im ate ly  tw o 
years. They re com m end ed  the linear incision techn ique  for BAHA surgery.
This PhD thesis shows th a t the long-term  clin ica l ou tcom es o f the linear 
incision techn ique  are c o m p a ra b le  to those reported  by Reyes e t al. in the 
only study known to  have  a co m p a ra b ly  long fo llow -up pe riod3 Supported 
by recent literature it is a d v o c a te d  tha t the linear incision techn ique  should 
be  considered for BAHA im p lan ta tion . 2
Recently, questions have  been raised a bou t the need for any soft tissue 
reduction  a t all. Preliminary reports on a b ando n ing  soft tissue reduction  
show promising results in se lected  patients w ith little pre-existing subcutis.4 
The omission o f soft tissue reduction  w ou ld  result in a shorter surgical 
p rocedure  and  few er w ound  healing problem s, while it cou ld  lessen 
com pla in ts such as p ro longed  hyperesthesia. It should be  taken into 
consideration tha t the initial decision to  perform  subcutis reduction  was 
based on a lim ited num ber o f patients.5 In tha t light, it w ou ld  be  w orthwhile  
to  e va lua te  its necessity, starting by studying patients w ith little pre-existent 
subcutaneous tissue. Factors such as skin cond ition , skin type , and  length of 
the im p lan t w ou ld  then have  to  be  e va lua ted .
In C hap te r 2.2 the linear incision tech n iq ue  is e va lua ted  for the p aed ia tric  
popu la tion . In genera l BAHA surgery and  usage in children addresses 
d iffe rent issues than in adults. This is due  to  the fa c t tha t ch ildren m ay have 
more im m ature  and  th inner bone, appositiona l tem pora l bone  overgrow th, 
more risk o f soft tissue overgrow th, co nge n ita l (syndromal) m alform ations of 
the pinna, and  c lean ing  problems, for instance. The present study concurs 
w ith the consensus6 tha t children are more a t risk o f im plan t loss and 
adverse skin reactions. Rates o f im p lan t loss due  to fa iled  osseointegration 
and  infection w ere found to  be  co m p a ra b le  to those reported  in the 
Birmingham and  the London series, irrespective o f w hich surgical techn ique  
was used.7-8 Short im plan t length (3 mm co m p a re d  to  4 mm) and  young 
a g e  are said to  be  risk factors for im plan t loss in ch ild ren.9 This study, 
however, dem onstrates tha t w ith the linear incision techn ique , there is no 
significant re lation be tw een  im plan t loss and a g e  or im plan t length. A 
no tew orthy finding is tha t most im plants w ere lost within e ight months a fte r 
surgery, suggesting tha t incom p le te  osseointegration m ight be  involved. 
In tra-operative  stability m easurements (resonance frequency  analysis) m ight 
p lay a role in optim izing the conditions for osseointegration, especia lly in 
ch ild ren .10 When an im p lan t is lost, the interval be tw een  its loss and  its
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rep lace m en t should pre ferab ly be  brief. To tha t end the p la ce m e n t o f a 
sleeper ‘im p lan t' during the im p lan t surgery has been a d v o c a te d . Serious 
skin reactions occu rred  in a t least one-quarte r o f the im p lan ted  children. 
Clearly, it is im portan t to  counsel the parents and  to see ch ildren in the 
o u tpa tien t c lin ic m ore frequently  than adults. One option for children with 
hypertroph ic skin m ight be  the use o f a longer (8.5-mm) abutm en t.
Overall, this PhD thesis shows tha t 31 out o f the 93 (33%) children required 
revision surgery (e.g. a new  im p lan t or new  a bu tm en t p la ce d  on a sleeper, 
tissue revision). For ch ildren, it seems to be  even more im portan t than for 
adults to explore ways o f im proving the im p lan t-to -bone  and  implant-to-skin 
in te rface. O ne w ay  forw ard m ight be  to  d e ve lo p  new  percutaneous 
im plan t designs and  m ateria l.
If one is in d o u b t as to w he the r or not a ch ild 's bone  is suitable for a 
percutaneous im plant, a lte rna tive  treatm ents are ava ilab le . These include 
the a p p lica tion  o f a conven tiona l transcutaneous bone co n du c tio n  d e v ice  
(such as the BAHA so ftband). However, research has shown tha t, for 
aud io lo g ica l reasons, percutaneous coup ling  is to  be  preferred over 
transcutaneous intervention, even in young ch ildren, a t least starting a t an 
a g e  o f 4 to 5 years.11 An a lte rna tive  invasive trea tm ent m ight be  found 
am ong  the recently  in troduced  sem i-im p lan tab le  transcutaneous bone 
co n duc tio n  devices, one being the O tom ag  d e v ice  in troduced  by Siegert.12 
Furthermore, on an experim enta l basis, sem i-im plantab le  m idd le -ear 
im plants have been app lied  to children with aural atresia. These a lternative  
treatm ents ca ll for extensive eva lua tion. The first N ijm egen experience  with 
a ch ild  using an O tom ag  d e v ice  showed results co m p a ra b le  to those found 
w ith a BAHA.
In C ha p te r 2.3 the N ijmegen linear incision techn ique  is eva lu a te d  for in 
o lde r adults. Special a tten tion  is d raw n to the  risk o f losing an im p lan t and  of 
adverse skin reactions tha t m ight have  co m e  from possible difficulties in 
c lean ing  the skin around the im plant, as a result o f their young ag e . The 
most com m on  reasons for im plan t loss in this popu la tion  w ere fa iled  
osseointegration and  traum a; the loss was not re la ted  to in fection  around 
the im plan t site. The inc ide nce  o f im p lan t loss was co m p a ra b le  to tha t seen 
in the genera l popu la tion  (C hapte r 2.1). N otably, severe skin reactions 
occu rred  significantly less often am ong  o lder adults than in the genera l 
popu la tion  and  tissue revision surgery was needed  significantly less often. 
Thus the o lde r adults in this study w ere  less a t risk o f deve lop ing  hypertroph ic 
skin around the implants. The normal ag ing  processes in the dermis, w hereby 
the degene ra tion  o f tissue is irreversible, m ight explain this find ing.
A lthough skin necrosis was not encoun te red , m inor or m odera te  w ound 
deh iscence  d id  occur. It can  be  specu la ted  tha t the rem oval o f the stitches
187
C hapter 4
within seven days m ight be  too  early in the o lde r adu lt popu la tion . This 
com p lica tion  was not observed in the genera l popu la tion . The loca tion  of 
the ab u tm en t pene tra ting  the skin in or just beside the incision line m ight be 
a fa c to r in deve lop ing  w ound deh iscence. However, this hypothesis was not 
tested.
C hap te r 2.4 describes the e ffe c t o f the im p lan t loca tion  and  skin thickness 
on the frequency  and  severity o f skin reactions around the a b u tm en t 
am ong  patients in w hom  the linear incision techn ique  was used. No 
correlations w ere found be tw een  the d is tance  from the superior part o f the 
bony external auditory ea r ca n a l to the im plan t nor be tw een  the horizontal 
and  vertica l positions o f the im plan t on the one hand and the type  and 
num ber o f skin reactions and  im plan t loss on the other. This means tha t from 
a m ed ica l point o f v iew  the surgeon's ch o ice  o f im p lan t loca tion  is not 
critica l. However, o ther factors m ight be  o f im po rtance . For instance, 
aud io lo g ica l factors (most sensitive d irection o f the m icrophone) cou ld  
a ffe c t the d ev ice . So cou ld  the d is tance be tw een  the im p lan t and  pinna, 
as the surgeon seeks to avo id  touch ing  the pinna with the transducer. In 
case o f anotia  or m icrotia  o f the p inna, the d is tance to a foreseen 
reconstructed  auric le  should be  a c c e p ta b le . A rigid a d he re n ce  to the rule 
o f 55 mm from the ea r ca n a l m ay therefore be  not necessary. In patients 
w ith a th ick sca lp  or th ick soft tissues, the  surgeon m ay custom ize the 
loca tion  to  the pa tien t, keeping the c lin ica l factors m entioned a b o v e  in 
m ind. The ra te  o f im plan t loss reported  in this ch a p te r is even lower than th a t 
described in the literature and  in the p reced ing  chapters. Nevertheless, the 
inc idence  o f severe skin reactions found in this study is in line w ith tha t 
reported  in previous studies.
Pa t ie n t  o u t c o m e  m e a s u r e s
The second part o f this thesis deals w ith ano the r im portan t o u tco m e  of this 
trea tm ent, nam ely sub jective  benefit or the patients ' own v iew  of changes 
in their qua lity  o f life. In recent years, the patients' op in ion has b e co m e  
more cen tra l to trea tm en t eva lua tion  and  m ay be  said to be  a va lua b le  
supplem ent to the a u d io log ica l outcom es.
In C hap te r 3.1, the IOI-HA questionnaire is used to eva lua te  the ou tcom es of 
BAHA-related benefit for adu lt subgroups o f various ages. The IOI-HA 
showed tha t a lm ost all users a p p re c ia te d  their BAHA d ev ice . The age- 
re la ted  sensorineural hearing loss co m p on e n t was p robab ly  the main fa c to r 
in the decreasing app rec ia tion  w ith increasing age . Patients in all a g e  
brackets w ere  c a p a b le  o f handling and  p lac ing  the BAHA. Interestingly, the 
youngest a g e  g roup reported  m ore d ifficu lty w ith c lean ing  the skin around
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the im plant. This supports the assumption tha t o lde r BAHA users are more 
c a p a b le  o f using and  taking ca re  o f the  im plan t and  the BAHA than 
younger, adu lt users. The standard BAHA is benefic ia l in the various dom ains 
to  patients w ho  have  co n d u c tive  or m ixed hearing loss w ith a m odera te  
sensorineural hearing loss co m p on e n t o f up to  40 dB.
C hap te r 3.2 eva luates the e ffe c t o f BAHA fitting on the da ily  pe rfo rm ance  
o f children with e ither unilateral or b ila tera l co n d u c tive  hearing loss. Several 
questionnaires w ere  used. In genera l, the ch ildren with b ila tera l co n d u c tive  
hearing loss derived significant bene fit from the BAHA in eve ryday situations. 
However, a residual disability was seen co m p a re d  to normal hearing 
children. Our findings are in ag reem en t w ith  those in o ther ped ia tric  BAHA 
publications. M oreover, the GCBI, w hich measures the ch a n g e  in health- 
re la ted  quality  o f life w ith respect to  the pre-im plant situation, revea led  a 
genera l benefit o f BAHA use in this group, particu larly on the 'learn ing ' sub 
dom ain . This underscores the im p a c t o f the BAHA on educa tion . The APHAB 
questionnaire, assessing aud ito ry function ing  in da ily  life, showed some 
benefit in listening conditions with backg round  noise. This m ay explain the 
positive e ffe c t on learning in these children. Younger a g e  a t the tim e of 
BAHA fitting was co rre la ted  w ith h igher scores on the GCBI, w hich 
emphasizes the need for early BAHA fitting in ch ildren with b ila tera l hearing 
loss. This PhD thesis supports the consensus tha t children w ith bila tera l 
c o n d u c tive  hearing loss derive g rea t bene fit from the BAHA.
Children with unilateral co n du c tive  hearing loss reported  tha t the BAHA was 
w orth the e ffort in genera l. However, they d id  not seem to  be  using the 
BAHA all day. Some responded tha t they only used the BAHA in the 
classroom; behavio r tha t has also been reported in o ther studies.21 As in the 
b ila tera lly hearing im paired children, the subjects scored highest on the 
'lea rn ing ‘ subdom ain. It can  be  co n c lu d e d  tha t for these children, the 
BAHA m ight be  specifica lly  benefic ia l in school. This study also shows that 
not all children with unilateral co n d u c tive  hearing loss had positive scores. It 
goes on to em phasize the im po rtance  o f perform ing a substantial trial of 
several weeks w ith a head  ba nd  to  assess w he the r a ch ild  will benefit from a 
BAHA, includ ing the use a t hom e and  a t school. It should be  realized tha t it 
is d ifficu lt to assess the bene fit from a trial with a BAHA on a h e a d b a n d . The 
use o f structured questionnaires like the APHAB m ight be  o f va lue. Only a 
few  children derived  significant overall benefit from the BAHA, a cco rd in g  to 
the disability-specific APHAB questionnaire. The relative ly positive results of 
the BAHA for these children w ere found for the subdom ains 'reve rbe ra ted  
rooms' and  'ba ckg ro u n d  noise‘ . This m ight be  due  to a lifting o f the head 
shadow  by the Baha. Especially the ch ild  w ith congen ita l unilateral 
c o n d u c tive  hearing loss m ight bene fit from  (semi) im p lan tab le -m idd le  ear
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im plants in the very near future. When a BAHA is app lied , the con tra la te ra l 
ea r is stim ulated as well, ow ing to the inev itab le  cross stimulation. In 
contrast, m idd le -ea r implants stim ulate only the im p lan ted  ear.
C hap te r 3.3 concen tra tes  on the bene fic ia l e ffe c t o f the BAHA in o lder 
adults (60+) by measuring certa in  quality-o f-life  aspects (remaining disability, 
rem aining han d ica p , benefit, and  satisfaction) by means o f questionnaires. 
Almost all patients w ere using their BAHA on a da ily  basis, and  most o f the 
patients d id  not have  any d ifficu lty handling the BAHA or c lean ing  the skin 
around the im plant. Overall, these results ind ica ted  tha t the BAHA was 
function ing  e ffective ly . The subjects experienced  some benefit, particu larly 
regard ing ease o f com m un ica tion . This ind icates tha t the BAHA enables 
g o od  pe rfo rm ance  in com m un ica tion  with others. In reverberant conditions 
and  situations with backg round  noise, however, the patients reported  less 
favo ra b le  results. One exp lanation  m ay be  tha t the majority had been fitted  
w ith only one BAHA. Secondly, all o f these patients had a significant 
sensorineural hearing loss com ponen t. Listening w ith b ila tera l BAHAs m ight 
be  o f specific  va lue  under these conditions and should therefore be 
considered. Almost 80% o f the subjects had a mild level o f residual 
h a n d ica p  (HHIE-S questionnaire). A trend was obvious: w ith increasing 
sensorineural hearing loss, the severity o f the rem aining h a n d ica p  also 
increased. When the sensorineural hearing loss co m p on e n t was severe, the 
benefit was lim ited, illustrating the lim itations o f BAHA for such patients.
In summary, this thesis shows tha t the linear incision techn ique  has the 
longest fo llow -up eva lua tion  and  shows, in the first years g o o d  c lin ica l 
ou tcom e. It is a safe, simplified surgical p rocedure . Children are more a t risk 
o f im p lan t loss and  skin reactions, irrespective o f w hich surgical techn ique  is 
used. The p lace m e n t o f a ‘sleeper' im plan t is advised and  more research is 
needed  into the p red ic ting  factors for im plan t loss in ch ildren. In add ition , 
research should focus on the process of osseointegration, especia lly in 
children. In the o lde r adult, specia l a tten tion  should be  given to the process 
o f w ound  healing.
Assessment quality  o f life and  benefit reveals that the BAHA is well 
a p p re c ia te d  and  e ffec tive . It has been shown tha t the patients ' satisfaction 
is a ffe c te d  by the sensorineural hearing loss co m p o n e n t ra ther than by age . 
This thesis also shows tha t the BAHA is bene fic ia l to children with bila tera l 
c o n d u c tive  hearing loss. Subjective evaluations o f ch ildren with unilateral 
c o n d u c tive  hearing loss showed va riab le  results. In these ch ildren, the 
decision to  use a BAHA should be  m ade  on an ind ividual basis. Overall, the 
BAHA was ra ted  as particu larly benefic ia l in e d uca tio n a l settings, w hich 
m ay be  largely due  to the reported  benefit o f speech recogn ition  in noisy 
surroundings.
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Summary /  samenvatting
The bone  -ancho red  hearing a id  (BAHA) is the  go ld  standard  for hearing 
rehab ilita tion  am ong  patients w ith significant b ila tera l co n d u c tive  hearing 
loss, m ixed hearing loss, unilateral co n d u c tive  hearing loss, or single-sided 
deafness. The BAHA system comprises an im plan t tha t is surgically p la ce d  in 
the tem pora l bone; a skin-penetrating a bu tm en t is a ffixed to  the  im plant 
and  an aud io  processor is co u p le d  to  this abu tm en t. Today, there are three 
genera lly com m on ly  a c c e p te d  surgical procedures for m ounting this 
dev ice : the  d e rm a tom e  techn ique , the  p e d ic led  flap  techn ique , an d  the 
linear incision techn ique . This thesis includes an eva lua tion  o f the long-term  
c lin ica l ou tcom es o f the  latter, w h ich  was d e ve lo p ed  in N ijmegen.
In C hap te r 2.1 a consecu tive  series o f 150 im plants in 142 patients was 
eva lua ted . The results, in terms o f im plan t failure and  adverse tissue 
reactions, w ere  co m p a ra b le  w ith those published in the literature. Therefore, 
it was co n c lu d e d  tha t the  linear incision te chn ique  can  be  considered a 
g o o d  a lte rna tive  to  the o ther techniques.
BAHA a p p lica tio n  in children addresses d iffe rent issues than in adults. The 
younger popu la tion  is known to  have m ore im m ature  and  th inner bone  and  
m ore risk o f tissue overgrow th , w hile skin c lean ing  problem s ten d  to  o ccu r in 
ado lescence . In C hap te r 2.2 the linear incision techn ique  was e va lu a te d  for 
children (93, 129 implants) o p e ra te d  on by this tech n iq ue  until July 2007. This 
study shows tha t their im plan t loss was m ore frequent than in the  adults. 
Im plant loss occurs mainly in the first yea r a fte r surgery, suggesting an 
incom p le te  osseointegration. The a g e  o f the child  and  the type  o f im plant 
d id  not co rre la te  w ith im plan t loss. Children are p robab ly  in need to 
undergo frequent check-ups a t the ou tp a tie n t clin ic. M ore research is 
needed  on osseointegration in children.
In C ha p te r 2.3, the  ou tcom es for 224 o lde r adu lt BAHA users, w ith  248 BAHA 
devices im p lan ted  by the  linear incision tech n iqu e  w ere  e va lua ted . This 
study showed tha t the ra te  o f im plan t loss was similar to  tha t in the  overall 
BAHA popu la tion  and the in c id e n ce  o f severe skin reactions was relatively 
low. There was less risk o f deve lop ing  hypertroph ic  skin around the  im plant, 
but a slightly increased te n d e ncy  tow ards postopera tive  w ound  healing 
problem s was observed. Therefore it is advised to  pay extra a tten tion  to  the 
skin during the  postopera tive  checkups.
In C hap te r 2.4, the  e ffe c t o f im plan t loca tion  and skin thickness on the 
frequency and  degree  o f adverse skin reactions around the  ab u tm en t was 
e va lu a ted  in a random  sam ple o f 248 BAHA users. This study showed tha t 
im plan t loca tion  and  skin thickness had no relation to  the frequency and 
severity o f skin reactions around the percutaneous abu tm en t.
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In recent years, pa tien t op in ion has b e co m e  m ore cen tra l in trea tm en t 
eva lua tion. Particularly the  pa tien ts ’ opin ion on their experienced  benefit 
and  quality  o f life are now  considered an im portan t aspect o f trea tm en t 
ou tcom e. This thesis presents three pa tien t op in ion studies eva lua ting  the 
BAHA using several va lid a te d  questionnaires in distinct populations.
In C hap te r 3.1, 135 experienced  users o f the  standard  BAHA C o m p a c t w ho  
have co n d u c tive  or m ixed hearing loss w ith an sensory neural hearing loss 
(SNHL) co m p o n e n t be tw een  0 and  44 dB w ere  asked to  e va lua te  the BAHA 
by means o f the  In ternational O u tcom e  Inventory-Hearing Aid (IOI-HA). Of 
particu la r interest w ere  the  questions o f a ge -re la ted  use and  satisfaction. It 
was shown tha t the BAHA C o m p a c t enhances partic ipa tion  in various 
dom ains o f com m un ica tion . D ifferences in the  patients' satisfaction seem ed 
to  be co rre la ted  w ith their SNHL co m p on e n t ra ther than w ith their age.
In the next ch a p te r (3.2), the eva lua tion  focused on 31 children with 
unilateral co n d u c tive  hearing loss or b ila tera l co n du c tive  hearing loss. The 
G lasgow C hild ren ’s Benefit Inventory (GCBI), the A bb rev ia ted  Profile of 
Hearing Aid Benefit (APHAB), and  the Health Utility Index Mark 3 (HUI3) w ere  
used to  assess d isease-specific benefit and  genera l quality  o f life. This study 
shows tha t the  BAHA is bene fic ia l to  children w ith b ila tera l co n d u c tive  
hearing loss. The results o f the evaluations o f children w ith unilateral 
co n d u c tive  hearing loss w ere  less stra ightforward. The decision to  use a 
BAHA in these children should be m a de  on an ind iv idual basis a fte r a longer 
trial period, a llow ing the  child  to  try out the BAHA in a varie ty o f settings. In 
this subgroup, the BAHA was particu larly bene fic ia l to  a c h ild ’s schooling, 
w h ich  m ay be largely due  to  its bene fic ia l e ffects in noisy surroundings. 
C hap te r 3.3 deals w ith benefits and  quality  o f life for the  o lder adu lt BAHA 
popu la tion . O ne hundred and  th irty-four o lder adu lt BAHA users w ere  
e va lu a ted  by means o f four questionnaires (G lasgow Benefit Inventory 
(GBI), A bb rev ia ted  Profile o f Hearing a id  Benefit (APHAB), N ijm egen 
C och lea r Im plant Questionnaire (NCIQ), and  the Hearing H and icap  
Inventory for the  Elderly - screening version (HHIE-S)). On the  ave rage , they 
w ere  ab le  to  p la ce  and  hand le  the d e v ice  a d e q u a te ly  and  c lean  the skin 
around the im plan t e ffective ly. Most patients reported  a co m p a ra b le  or 
increased genera l benefit and  a go od  quality  o f life w ith the BAHA.
In conclusion, this PhD thesis shows tha t the  linear incision te chn ique  is a 
g o o d  a lte rna tive  to  o ther BAHA im p lan ta tion  techniques. Now adays, the 
linear incision techn ique  is w ide ly  app lied  and  recognized as an established 
trea tm ent. In ag reem en t w ith previous studies, the  present d a ta  show high 
pa tien t co m p liance , satisfaction, and  a genera l sense o f well being am ong 
the BAHA users
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Het bo t verankerd hoortoestel (BAHA) is de  gouden  standaard  voo r de  
reva lida tie  van pa tiën ten  m et een significant b ila te raa l co n d u c tie f 
gehoorverlies, g e m en g d  gehoorverlies, eenzijdig co n d u c tie f gehoorverlies 
en enkelzijd ige doo fhe id . Het BAHA-systeem bestaa t uit een im p lan taa t d a t 
op era tie f w ord t gep laa ts t in het tem pora le  bo t m et d a a ro p  een ab u tm en t 
w a a ro p  de  BAHA processor gep laa ts t kan w orden . De drie chirurgische 
techn ieken, d ie  hier het meest voor gebru ikt w orden  zijn d e  de rm a toom  
techn iek, de  gestee lde  flap -techn iek  en d e  lineaire incisie techn iek. De 
laatste techn iek is d o o r N ijmegen ontw ikkeld. Dit proefschrift eva lueert 
onde r andere  d e  klinische lange termijn resultaten van deze techn iek. In 
hoofdstuk 2.1 w erd  een o p e e n vo lg e n d e  reeks van 150 im p lan ta ten  (142 
pa tiën ten) geëva lueerd . De resultaten, inc identie  van uitval van het 
im p la n taa t en ongunstige weefselreacties, zijn ve rge lijkbaar m et de  
literatuur. Om d ie  reden kan de  lineaire incisie techn iek een go ed  
a lte rna tie f zijn voo r de  andere  techn ieken.
BAHA toepassing bij kinderen be tre ft een ande re  p rob lem atiek dan bij 
volwassenen. Van jongere  kinderen is bekend d a t zij m inder vo lg roe id  en 
dunner bo t hebben  en d a t er m eer risico o p  weefsel overgroei is. In de  
ado lescentie  kan juist het schoonm aken van d e  huid rondom  het 
im p la n taa t een probleem  zijn.
In hoofdstuk 2.2 w erd  d e  lineaire incisie techn iek  geëva lueerd  voor 93 
kinderen (129 im p lan ta ten) ge ïm p lan teerd  m et deze techn iek. Deze studie 
toon t aan d a t im plantaatverlies vaker voorkom t bij kinderen dan bij 
volwassenen. Het verlies van een im p lan ta a t treed t voornam elijk  o p  in het 
eerste ja a r na im p lan ta tie . M ogelijk is incom p le te  osseointegratie (ingroei in 
het bot) hier de  oorzaak van. De leeftijd van het kind en d e  leng te  van het 
im p la n taa t lijken de  stabilite it van het im p la n ta a t niet te  beïnvloeden. Een 
vervolgstudie d ie  zich specifiek richt o p  de  osseointegratie bij kinderen is 
nodig om dit ve rder te onderzoeken.
In hoofdstuk 2.3 w erden  224 oudere  BAHA gebruikers (248 BAHA 
im p lan ta ten) geëva lueerd . Alle im p lan ta ten  w erden  gep laa ts t m et de  
lineaire incisie techniek. Deze studie to o n d e  aan  d a t het p e rcen ta g e  
verloren im p lan ta ten  bij ouderen gelijk is aan d a t bij de  g e m id d e ld e  BAHA 
popu la tie . De inc iden tie  van ernstige huidreacties was laag. Bovendien was 
er m inder risico op  het ontw ikkelen van hypertrofische huid rond het 
im p lan taa t. w e l w erd  er een licht ve rh oog de  neiging to t postopera tieve  
w ondgenezingsprob lem en w aa rg enom en . Derhalve w erd  geadviseerd  hier 
extra a a n d a c h t aan  te blijven besteden in de  postopera tieve  periode.
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In hoofdstuk 2.4 w erd  het e ffe c t van d e  im p la n ta a tlo ca tie  en d ikte van de  
huid op  de  frequentie  en de  m ate  van huidirritatie rond het pe rcu tane  
abu tm en t geëva lueerd  in een ase lecte  steekproef van 248 BAHA 
gebruikers. Deze studie to o n d e  aan  d a t de  loca tie  van het im p la n ta a t en 
de  d ikte  van d e  huid geen re latie  hadden  m et de  frequentie  en ernst van 
hu idreacties rond het p e rcu tane  abu tm en t.
In de  a fge lope n  jaren, is de  m ening van de  pa tiën t steeds m eer cen traa l 
komen te  staan in de  eva lua tie  van behande lingen . M et nam e de  m ening 
van d e  pa tiën t over het ervaren nut en de  kwalite it van leven w orden  
tegenw oord ig  gezien als een belangrijk onderdee l. Dit proefschrift beschrijft 
de  m eningen van drie pa tiën teng roepen  ter eva lua tie  van de  BAHA, met 
behu lp  van verschillende g e va lide e rde  vragenlijsten.
In hoofdstuk 3.1, w erden  135 ervaren BAHA C o m p a c t gebruikers, m et een 
geleidings- o f gem engd  gehoorverlies g e v ra a g d  om de  BAHA te  evalueren 
d o o r m idde l van het In ternational O u tcom e  Inventory for hearing aids (IOI- 
HA). M et nam e het leeftijd ge re la tee rde  gebru ik en de  tevredenhe id  van 
de  pa tiën t w erden  geëva lueerd . Deze studie to o n d e  aan  d a t de  BAHA 
C o m p a c t de  p a rtic ipa tie  in diverse dom einen  van de  co m m un ica tie  
versterkt. Verschillen in pa tiën ttevredenhe id  lijken eerder te  zijn gecorre leerd  
m et de  g roo tte  van de  pe rcep tie ve  co m p on e n t in het gehoorverlies dan  
m et d e  leeftijd.
In het vo lgen de  hoofdstuk (3.2), w erden  31 kinderen m et een unila teraal en 
b ila te raa l gele idingsgehoorverlies ge v raa g d  hun BAHA te  evalueren. De 
G lasgow Children's Benefit Inventory (GCBI), A bb rev ia ted  Profile o f Hearing 
Aid Benefit (APHAB) en de  Health Utility Index Mark 3 (HUI-3) w erden  
gebruikt om  het profijt m et betrekking to t gehoorverlies en de  a lgem ene  
kwalite it van leven te  beoorde len . Deze studie toon t aan d a t m et nam e 
kinderen m et een b ila te raa l geleidingsverlies profiteren van de  BAHA. Het 
profijt van de  BAHA bij kinderen m et een un ila teraal geleidingsverlies liep 
m eer uiteen. Bij deze kinderen zal het besluit om  al dan niet de  BAHA toe  te 
passen op  ind iv idue le  basis genom en m oeten w orden . Het d ragen  van een 
BAHA o p  een tes tho o fdband  ge du rende  een langere p roe fpe riode  kan 
hierbij behu lpzaam  zijn. Zodoende  kunnen verschillende situaties getest 
w orden . Over het a lgem een  was de  BAHA bijzonder gunstig voor de  
schoo lgang  van een kind. Dit is gro tendeels te  danken aan  de  gunstige 
e ffec ten  in een rum oerige om geving .
Hoofdstuk 3.3 g a a t over het profijt van de  BAHA en de  ervaren kwalite it van 
leven van 134 oudere  BAHA gebruikers. Zij beoo rdee lden  hun BAHA do or 
m idde l van vier vragenlijsten; de  G lasgow Benefit Inventory (GBI),
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A b brev ia ted  Profile o f Hearing Aid Benefit (APHAB), N ijm egen C och le a r 
Im plant Questionnaire (NCIQ) en d e  Hearing H and icap  Inventory for the 
Elderly screening version (HHIE-S). G em idde ld  genom en w aren ze g o e d  in 
staat de  BAHA te  p laatsen, te  hanteren en d e  huid rond het im p la n ta a t te 
onderhouden . De meeste pa tiën ten  verm e ldden  een verge lijkbaar o f hoger 
a lgem een profijt en een g o e d e  kwaliteit van leven m et de  BAHA te 
ervaren.
C onc luderend  laat d it proefschrift zien d a t de  lineaire incisie techn iek een 
g o e d  a lte rna tie f is voor ande re  BAHA im p lan ta tie techn ieken . Inmiddels 
w ord t deze techn iek derha lve  o p  g ro te  schaal toegepast. u it dit proefschrift 
blijkt, in overeenstem m ing m et eerdere  studies, d a t er een hoge  
therap ie trouw , tevredenhe id  en een a lgem een  gevoe l van welzijn bij BAHA 
gebruikers bestaat.
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O nderzoek d o e n  is ge lukk ig  n ie t b e p a a ld  een  solitair tra je c t, zeker n ie t 
als je  in d e  g e lu kk ige  positie  b e n t om  in een  reeds rijd e n d e  trein je  
s teen tje  bij te  d ra g e n . V e le  m ensen h e b b e n  ee n  rol g e spe e ld  in d it 5e 
BAHA p ro m o tie tra je c t en d e  to ts ta n d ko m in g  van  d it p roefschrift. Enkelen 
wil ik h ier m e t n a m e  no em en .
Beste Professor Crem ers, al ve le  ja ren  vo o r a a n v a n g  van  d it 
p ro m o tie tra je c t w as “ d o k te r C rem ers” , en “ d e  KNO in N ijm e g e n ” een  
b e g rip  in Huize d e  W olf. Toen had  ik n ie t kunnen w e te n  d a t er een  
p re ttig e , e ffic ië n te  en  v ru c h tb a re  sam enw erk ing  zou vo lg e n . G ra a g  w il ik 
u b e d a n k e n  vo o r uw  to m e loze  inzet en  grenze loze m oge lijkhe id  om  ove r 
a lle  fa c e tte n  van  he t “ o n d e rzo e ke n ” te  p ra te n . W onderlijk  hoe  
b e sch ikb a a r u ondanks uw  d rukke p ro g ra m m a  h e e ft kunnen zijn. M e t 
n a m e  w il ik re fe reren  a a n  d e  laa ts te  KNO ve rg a d e rin g . Toen b leek  d a t er 
g e e n  o to lo o g  a a nw e z ig  kon zijn om  mijn v o o rd ra c h t bij te  w o n e n , h e b t u 
uw  a g e n d a  a a n g e p a s t en  b e n t u sp e c ia a l o p  en neer g e re d e n . M e t u 
kan m en w e l een  b o e k je  schrijven!!
Professor Snik, beste  A d , vo o r a u d io lo g isch e  p ro b le m en , m a a r voo ra l ook 
‘kw a lite it va n  le v e n ’ v raagstukken  kon ik g e re g e ld  en  o n g e lim ite e rd  bij je  
te re ch t. Je in te g e re  en  g e d re v e n  w erkw ijze  w a a rb ij d e  mens a c h te r  d e  
onde rzoeke r n ie t o n g e m o e id  w o rd t g e la te n  m a a k t g ro te  indruk. B edankt 
vo o r d e  p re ttig e  sam enw erk ing .
D okter Hol, beste  M yrthe, jij b e n t d e  v e rb in d e n d e  fa c to r  g e w e e s t d o o r 
he t g e h e le  p ro je c t heen. Je h e b t a lle  stukken in ra p  te m p o  kunnen 
voorzien van  d e  n o d ig e  en zeer n u ttig e  co rrec ties  en  suggesties. Zo 
h e b b e n  w e  re g e lm a tig  to t la a t bij jou  a a n  d e  e e tta fe l stukken besproken  
o n d e r he t g e n o t va n  een  bruin b ie rtje . Ik ben  o n d e r d e  indruk va n  hoe  je  
je  w erk  en  privé  kunt c o m b in e re n . D at m a a k t d a t ik zow el o p  o to lo g ie  
g e b ie d  als d a a rb u ite n  vee l va n  je  h o o p  te  leren.
D okter M ylanus, beste  Em m anuel, o ve rle g g e n  m e t jou  h e e ft a ltijd  een  
b e p a a ld e  flair; v a a k  haastig  lo p e n d  kom  je  a a n , druk als a ltijd . Toch ben 
je  ook  a ltijd  in s ta a t en thous iasm e vo o r on de rzoek ove r te  b reng en , 
sch e rpe  kritische o p m e rk in ge n  te  m aken  en  d e  soc ia le  kan t va n  he t 
leven te  b e na d ru kke n  om  vervo lgens w e e r d o o r te  rennen  n a a r d e  
v o lg e n d e  a fsp raak. Ik w il je  b e d a n k e n  d a t ook  jij je  h e b t w illen  ve rb in d e n  
a a n  d it p roefschrift.
G e a c h te  leden  van  d e  m anuscrip tcom issie , b e d a n k t vo o r d e  v lo tte  
b e o o rd e lin g  van  d it p roefschrift.
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Beste Patrick H uygen, b e d a n k t vo o r je  inzet bij hoo fdstukken  2,1 en 2,2 
m e t n a m e  be trekk ing  h e b b e n d  o p  he t statistische g e d e e lte .
Beste Hubert, je  h e b t een  g ro te  b ijd ra g e  g e le ve rd  a a n  hoofdstuk 2.4 in 
d it boek, b e d a n k t. O n langs ben  je  a a n g e n o m e n  vo o r d e  o p le id in g  to t 
KNO-arts en is d e  basis g e le g d  vo o r jo u w  BAHA p ro m o tie tra je c t. Ik kijk uit 
n a a r ee n  p re ttig e  sam enw erk ing  en he t slaan va n  e n ke le  balle tjes.
Beste Jo o p  Leijendeckers, jij h e b t he t fu n d a m e n t g e le g d  vo o r hoofdstuk 
3,1. O nze sam enw erk ing  ve rlie p  a ltijd  b u ite n g e w o o n  p re ttig , b e d a n k t 
vo o r al je  inpu t.
Beste M y-linh Shival, b e d a n k t vo o r jo u w  a a n d e e l in een  n a u w g e ze tte  
ana lyse  va n  kw a lite it va n  leven va n  d e  o u d e re  BAHA gebru ike r, b e d a n k t 
vo o r je  inzet vo o r hoofdstuk 3,2.
Beste Ja co lie n  Dun, als “ o p v o lg e n d e ” BAHA p ro m oven dus  ben  je  m e t 
o v e rg a v e  b e g o n n e n  m e t h e t o p ze tte n  va n  je  e ig e n  p ro je c te n . 
D aarnaast h e b  je  mij vee l w erk  uit h a n d e n  g e n o m e n  tijdens d e  b e k e n d e  
laa ts te  loodjes. Dit en  ve le  a n d e re  g o e d e  e ig e n s c h a p p e n  m aken  je  een  
fijne c o lle g a  om  m e e  te  w erken . O nze K N O -co lle g a ’s in G ron ingen  zullen 
blij m e t je  zijn. B edankt vo o r je  be tro kken h e id  o p  ve le  v lakken.
BAHA p a tië n te n , zo n d e r ju llie  zou d it p roe fschrift natuurlijk  n ie t m oge lijk  
zijn g ew eest. B edankt vo o r he t invu llen va n  d e  vragen lijs ten , m e t soms 
zo ’ n 150 v ra g e n  is d a t n ie t ge ring . Toch w as he t n ie t ongebru ike lijk  om  
een  fo rm u lie r te rug  te  krijgen vo l m e t o p - en  a a nm e rk in g e n . Het is zeer 
m o tive re n d  om  te  zien hoe  g e d re v e n  en  be trokken  m ensen kunnen zijn.
Beste m edew erkers  va n  he t Volwassen A ud io log isch  C en trum  en m e t 
n a m e  M ieki en  Teja. Elke keer d a t ik he t VAC  o p lo o p  heerst e r een  
p re ttig e  en  g e m o e d e lijk e  sfeer. N oo it is h e t e e n  p ro b le e m  om  d e  
n ieuw ste  w ee tjes  o ve r d e  BAHA uit te  w isselen. Jullie zijn een  
voortre ffe lijke  v ra a g b a a k  g ew ees t, b e d a n k t.
Beste C arine  Hendriks, ve rscho len  a c h te r  d e  ka m e rp la n te n  g a a t iets 
w a a rd e vo ls  schuil. De B A H A -da tabase  d ie  j i j b e h e e r t  vo rm t he t 
u itg an g sp u n t vo o r he t m e ren d e e l va n  d e  BAHA onde rzo eken  in d it 
proefschrift. B edankt vo o r d e  p re ttig e  sam enw erk ing .
Beste Niels va n  Druten, b e d a n k t vo o r je  b e trokken he id  bij d it p roe fschrift 
en je  b e re id h e id  d a a r  w a a r  je  kon onde rs teun ing  te  b ie d e n . V ee l succes 
m e t je  ve rd e re  ca rriè re  in Londen.
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Beste secretaresses, ve rp le g in g , ba lie - en a rch ie fm ede w erke rs , b e d a n k t 
vo o r d e  p re ttig e  w erksfeer o p  d e  poli, he t K inder A ud io lo g isch  C entrum , 
he t Volwassen A ud io log isch  C en trum , d e  OK, d e  a fd e lin g  en  d e  poli.
Beste Jud ith  Abm a-H ill, b e d a n k t vo o r je  inzet m e t be trekk ing  to t d e  
co rrec ties  va n  mijn Engels gestun te l. Je ge reg isseerde  stukken g e ve n  he t 
fe n o m e e n  puzzelen een  g e h e e l n ieuw e  d im ensie. Toch g in g e n  d e  
ve rb e te rin g e n  vee la l ve rd e r d a n  a llee n  d e  ty p o ’s, b e d a n k t v o o r je  
n a u w g e ze th e id .
Beste Diny Helsper, b e d a n k t vo o r je  kw a lite itscon tro le  in d e  laa ts te  fase 
van  h e t to t s tand  kom en  va n  d it p roefschrift.
Beste Thomas en  R inaldo, als te c h n e u te n  va n  h e t a a n g re n ze n d  M o n d ­
Kaak- en A a n g e z ich t ch irurg isch spec ia lism e zijn ju llie  vee l bezig m e t 3D 
b e e ld vo rm in g . M e d e  d o o r ju llie  inzet en  m e e d e n ke n  is er een  m o o ie  ka ft 
om  d it b o e k je  g e ko m e n , b e d a n k t.
V oor he t m e re n d e e l va n  d e  m ed isch e  prom oties g e ld t d a t d it in he t 
ka d e r van  een  o p le id in g s tra je c t ve rrich t w o rd t. Ik ben  d e  sta f van  d e  
KNO in he t R adboud , m e t n a m e  Professor Marres, d a n k b a a r d a t er in d e  
o p le id in g  ru im te  is vo o r w e te n sch a p p e lijke  o n tp lo o iin g .
Beste m a a tsch a p s le d e n  en  po lidam es in he t Rijnstate ziekenhuis. De 
laa ts te  lood jes va n  d it p ro m o tie tra je c t va llen  in he t pe rife re  d e e l van  
mijn o p le id in g . B edankt vo o r een  b u ite n g e w o o n  leuke en lee rzam e tijd. 
M e t n a m e  wil ik dr. Stengs b e d a n k e n  v o o r he t kennen  van  d e  m azen in 
he t CT w e b .
M isschien w e l he t be langrijks te  in een  w e rke n d  leven is een  g o e d e  w e rk ­
sfeer en leuke c o lle g a ’s. D at d it g e re g e ld  resu lteert in een  borrel in 
‘A n n e k e ’ , m a a k t h e t h e le m a a l a f. Beste KNO-assistenten, A m ic i, 
c o lle g a e , ju llie  zijn een  fijne c lub .
Beste Sylvia, ik v ind  he t heel b ijzonder d a t j i j a l s  ‘o u d  BAHA 
p ro m o ve n d u s ’ nu mij als p a ra n im f w il b ijs taan tijdens mijn ve rd e d ig in g .
Dispuut; Heeren van  he t g o e d e  leven, w e e r een  b o ek je  d a t o p  d e  p lank  
in “ d e  g ro t” b ijgeze t kan w o rd e n . Broeders, b e d a n k t vo o r a lle  interesse.
C lub; e inde lijk  is he t d a n  zo ver, he t b o e k je  is er. Inhoude lijk  h e b b e n  ju llie  
n ie t vee l b ijg e d ra g e n  a a n  d eze  p rom o tie , m a a r ju llie  w a re n  een  
w e lko m e  on d e rb re k in g  in he t w esten  va n  h e t land .
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Lieve Pien; jij h e b t he t o v e rg ro te  d e e l va n  d it p ro m o tie p ro je c t van  
d ich tb ij m e e g e m a a k t en  je  h e b t m e  a ltijd  o n vo o rw a a rd e lijk  ges teund . Je 
v e rm o g e n  om  zaken ne t in een  a n d e r d a g lic h t te  stellen zijn ve le  keren 
een  e y e o p e n e r gew ee s t. De tijd m e t jou  sam en is m e  nog  steeds zeer 
d ie rb a a r.
Lieve Loes, d a t w e  a lle b e i arts zijn is n ie t h e t e n ig e  w a t w e  q u a  w erk  
g e m e e n  h e b b e n . O ok jij c o m b in e e rt je  o p le id in g  m e t e e n  p ro m o tie - 
tra je c t. Ik h e b  b e w o n d e rin g  vo o r je  g e d u ld , rust, to e w ijd in g  en 
b e trokkenh e id  in d e  d in g e n  d ie  je  d o e t. Dit zal je  la te r als huisarts nog 
g o e d  va n  pas kom en.
Lieve A d riaan , fe ite lijk  sta jij a a n  d e  basis va n  d it b o e k je  en  mijn ve rd e re  
o p le id in g  to t KNO-arts. Zonder jou  w as ik h ier nu n ie t gew ees t. Ik ben  
o n tze tte n d  trots d a t jij ondanks je  gehoorverlies  zo ’ n fijn en  uiterst soc iaa l 
persoon b e n t g e w o rd e n . Je rol als p a ra n im f en b e re id h e id  te  poseren 
vo o r d e  ka ft va n  mijn p roe fschrift g e v e n  mijn p ro m o tie  ee n  extra  
persoonlijke d im ensie.
Lieve Ouders, Lieve p a p a , sam en m e t jou  h e b  ik d e  eerste s ta p p e n  in d e  
w o n d e re  w e re ld  van  d e  w e te n s c h a p  gezet. Je h e b t m e  enthousiast 
g e k reg e n  vo o r he t d o e n  va n  onderzoek. D a a rd o o r had  ik ee n  v lie g e n d e  
start in N ijm egen. Lieve M am , jij w e e t als g e e n  a n d e r w a t ‘ lezen ’ vo o r 
een  p lek b i j m i j h e e f t  in g e n o m e n . Je h e b t m e  letterlijk d o o r m eters 
bo eke n  heen  g e h o lp e n . D oor al jo u w  inzet in m ijn k inderjaren  w e e t ik nu 
d a t je  B om m el-d ing  b e te r kunt lezen als B om -m eld ing . Ik ben  je  heel erg 
d a n k b a a r d a t jij mijn do o rze ttin g sve rm og e n  d usdan ig  h e b t w e te n  te  
stim uleren d a t ik nu in d e  m ed isch e  voe tspo ren  van  p a p p a  kan treden . 
Lieve p a p , m am , Ik ben  ju llie  onge lo fe lijk  d a n k b a a r vo o r al ju llie  steun d ie  
h e e ft g e le id  to t w a a r  ik nu sta en w ie  ik nu ben.
Joanneke , lieverd , he t b e g in  va n  ons leven sam en s ta a t g e m a rke e rd  
d o o r onze prom oties. Ik v ind  he t zeer b ijzonder d a t w ij zij a a n  zij n a a r 
deze  a fro n d in g  h e b b e n  kunnen w erken . Ik kijk uit n a a r ee n  ene rve re nd  
en ge lukk ig  rest va n  ons leven.
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